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Abstract 
Histone modifications form an important part of the epigenetic landscape that 
controls many aspects of cellular function, including regulation of gene expression 
and cell differentiation. The persistence and inheritance of many of these 
modifications through the cell cycle and differentiation are still unknown. Here, I 
show global epigenetic karyotypes of metaphase chromosomes labelled to 
highlight specific marks. Metaphase is transcriptionally inactive and so epigenetic 
marks here are not simply reflective of gene transcription. I found that histone 
marks such as H3K27me3 are inherited through differentiation, whereas others 
such as H4K20me3 have re-organised distributions. FISH analysis allowed the 
alignment of genetic features with H3K4me3 and H3K27me3 distributions, 
showing that these marks are correlated with increased gene density, revealing a 
deeply intertwined distribution in ES cells, indicating bivalency. 
Focusing on the Hoxa cluster using N-ChIP in ES cells allowed the analysis of 
histone modification prevalence at the single gene level in ES cells. Most histone 
modifications remain stable between G1/S phase and G2/M phase, although 
H3K9ac decreases in ES cells at G2/M. Results for bivalent modifications show 
permissive chromatin environments denoted by high H3K4me3 and low 
H3K27me3 methylation at gene promoters that are expressed soon after the onset 
of differentiation, denoting a predictive chromatin signature. This signature was 
altered after five days of differentiation, where H3K4me3 increases and 
H3K27me3 decreases at most Hoxa promoters, concomitant with the rise in 
expression of some Hoxa genes, displaying the dynamic properties necessary to 
represent a mechanism for control of transcription during differentiation.  
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1. INTRODUCTION 
1.1 THE CELL CYCLE 
1.1.1 The components of the eukaryotic cell cycle 
 
In eukaryotes, cell division is regulated by a series of proteins that prevent 
unregulated cell division and promote genome stability. This results in four 
discrete periods of time which a cell spends between one division and the next. G1 
(gap 1) phase starts after a parent cell has fissioned, and ends at the G1 restriction 
point, which is a checkpoint where a cascade of proteins prevent the cell from 
moving to the next phase of the cycle while assessing the extent of any DNA 
damage accrued by the cell since mitosis (Rossow et al., 1979, Branzei and 
Foiani, 2006). At this point, damaged or senescent cells can withdraw from the cell 
cycle and enter a quiescent state known as G0, characterised by the continuing 
metabolic activity but suspended reproductive capacity of the cell (Iwamoto et al., 
2008). The network of proteins provides a tightly regulated system that enables 
cell cycle progression. The balance between progression and inhibition is kept by 
proteins that respond to DNA damage and genome instability, and prevent the 
uncontrolled division of a cell (Di Leonardo et al., 1994, Khan et al., 2003). 
1.1.2  Genome integrity maintained by cell cycle checkpoints 
 
Checkpoints in mitosis have evolved to mitigate the accumulation of copying 
errors during DNA replication and also to prevent damaged DNA from being 
copied to a daughter cell (Kaufmann and Paules, 1996, Deckbar et al., 2011). In 
eukaryotes, cellular pathways are in place that detect any DNA errors or mutation, 
mediate the signal produced from these sensors, transduce the signal, and 
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instigate blockage of the cell cycle and DNA repair, and also effect alterations in 
gene expression (Navas et al., 1996, Sclafani and Holzen, 2007). These sensors 
are often closely linked to other cellular processes such as cell cycle regulation 
and DNA replication (Navas et al., 1996). CDK-Cyclin complexes are critical for 
the progression of the cell cycle. The four cyclins (A, B, D, E) associate with their 
respective CDKs (cyclin dependent kinases) to move cells through the G1/S block 
(Cyclins D and E, CDKs 4 and 2) and the G2/M block (Cyclins A and B, CDKs 2 
and 1) (Morgan, 1997, Choi and Anders, 2013, Dai et al., 2013). These CDK-
cyclin complexes are part of an intricate regulatory mechanism that enforces each 
checkpoint. 
1.1.3 The G1/S checkpoint 
 
At G1/S, cells make the decision whether or not to divide. If DNA is undamaged, 
accumulation of Cdc25A causes dephosphorylation of CDKs 2 and 4, which are 
complexed with cyclins E and D (Iavarone and Massague, 1997, Iwamoto et al., 
2008). These subsequently phosphorylate pRB (retinoblastoma protein), which 
dissociates from the E2F transcription factor. This protein activates transcription of 
itself, cyclin genes and S phase-specific genes that promote entry into S phase 
(Mudryj et al., 1991, Piao et al., 2011). However, upon DNA damage, cellular 
proteins act to disrupt the action of the CDK-Cyclin E complex to stall the cell’s 
passage into S phase (Branzei and Foiani, 2006). At this point, the DNA repair 
and cell cycle control mechanisms are intertwined, which indicates the critical 
importance of both these processes to the longevity of the cell.   
1.1.4 DNA replication during synthesis phase 
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After the G1 checkpoint, the nucleus begins to replicate its DNA. Thus begins the 
synthesis, or S, phase (Taylor, 1973).  The main function of S phase is to faithfully 
reproduce the genome in order to have enough genetic material for two daughter 
cells. The speed of cell growth and division is another carefully controlled facet of 
mammalian cells, and can vary greatly even between cells of the same organism. 
Embryonic stem cells (ESCs), for example, can be distinguished from 
differentiated cells from the length of their G1 phase (Arai et al., 2011, Ruiz et al., 
2011). Adult differentiated cells have a tightly regulated and effective G1 block, 
whereas in stem cells there is a less lengthy control on the passage from G1 into S 
phase, and so cells progress quickly into DNA synthesis. Figure 1.1 shows that a 
much larger proportion of an unsynchronised cell population are in G1 phase in 
differentiated cells (MEFs) than ES cells (Tichy, 2011). However, it has also been 
found that embryonic stem cells still have the capacity to impose a strict G1 block 
after induction of DNA damage with UV light, indicating that ES cells still maintain 
effective DNA repair pathways (Barta et al., 2010). It has even been suggested 
that artificially blocking the cell cycle of ES cells is sufficient to cause the cells to 
differentiate (Ruiz et al., 2011). This confirms the influence that cell cycle control 
has over the behaviour of pluripotent and differentiating cells.  
1.1.5 G2 phase 
 
S phase is followed by the second gap phase: G2 phase. Similar to G1, this is also 
a period with high protein synthetic activity, and again contains a checkpoint 
through which the dividing cell must pass (Weinert and Hartwell, 1990, 
Khammanivong et al., 2013). The purpose of this checkpoint is to ensure that 
nuclear DNA has been replicated properly before the onset of mitosis 
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Figure 1.1 Cell cycle profiles of mouse embryo fibroblasts (MEF) and
murine embryonic stem cells (ES). Asynchronous mESCs or early
passage mEFs were grown to 60% confluency before harvest and
fixation. Cells were treated with RNase A and stained with
propidium iodide prior to analysis by flow cytometry for DNA
content. Figure taken from Tichy, 2011.
4 
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(Plesca et al., 2007). The G2 checkpoint has a similar mechanism to the G1 
checkpoint, in that it again relies on cyclin-CDK interactions to control progression 
to the next cell cycle phase (Messier et al., 2013).  
1.1.6 Cell division during mitosis phase 
 
Mitosis phase, or M phase, begins when the cell’s chromosomes begin to 
condense, and ends when the two daughter cells have separated. M phase can 
be subdivided into another four phases, according to the appearance of 
chromosomes under a light microscope (Bishop and Young, 1977, De Arce et al., 
1982, Bolzer et al., 2005). The first section, prophase, is characterised by the 
initial condensing of the chromosome into a more highly packaged structure. 
Centrioles start to form, the mitotic architecture of microtubules begin to align, and 
the nuclear membrane breaks down. Metaphase can be identified as the stage by 
which time chromosomes have condensed into distinct, separate units of DNA and 
align themselves in preparation for the separation of chromatids (Bishop and 
Young, 1977). Metaphase chromosomes are widely studied due to the ease of 
their microscopic identification and the reproducible banding patterns they 
produce when stained with various dyes. One such dye is Giemsa, which 
preferentially binds to AT rich regions of the chromosome to produce numerous 
bands along the chromosome that correspond to areas with relatively low gene 
density (De Arce et al., 1982, Hurst and Eyre-Walker, 2000). Separation of 
chromatids occurs during anaphase, at which point chromosomes are pulled apart 
by the action of the microtubules of the mitotic spindle towards opposite poles of 
the cell (Royle, 2012). The final stage of mitosis is telophase, where nuclei of the 
daughter cells begin to form, cytokinesis separates the cells, and the final 
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cleavage of the two resultant cells occurs (Ashraf and Godward, 1980). The tightly 
packaged DNA/histone complex is relaxed and becomes de-condensed 
(Matsuoka et al., 1994). The mitosis phase of the cell cycle demonstrates one 
essential facet of the DNA-histone interaction; that of proper packaging of DNA 
into condensed structures. However, there are other important roles for this 
nuclear complex, including its influence on transcription factor binding and gene 
expression.  
 
1.2 PLURIPOTENCY AND STEM CELLS 
1.2.1 Pluripotency in embryonic stem cells 
 
Pluripotency refers to the state of embryonic cells at a very specific stage of 
development. The inner mass cells of the mammalian embryonic blastocyst have 
the potential to differentiate into any corporeal cell type (Martin, 1981). Embryonic 
stem cells (ESCs) can be isolated in vitro from the inner cell mass of the 
blastocyst. These cells were first extracted from mice in 1981, and were identified 
by their ability to differentiate into ectoderm, mesoderm and endoderm, but not 
extra-embryonic tissues, so are therefore described as pluripotent (Martin, 1981, 
Evans and Kaufman, 1981). These cells can divide symmetrically to produce two 
ES daughter cells, or they can differentiate to occupy all the niches vital to the 
development of the organism (Niwa, 2007).  
Pluripotency is a robust state that is only disrupted by specific cues that instruct 
the cell to differentiate. A recent study involved knocking down many different 
genes in human ES cells; only a handful produced significant phenotype change. 
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One of these was the transcription factor Oct4, encoded by the Pou5f1 gene 
(Nishiyama et al., 2013). This transcription factor is also known to interact with a 
great many other components of the network of factors that maintain pluripotency, 
and is thought to be a key regulator of the undifferentiated state of ESCs (Gao et 
al., 2013). Differentiation of the blastocyst into the various embryonic tissues is 
accompanied by a rapid loss of Pou5f1 (a hallmark of stem cells) expression 
(Scholer et al., 1989). This is followed by the development of the three primary 
germ layers: endoderm, mesoderm and ectoderm and eventually the entire cohort 
of cell types present in the adult (figure 1.2) (Meregalli, 2011). It is not fully known 
by what mechanism these cells differentiate, and why some cells become 
ectodermal and others endodermal, however the levels of several pluripotency 
factors seem to be critical in the early stages of ESC differentiation (Zhou et al., 
2007).  
1.2.2 Nuclear factors involved in the maintenance of pluripotency 
 
Control of the process of differentiation is also thought to lie with transcription 
factors such as Oct4, as well as Nanog and Sox2 (Boyer et al., 2005, Abranches 
et al., 2013). These proteins are known to be markers of pluripotency, and induce 
a pattern of gene expression that maintains the undifferentiated state of ESCs 
(Zhou et al., 2007, Whyte et al., 2013). Nanog is a key regulator of pluripotency, 
and its expression is greatly reduced as soon as cells differentiate from the 
blastocyst stage of development, and loss of Nanog activity mirrors loss of 
pluripotency very closely (Chambers et al., 2003, Abranches et al., 2013). This 
transcription factor further activates its own expression, in a positive feedback 
loop, and also activates other genes vital for the maintenance of pluripotency 
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Figure 1.2 Diagram describing the differentiation process in
mammals. Differentiation potentiality of human embryonic cell
lines. ES cells are taken from the inner cell mass of the
embryonic blastocyst and can be cultured in vitro for prolonged
periods of time. Figure from Meregalli et al. 2011
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(Boyer et al., 2005). Nanog can promote expression of factors such as Oct4 and 
Sox2, which can interact via heterodimerisation to influence gene expression 
(Jauch et al., 2011). All three pluripotency factors are associated closely with each 
other, targeting the same genes and promoting each other’s production (figure 
1.3) (Niwa, 2007). Data mining studies have indicated that 50% of Oct4 target 
regions were also bound by Sox2, and that of these regions, over 90% were also 
a target for Nanog binding (Boyer et al., 2005, Ng and Lufkin, 2011). It is thought 
that these three transcription factors have a strong influence in the process of 
maintaining pluripotency by bringing about the particular pattern of gene 
expression that keeps embryonic stem cells from spontaneously differentiating. 
The loss of one or more of these transcription factors can be a cue, or a marker, 
for cell differentiation (Osorno et al., 2012, Sterneckert et al., 2012). In a normally 
developing embryo, pluripotent cells are only present transiently, for a matter of 
hours or days, depending on the species (Theunissen and Silva, 2011). However, 
in vitro and in artificially induced stem cells, pluripotent cells can be prolonged by 
maintaining an exogenous supply of Leukaemia Inhibitory Factor (LIF) (Cheng et 
al., 2012). This cytokine binds to the receptor LIFR to act on the JAK/STAT 
pathway, among others, to maintain the pluripotent state of the cell (Dani et al., 
1998). The JAK/STAT pathway is a signal-transduction pathway that receives a 
stimulus (in this case the binding of LIF to the LIF-Receptor) and initiates protein-
protein and protein-DNA interactions in order to bring about a change in the cell’s 
gene transcription activity (Abranches et al., 2013). This pathway is not only 
activated to regulate the maintenance of pluripotency, but is also involved in 
apoptosis and differentiation processes (Chen et al., 2012).  The importance of the 
proper regulation of this pathway can be shown by the increased susceptibility to
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Figure 1.3 Diagram showing the interactions between Oct3/4, Sox2,
Nanog and tissue-specific regulators in the embryo. Feedback loops
show how Oct3/4 and Sox2 levels are maintained. The pluripotency
factors promote their own transcription, but this is carefully controlled
by the cell to prevent loss of pluripotency. Figure adapted from Niwa
2007.
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cancer if the pathway is constitutively expressed, for example due to mutation or 
polymorphisms in the underlying gene sequences (Chen et al., 2013b). 
1.2.3 Differentiation of embryonic cells and the loss of pluripotency 
 
Embryo development results in the loss of pluripotency, however some forms of 
stem cells are present throughout the life of an organism. Adult stem cells are 
differentiated cells, but still have the capacity to differentiate further in order to 
replace dead or damaged cells (Chicha et al., 2011). These can usually only 
differentiate into one or a few types of terminally differentiated cells, and as such 
there are many classes of adult stem cells maintained at all times, often termed 
progenitor cells, which can differentiate into only a few different final cell types 
(Wang et al., 2005, Yanagida et al., 2013).  
1.2.4 The cell cycle and control of pluripotency 
 
In ESCs, the cell cycle is thought to be a key factor in the maintenance of the cell’s 
pluripotency (Andang et al., 2008, Chen et al., 2013a). Oct4, also known as Oct3 
or Oct3/4, is a transcription factor highly up-regulated in pluripotent cells and is 
closely linked to this process, as a loss of Pou5f1 (the name for the Oct4 gene) 
expression is quickly followed by changes in the timings of the cell cycle phases, 
and subsequently differentiation of the cell (Becker et al., 2007, Becker et al., 
2010). The increased length of the cell cycle then inhibits rapid proliferation of 
cells, driving cells further down the path to differentiation (Calder et al., 2013). 
Conversely, in order to induce pluripotency in differentiated cells, the cell cycle 
must be reverted to an ES cell (short G1) cycle for pluripotency to be stably 
maintained (Maherali et al., 2007). In pluripotent cells, Pou5f1 expression causes 
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a partial bypass of the G1 checkpoint by repressing p21 (a G1 block component), 
thus the loss of Oct4 results in a re-instatement of the complete gap 1 block 
(Hanna et al., 2009). The role of micro-RNAs (miRNA) in the bypassing of the G1 
block has also been recently explored (Wang and Blelloch, 2009). These short 
RNA sequences, along with the RNA induced silencing complex (RISC) bind to 
specific mRNA transcripts to interrupt their translation into protein. In ES cells, 
there is a relative abundance of a specific class of miRNAs that promote G1 to S 
transition(Wang and Blelloch, 2009). These are thought to act on pRB, p21, as 
well as other components of the G1 checkpoint machinery, can act in a checkpoint-
independent manner, and may be upregulated by Oct4 or other pluripotency 
factors (Wang and Blelloch, 2009, Wang et al., 2013).   
 
1.2.5  Induced stem cells: the potential to reverse the differentiation 
pathway 
 
Until relatively recently, it was though that differentiation was a one-way pathway 
towards a fully committed cell state. Takahashi and Yamanaka discovered that the 
process of differentiation could be artificially reversed in mice by introducing 
extrinsic pluripotency factors to a population of adult fibroblasts (Takahashi and 
Yamanaka, 2006). A small proportion of these cells became pluripotent as 
denoted by the resumption of expression of ES cell marker genes. This was later 
found to be possible also for human cells (Takahashi et al., 2007). These induced 
pluripotent stem cells (iPS cells) can maintain their pluripotency in vitro using LIF 
in a similar manner to ES cells (Cheng et al., 2012). As well as foreshadowing 
important research into the nature of development and differentiation, these cells 
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can also act as tools to further many other fields of biology. The possibility to 
derive cells that are pluripotent and yet have the same genotype as the donor 
cells have important implications for the field of regenerative medicine and others.  
For example, cells that are difficult to isolate and culture in vivo can now be 
derived from induced pluripotent cells, given the right developmental cues 
(Yanagida et al., 2013). A potential difficulty in the clinical use of transplanted iPS 
cells is their ability to form tumours (Marzi et al., 2013). This is closely related to 
the ES cell-like profile of the iPS cells and their associated rapidly cycling nature. 
The G1 checkpoint is reduced in pluripotent cells, as described earlier, which 
leaves pluripotent cells susceptible to tumorigenesis (Kawai et al., 2010). The 
uncontrolled, but undifferentiated, cells go on to form teratomas, similar to those 
found in the earliest experiments with mice using ES cells (Martin, 1981, Lim et al., 
2013). A strong link has been found between the re-establishment of pluripotency 
and a genome-wide shift in post-translational histone modifications in induced 
pluripotent stem cells (Mattout et al., 2011). This study found that iPS cells 
undergo an initial reorganisation of nuclear heterochromatin as an early event in 
the reprogramming of somatic cells. The heterochromatic signature for 
pluripotency foreshadows the upregulation of pluripotency genes and other 
epigenetic features necessary to maintain a stem cell phenotype. 
 
1.3 CHROMATIN AND CHROMOSOMES 
1.3.1 Chromosomes, DNA packaging and histones 
 
Chromosomes are self-contained units of genetic material consisting of a length of 
DNA wound around histones, this DNA-histone complex being known as 
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chromatin. The basic unit of chromatin is the nucleosome, a structure of a single 
histone octamer wrapping around 147 base pairs of DNA (Luger et al., 1997). 
Components of the octamer are two units each of histones H3 and H4, and two 
units each of histones H2A and H2B (Bakayev et al., 1977, Blacketer et al., 2010). 
The action of chromatin condensation can occur as neighbouring nucleosomes 
move closer together and organise themselves into fibres of 10nm diameter 
(Blacketer et al., 2010, Fussner et al., 2011). As a result of the compaction of the 
DNA-histone complex, transcription of genes by RNA polymerase (as well as other 
factors involved in the transcription machinery) is less frequent, due to the reduced 
accessibility of promoters and DNA binding sites to proteins (Mirsky, 1971, Belch 
et al., 2010). Fibres of chromatin can be further compacted due to interactions 
between histones on different nucleosomes, thought to be the H4 tail and histone 
H2A, and compacted even further to form the thickly condensed chromosome that 
can be seen at metaphase under a light microscope (figure 1.4) (Lafontaine and 
Chouinard, 1963, Liu et al., 2006, Sha, 2009, Yamagata et al., 2009, Bian and 
Belmont, 2012). It is generally thought that the formation of the chromosome 
structure may be due to the association between chromatin and a protein-based 
nuclear matrix, or scaffold, which facilitates condensation of chromatin (Heng et 
al., 2004, Bian and Belmont, 2012). This has been disputed, however, by studies 
in newts that imply that cross-links in chromatin, approximately 15kb apart and 
facilitated by linker proteins, are the basis of DNA condensation (Poirier and 
Marko, 2002). The mechanisms of chromatin compaction are not yet fully 
understood, but have roles in gene expression and cell division (Bian and 
Belmont, 2012). The compaction of chromatin has important consequences for the 
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cell, not only to fit the genetic material into the nucleus, but also to selectively 
inactivate regions of the genome into heterochromatin. 
1.3.2 Heterochromatin: Dense and inactive chromatin 
 
Heterochromatin is a highly condensed structure present throughout the cell cycle 
(except during replication) that represses activity of genes contained within its 
boundaries (Honda et al., 2012). Heterochromatin is repeat-rich and contains few 
functional promoters, and can be constitutive or facultative (Trojer and Reinberg, 
2007). Constitutive chromatin represents a permanent state of tight compaction, 
such as can be found at the centromeres of eukaryotic chromosomes (Fodor et 
al., 2010). Conversely, facultative heterochromatin can be formed in a 
chromosomal region whose transcription is no longer required. The female 
inactive X chromosome is an example of facultative chromatin that has been 
formed from euchromatin during embryo development. As the embryo develops, a 
random copy of the X chromosome is inactivated, leaving a dense mass of 
chromatin termed a Barr body (Augui et al., 2011). Both types of heterochromatin 
are associated with decreased histone acetylation and increased histone 
methylation at H3K9 and H4K20 (Trojer and Reinberg, 2007). These are examples 
of epigenetic carriers of information, which are crucial to the understanding of both 
the structure and function of chromatin, as well as having a critical role to play in 
the control of the cell cycle.  
1.3.3 Epigenetic marks  
 
Epigenetic information is defined as markers that can alter gene expression 
without changing the sequence of DNA (Reik et al., 2001, Kouzarides, 2007). 
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Figure 1.4 Diagram showing the various levels of chromatin packaging. Naked DNA (black 
line) is coiled around nucleosomes (blue spheres). This chromatin can be arranged into a fibre 
and then further compacted to form a metaphase chromosome as above. Figure taken from 
Sha and Boyer 2009.
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These can be altered by, or respond to, changes in the cellular environment, and 
persist through multiple cell divisions to remain as a stable, heritable carrier of 
information (Buckley et al., 2012, Huang et al., 2013). However, this definition is 
somewhat misleading, as epigenetic motifs have a role in eukaryotes that is 
distinct from the relatively immutable and infinitely heritable genetic information 
encoded by DNA sequences. In several contexts, epigenetic information performs 
an analogous role to the DNA sequence, such as maintaining the cell identity of a 
terminally differentiated cell (Hanna et al., 2009, Zheng and Pan, 2010). But an 
equally important aspect of the nature of epigenetic marks is their plasticity, i.e. 
the ability of these marks to change the phenotype of the cell; for example by 
being lost or gained through the course of differentiation to result in a distinct cell 
type, which then maintains a steady state level of epigenetic marks as above 
(Breiling et al., 2004, Martino et al., 2013). Currently, it is not known whether 
epigenetic marks fit the description of a heritable mechanism for carrying 
information across generations, but it has been discovered that there are several 
elaborate mechanisms for making sure that epigenetic markers are conveyed from 
one cell generation to the next (Breiling et al., 2004, Francis, 2009). It may be the 
case that some epigenetic marks fulfil only functions to do with cell plasticity and 
may be easily and dynamically changed to meet the need for a switch in cell 
expression involved in cell differentiation. Other marks may display greater 
longevity through the cell cycle and mitosis to provide a steady and heritable 
mechanism to preserve epigenetic information through the generations. A 
molecular basis for these contrasting roles of epigenetic marks is evident in the 
varying half-lives of some of these modifications in mammalian cells. Acetyl- and 
phospho- groups display a much shorter longevity in cells than methyl- groups, 
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indicating a possible role in inheritance for methylated chromatin (Jackson et al., 
1975, Zee et al., 2010). 
 
1.3.4 DNA methylation: Epigenetic modification of the DNA molecule 
 
There are several different forms and chromosomal locations of epigenetic 
marker, including DNA methylation and histone modifications. DNA methylation is 
facilitated by DNA methyltransferase enzymes (DNMTs) that methylate cytosine 
bases on the DNA double helix (Tucker et al., 1996, Athanasiadou et al., 2010). 
70-80% of CpGs are methylated in the genome, indicating its abundance 
(Illingworth et al., 2010). Regions free of methylated cytosines in stretches of CG-
rich DNA are known as CpG islands (Bird, 1986, Jones, 2012). These are 
associated with gene-rich and highly conserved areas of the genome, probably 
because methylated cytosine residues can easily mutate to thymidine, and these 
mutations are often carried through the cell cycle due to the failure of DNA repair 
enzymes to recognise the mutation (Bird, 1986, Olinski et al., 2010). This can also 
explain the depletion of CpGs relative to other dinucleotides. Genes vital for cell 
survival must be protected from such damage, and so remain free of CpG 
methylation, leading to the persistence of these islands of CpG integrity 
(Antequera et al., 1990). DNA methylation is generally associated with repressing 
gene transcription, and is often aberrant or erroneously positioned during the 
progression of cancer cells, activating oncogenes or repressing tumour 
suppressors, highlighting its importance as a negative regulator of gene 
expression (Pai et al., 2011, Cannuyer et al., 2013, Rhee et al., 2013).  
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CpG methylation is faithfully replicated onto newly replicated strands of DNA 
because DNMT1 enzyme has a high affinity for hemi-methylated CpG sites, 
methylates the unmodified strand, and completes the inheritance of epigenetic 
DNA methylation for that cell cycle (Pradhan et al., 1999, Probst et al., 2009). DNA 
methylation appears to be a stably inherited epigenetic mark that is carefully and 
faithfully maintained. Other DNMTs, such as DNMT3a and 3b, methylate 
previously unmodified CpGs at some loci, which implies a role for these enzymes 
in the establishment of a new epigenetic signature, possibly in response to 
external or developmental stimuli (Okano et al., 1999, Athanasiadou et al., 2010). 
Crucially, when all three DNMT enzymes are inducibly knocked out in mouse cells, 
it was found that DNA methylation levels reverted to almost zero (Tsumura et al., 
2006). This indicates that DNMT enzymes are indispensible for maintaining this 
chromatin modification, and that any previous DNA methylation patterns are lost 
upon removal of these DNA methyltransferases (Tsumura et al., 2006, Yamanaka 
et al., 2010). This mechanism was confirmed for the Pou5f1 locus, which 
undergoes CpG methylation after differentiation of ES cells. However, upon 
knockout of the establishing DNMTs 3a and 3b, promoter and enhancer regions of 
Pou5f1 showed a constant low level of DNA methylation (Athanasiadou et al., 
2010). These findings highlight the importance of enzymatic processes in 
maintaining the DNA methylation signature throughout cellular growth and 
development. These observations point to an active mechanism of stability, as 
opposed to the more passive mechanisms of genetic DNA inheritance. 
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1.4 EPIGENETICS AND HISTONE MODIFICATIONS 
1.4.1 Post-translational histone modification 
 
Facilitating chromosome compaction is not the only function of histones. A key 
structural feature of the histone molecule is the protrusion of the N-terminal 
histone tail. This is a primary structure amino acid sequence that sits on the 
outside of the nucleosome, and as such is accessible to enzymes and factors that 
can chemically modify individual amino acid residues (Luger et al., 1997, Schwartz 
et al., 2010, Margueron and Reinberg, 2011). There are over 80 histone tail sites 
which can be modified, and several different organic and inorganic chemical 
groups can be added.  Methyl, acetyl and phosphate moieties are most commonly 
added, but there are other possible larger modifications including ubiquitylation, 
ADP ribosylation and citrullination (Kouzarides, 2007, Arnaudo and Garcia, 2013). 
Figure 1.5 shows an array of possible post-translational histone modifications, 
which are deposited and removed by enzymes and cofactors such as Acetyl CoA 
(provides an acetyl group) and S-adenosyl-methionine (provides a methyl group) 
(Pestana et al., 1971, Bhaumik et al., 2007). In the case of acetylation, histone 
acetyltransferases (HATs) add acetate from Acetyl CoA to histone tail residues, 
whereas histone de-acetylases (HDACs) remove them (Ekwall et al., 1997). The 
same is true of methylation, with histone methyltransferases (HMTs) and histone 
de-methylases (HDMs) adding and removing methyl groups (taken from S-
adenosyl-methionine) from the N-terminus (Shi et al., 2004). The opposing actions 
of these enzymes result in a dynamic equilibrium of histone modifications as they 
are constantly being added and removed (figure 1.6). Any heritable, epigenetic, 
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Figure 1.5 Histone modifications include acetylation (ac), 
methylation (me), phosphorylation (ph) and ubiquitination (ub1). 
Most of the known histone modifications occur on the N-terminal 
tails of histones, with some exceptions including ubiquitination of 
the C-terminal tails of H2A and H2B and acetylation and 
methylation of the globular domain of H3 at K56 and K79, 
respectively. Globular domains of each core histone are 
represented as coloured ovals. Figure taken from Bhaumik et al. 
2007.
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mark is stable through the cell cycle, and so the equilibrium in this case would 
favour the action of the transferases, ensuring maintenance of that mark. 
 1.4.2 Histone acetylation 
 
Histone acetylation was the first to be recognised as a post translational histone 
modification (Allfrey et al., 1964). It is associated with an open configuration of 
chromatin and in turn with actively transcribed regions of the genome (Bode et al., 
1983, Johnson et al., 1998). It is mainly lysine residues that are acetylated, most 
of which are located on histones H3 and H4 (Turner and O' Neill, 1995, Kuo et al., 
1996, Arnaudo and Garcia, 2013). The structure of the lysine amino acid contains 
a positively charged ammonium species on its -R group, which can form ionic 
interactions with DNA and nearby histone molecules to form more tightly bound 
chromatin (Hong et al., 1993). The disruption of this net positive charge by 
introducing the negatively charged acetate moiety causes the weakening of these 
(Nightingale et al., 2006, Jorgensen et al., 2013). intermolecular forces and leads 
to relaxation of the chromatin (Bannister and Kouzarides, 2011). Acetylation of N-
terminal histone tails is a highly dynamic process and is quickly turned over by the 
opposing actions of HATs and HDACs. This can be observed in studies that 
employed inhibitors of HDACs, where a significant accumulation of histone 
acetylation is noticed (Candido et al., 1978, Das et al., 2009).  However this is not 
the only action of acetyl marks on chromatin. Acetylated lysine residues can also 
recruit chromatin binding proteins that interact with other modified residues 
nearby, creating a form of communication between epigenetic marks (Forneris et 
al., 2005, Bronner, 2011). 
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Figure 1.6 Representation of the chemical structures of the R groups of modified 
and unmodified lysine residues. The section in red denotes the end of the molecule 
that is modified by chromatin- modifying enzymes. For this representation, mono-
methyl lysine has been used, however further methylation of the lysine molecule can 
result in di-methyl lysine (as above, but with CH2-CH3 instead of –CH3) and tri-methyl 
lysine (CH2-CH2-CH3 in place of the mono-methyl group). Enzymes involved in these 
modifications have been annotated above.
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Lysine residues can be acetylated on histones H2B, H3 and H4, at several 
different sites (figure 1.5). This allows for many combinations of histone 
modifications, and therefore presents the opportunity to store a great deal of 
epigenetic information (Turner, 1998, Strahl and Allis, 2000). Several classes of 
enzymes have been found to interact specifically with modified chromatin (Agalioti 
et al., 2002, Palacios et al., 2008). These often have characteristic domains that 
recognise specific histone modifications; acetylated lysines are often recognised 
by proteins containing bromodomains, which are peptide motifs highly conserved 
between mammals, plants and yeast (Tamkun et al., 1992, Bannister and 
Kouzarides, 2011).  
 
1.4.3 Histone methylation 
 
As well as being acetylated, histone tail residues can also be methylated at lysine 
and at other residues. Firstly, unlike lysine acetylation, addition of a neutral methyl 
group does not affect the net charge of the lysine molecule (Kubicek and 
Jenuwein, 2004). Also, multiple (1, 2 or 3) methylations can occur on the same 
amino acid residue that can interact with different chromatin-binding enzymes, as 
shown in figure 1.5 (Martin and Zhang, 2005). Until recently, it was thought that 
histone methylation was a stable and persistent modification, similar to DNA 
methylation (Rice and Allis, 2001, Peters and Schubeler, 2005). However, after 
the discovery of histone demethylases, beginning with Lsd1, it became clear that 
methylation is also controlled through equilibrium between histone 
methyltransferases and demethylases (Shi et al., 2004, Forneris et al., 2005).  
Now it is clear that many different classes of chromatin-binding proteins interact 
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with methylated residues (Matthews et al., 2007, Adams-Cioaba and Min, 2009). 
These proteins can bind to methylated histones via specific domains such as 
chromodomains and PHD fingers (Palacios et al., 2008, Oliver et al., 2012). The 
possibility of four different states of methylation at each lysine residue, and the 
possible acetylation of the same residue, provides a highly nuanced and flexible 
system for the changing of chromatin states and signalling between histone 
modifications and chromatin-binding enzymes.  
 
1.4.4 Histone phosphorylation 
 
Phosphorylation of N-terminal histone tails occurs mostly on serine, threonine and 
tyrosine residues (Berger, 2010). Similar to acetylation, this adds a negatively 
charged chemical species to the side chain of the amino acid, although phosphate 
is more highly charged (PO4
3-) than acetate (H3CCOO
-). This is thought to have a 
repressive effect on chromatin by attracting more ionic bonding to the nucleosome 
and so to decrease the potential for the underlying DNA to be read by RNA 
polymerase (Bannister and Kouzarides, 2011, Ribeiro-Mason et al., 2012). The 
level of phosphorylation is controlled by the opposing actions of kinases and 
phosphatases. One such enzyme is Aurora B kinase, which phosphorylates 
serines 10 (a mark associated with mitotic chromatin) and 28 on histone H3 
(Sugiyama et al., 2002, Hirota et al., 2005). This enzyme is also an important link 
between the action of histone modification and the progression of the cell cycle, as 
the action of phosphorylating H3S10 disrupts the binding of HP1 protein to 
heterochromatic DNA, allowing the nuclear chromatin to undergo mitosis properly 
(Murzina et al., 1999, Hirota et al., 2005).  
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1.4.5 Histone variants 
 
Another feature in the changeable epigenetic landscape is the existence of variant 
histones. These are histone molecules such as H2A.X, H2A.Z, Cenp-A H3.2 and 
H3.3 that contain differences in the amino acid sequences of the protein (Sullivan 
et al., 1994, Meneghini et al., 2003, Shaw et al., 2009). These variant molecules 
are recognised as such by nuclear factors and are distributed within certain 
specific regions of the genome (Shaw et al., 2009, Van Attikum and Gasser, 2009, 
Fachinetti et al., 2013). For example, the histone variant H2A.Z is highly 
conserved across species, and is found in S phase as a small fraction of total H2A 
(Santenard and Torres-Padilla, 2009). It also displays only 60% amino acid 
sequence homology with H2A, although the crystal structures appear more similar 
(Svotelis et al., 2009). H2A.Z is located at boundary elements situated at the 
interface between repressed chromatin and active chromatin (Meneghini et al., 
2003). The function of the boundary element is to prevent the silencing of active 
chromatin (euchromatin) by neighbouring repressive chromatin (heterochromatin) 
(Li and Zhou, 2013). This is a good example of a mechanism that prevents the 
over-writing of a previously established epigenetic state. In this case, the 
importance of the boundary element structure is highlighted by the highly 
conserved nature of the H2A.Z protein, indicating that this mechanism is 
evolutionarily vital for the continued stability and proper function of the genome 
(Meneghini et al., 2003). Although H2A.Z is expressed at S phase in dividing 
mammalian cells, it has also been found to promote the progression of the cell 
cycle through the G1 block. It has also been found that the prevalence of H2A.Z at 
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gene promoters falls rapidly after the start of S phase and is not immediately 
reinstated (Nekrasov et al., 2012). This highlights the potential for epigenetic 
marks to be erased after the replication phase of the cell cycle. 
Another histone variant, Cenp-A, is substituted for histone H3 in centromeric 
chromatin (Sullivan et al., 1994, Hake and Allis, 2006). Cenp-A shows a degree of 
sequence homology with H3.1 (~60%), but is incorporated very specifically into 
centromeric regions by recognising DNA elements located within the centromeres 
(Sullivan et al., 1994). It is now thought that Cenp-A, independent of the DNA 
sequence, is the defining epigenetic mark for centromere identity, the 
maintenance of which is essential for the proper location and functioning of the 
centromere (Fachinetti et al., 2013). The complexity of the epigenetic state of cells 
can provide for an elaborate and sensitive mechanism for the control of gene 
expression. This potential can be further increased as combinations of epigenetic 
features communicate, regulate and influence not only each other, but also the 
transcription of genes.  
1.4.6 Chromatin remodelling 
 
As well as the several different types of possible modifications that enzymes can 
deposit or remove from chromatin, another epigenetic mechanism that can affect 
gene expression is ATP-dependent chromatin remodelling. This is a process by 
which nucleosomes are repositioned or removed from discrete loci so as to affect 
the transcription of the underlying gene (Kwon et al., 1994, De La Serna et al., 
2006, Belch et al., 2010, Euskirchen et al., 2012). This is done to allow 
transcription factors and polymerases to access the DNA and maintains the 
plasticity of the chromatin structure. The SWI/SNF complex in yeast was one of 
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the first remodelling enzymes to be described, and is conserved in mammals 
(Kwon et al., 1994). This protein complex interacts with nucleosomes at their 
ATPase domains to disrupt the contacts between DNA and histones, in 
preparation for the removal of the nucleosome from the target region of DNA 
(Belch et al., 2010, Euskirchen et al., 2012). There is also a role for modified 
histones in this process, as recent studies have shown that acetylation of histones 
at specific residues may be marked for eviction and so contribute to a more open 
chromatin state (Elliott et al., 2013). Crucially, these remodelling factor complexes 
can also contain histone acetyl- and methyltransferases, highlighting the potential 
and importance of communication between chromatin-modifying enzymes, histone 
modifications and the transcription machinery (Xu et al., 2004, Nightingale et al., 
2007).  
1.5 INTERACTIONS BETWEEN EPIGENETIC MARKS 
1.5.1 Epigenetic communication  
 
Communication between epigenetic marks can occur among histone 
modifications, histone variants and methylated DNA through the concerted actions 
of chromatin-binding and modifying enzymes (Zippo et al., 2009, Xu et al., 2012). 
Marks can promote or antagonise each other’s actions and maintenance, and can 
produce carefully controlled feedback regulation mechanisms that provide an extra 
level of gene regulation (as well as epigenome regulation) that DNA sequence is 
too rigid to accomplish (Kowenz-Leutz et al., 2010). This example is focused on 
the C/EBPβ transcription factor, which is methylated at its N terminus by the 
PRMT4/CARM1 arginine methyltransferase, reducing its binding affinity with the 
SWI/SNF chromatin remodelling complex and downregulating downstream 
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processes. Phosphorylation of the C/EBPβ enzyme reduces its interaction with 
PRMT4/CARM1, reducing arginine methylation and leading to adipogenic 
differentiation led by the enhanced recruitment of the SWI/SNF complex.  
Often the mechanisms involved with the careful regulation of transcription involve 
many elements of epigenetic information, such as the double strand break repair 
pathway, which requires H2A.Z, chromatin remodelling enzymes and proper 
histone methylation and acetylation to function properly (Rossetto et al., 2010, Xu 
et al., 2012). 
 
1.5.2 Mechanisms of epigenetic crosstalk 
 
Crosstalk between epigenetic marks is vital for the proper function of the 
eukaryotic genome. The varied array of modifications to chromatin must be 
controlled carefully and be appropriate to the context of the cell in order to fulfil 
their functions. UHRF1 is involved in the methylation of DNA by DNMT1, and can 
also interact with several different histone modifications and histone-modifying 
enzymes (Bostick et al., 2007, Unoki et al., 2009, Bronner, 2011). UHRF1 is a 
target of E2F, a transcription factor that promotes progression of the cell cycle, 
and has a critical role in the maintenance of DNA methylation by acting as a 
chaperone for DNMT1 to bind to hemimethylated sites (Unoki et al., 2004, Unoki 
et al., 2009, Oda et al., 2013). This observation confirms the existence of enzymes 
that can read complex epigenetic states and alter cell behaviour accordingly.  
UHRF1 also influences heterochromatin formation and ubiquitylation of histone 
H3, as well as binding to di- and tri-methylated H3K9 and HDAC, to form a 
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network of links between many different epigenetic marks, linking chromatin 
structure with histone modifications (Unoki et al., 2009). 
Another example of epigenetic communication is cross talk between modified 
histone tail residues. This can be illustrated by the interaction between tri-
methylated lysine 9 of histone H3 (H3K9me3) and the adjacent phosphorylated 
serine 10 (H3S10P) (Rea et al., 2000, Nightingale et al., 2006). H3K9me3 is 
associated with heterochromatin, and is equated with being a marker for silent 
areas of DNA (Puschendorf et al., 2008). HP1 protein, which is involved with the 
formation and maintenance of a heterochromatic state, is recruited by H3K9me3, 
causing repression of the underlying sequence (Fanti and Pimpinelli, 2008). 
However, during mitosis, the adjacent H3S10 residue is phosphorylated. This 
disrupts the interaction between H3K9me3 and HP1, by interfering with the 
binding site of HP1 to the H3 histone tail and thereby reversing its inhibitory effect 
in order for the DNA to properly segregate during mitosis (Fischle et al., 2005, 
Papamokos et al., 2012). This phospho switch underlines the way in which histone 
modifications can influence each other, and how the functions of certain 
modifications can be altered or nullified due to subtle variations in the epigenetic 
landscape. 
The phenomenon of histone modifications interacting with each other is not limited 
to adjacent residues, however. Forneris et al. discovered that binding affinities of 
the histone demethylase LSD1 was greatly affected by histone modification 
(Forneris et al., 2005). LSD1 demethylates H3K4 to have a negative effect on 
underlying gene transcription. However, in this case, acetylation of H3K9 reduces 
the activity of the LSD1 enzyme, and phosphorylation of H3S10 inhibits the 
demethylase action entirely (Forneris et al., 2005). Other histone demethylase 
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enzymes are similarly affected by nearby non-target post-translational histone 
modifications (Lohse et al., 2013). These can be seen as examples of an enzyme 
reading the ‘histone code’. 
Chromatin associated proteins can also have their affinities for modified histones 
altered by the presence or absence of methylated DNA. Bartke et al. identified a 
group of proteins that are up or down-regulated, as a result of CpG island DNA 
methylation (Bartke et al., 2010). A number of proteins were identified that bind to 
histones only when underlying CpGs are methylated. Others are prevented from 
binding to their target sites in chromatin by the presence of methyl-CpG. In this 
study, several genes were affected by changes in CpG DNA methylation, which 
indicates that this form of epigenetic communication could be widespread and 
offer control of a large part of the epigenome (Bartke et al., 2010). 
Histone modifications are also intimately linked with the process of transcription 
initiation, elongation and termination (Li et al., 2011). It has been found that a 
carefully controlled concert of histone methylation and acetylation is associated 
with the progress of the transcription machinery; histone marks such as 
H4K20me1 and H3K36me3 are present at the transcription elongation stage and 
may have a function to do with exon splicing, so can generally be found in the 
body of genes (Li et al., 2011, Zhu et al., 2013). These combinations are not 
definitive, however, as genes with CpG island-containing promoters tend to 
display H3K36 monomethylation in their gene bodies, much closer to the 
transcription start sites (TSS) than for trimethylation (Vavouri and Lehner, 2012). 
Transcription initiation is marked by promoter or enhancer associated histone 
marks such as H3K4me1, 2, 3 and H3K27me3 (Birney et al., 2007). The 
relationship between histone modifications is a reciprocal one, as the same marks 
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that direct the polymerase’s elongation are disrupted once the enzyme is stalled 
artificially (Li et al., 2011). It may be the case that the chromatin landscape is 
disrupted by RNA polymerase, just as the DNA double helix is disrupted, by the 
rapid changing of histone methylation states caused by the proximity and action of 
the polymerase enzyme (Le Martelot et al., 2012).   
 
1.5.3 The epigenetic/histone code hypothesis 
 
Some better-studied marks have well established effects on the transcriptome and 
other cellular functions. For example, it is known that H3K4me3 has a broadly 
activating effect on underlying genes, and H3K27me3 and H3K9me2 have a 
repressive effect (Pauler et al., 2009, Lloret-Llinares et al., 2012). It is also known 
that H3K9me3 and H4K20me3 are associated with heterochromatin (Kouzarides, 
2007, Bannister and Kouzarides, 2011, Honda et al., 2012). However, it is 
becoming clear that histone modifications should no longer be thought of as 
simply promoting transcription, marking heterochromatin or other singular 
functions, but as part of a landscape of modified chromatin that is uniquely tailored 
to the specific context of the locus, the need for its transcription, its packaging 
status and so on (Mattout et al., 2011, Le Martelot et al., 2012, Abraham et al., 
2013). A much more holistic view is required, and the complex array of chromatin 
binding enzymes that can distinguish subtle differences in the epigenetic 
landscape of a genomic region indicate that the histone and epigenetic codes are 
capable of controlling many aspects of the cell’s genome and epigenome 
(Kouzarides, 2007, Bartke et al., 2010, Bannister and Kouzarides, 2011).  
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What is not currently known is the combined effect of a set of histone 
modifications, histone variants and/or DNA methylation on gene transcription. This 
concerted action on chromatin is discussed in the histone code, and the 
epigenetic code, hypothesis (Strahl and Allis, 2000, Turner, 2000, Turner, 2007). 
According to this theory, the epigenetic state of a cell, however complex, predicts 
the gene transcription of the associated DNA (Nightingale et al., 2006, Turner, 
2007). Like the genetic code, it is thought to be heritable, passing its information 
down through cell generations, such as that observed for the inheritance of 
heterochromatic marks (Hathaway et al., 2012). However, in order to stably pass 
epigenetic information on, it must pass through the greatest challenge to its 
longevity; the eukaryotic cell cycle, and more specifically the replication fork of S 
phase. 
 
1.6 EPIGENETIC INHERITANCE 
1.6.1 Inheritance of epigenetic marks  
 
Translation of histone proteins from their respective mRNAs results in an 
unmodified single histone protein (Leffak et al., 1977). These are then assembled 
into dimers (H3-H4, H2A-H2B), then these dimers bind to each other and are 
integrated into a new strand of chromatin at S phase (Gruss et al., 1993, Probst et 
al., 2009). It may be that newly synthesised H2A-H2B dimers bind to old H3-H4 
dimers in a semi-conservative manner, or entirely new nucleosomes could be 
produced to package the newly synthesised DNA strand (Jansen et al., 2007, Xu 
and Zhu, 2010). Epigenetic information is added and removed from newly 
synthesised histones throughout this process, but according to the epigenetic 
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code hypothesis, the marks on old chromatin should be copied and transferred 
onto the newly synthesised strand (Turner, 2000). Several mechanisms have 
already been described that confirm this theory, one of which is the faithful 
reproduction of methylated cytosines onto the new DNA double helix (Bostick et 
al., 2007, Athanasiadou et al., 2010).  
 
1.6.2 Inheritance of CpG methylation 
 
Semi-conservative replication of DNA causes the two new strands of DNA to bind 
not to each other, but to the old strands (Meselson and Stahl, 1958). This results 
in methylated cytosine residues being methylated on one strand of a CpG 
sequence, but not on the opposite side: a hemimethylated site (Pradhan et al., 
1999). This site is recognised by UHRF1, a protein that recognises methylated 
DNA and also binds DNMT1, which proceeds to modify the unmethylated DNA so 
that the mark is copied to the new strand of DNA (Bostick et al., 2007). DNMT1 
has an approximately 40-fold affinity preference for hemimethylated sites, and so 
as long as DNMTs are properly expressed, these enzymes can efficiently maintain 
this epigenetic mark across generations (Reik et al., 2001, Goyal et al., 2006). 
 
1.6.3 Inheritance of histone modifications 
 
The mechanism for the re-establishment of histone modifications has remained 
somewhat cryptic. It is known that half of histones on newly formed chromatin are 
taken from pre-replication chromatin, and half are drawn from newly synthesised 
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histone proteins, but it is not fully known how this is done (Probst et al., 2009, 
Jasencakova et al., 2010). Newly synthesised histones are very quickly acetylated 
at lysines 5 and 12 whilst still being processed in the cytoplasm (Loyola et al., 
2006). These are removed after incorporation into chromatin, however, so as not 
to interfere with the previous epigenetic signature (Xu and Zhu, 2010). How 
previously expressed histone modifications are faithfully replicated on new 
chromatin is not clear. It has been discovered that molecules such as PCNA and 
DNMT1 can recruit chromatin modifying enzymes to newly replicated DNA, 
implying that there is a mechanism for making sure replicated chromatin 
modifications match the old, but so far there is a paucity of knowledge as to the 
association of histone modifications with chromatin through the entire cell cycle 
(Lehnertz et al., 2003, Probst et al., 2009, Bartke et al., 2010). Some of the 
specific examples of epigenetic inheritance discovered thus far are described 
below. 
H3K9me3 is known to be maintained due to a positive feedback loop between its 
methyltransferase (SuVAR39) and HP1, where HP1 recruited by pre-replication 
SuVAR39 then contributes to the re-establishment of methylated H3K9 after 
replication (Fodor et al., 2010, Haldar et al., 2011). An analogous system is 
thought to exist for H3K27me3, where its methyltransferase complex (PRC2) 
persists throughout DNA replication and facilitates the deposition of H3K27me3 on 
daughter strands of chromatin (Hansen et al., 2008, Santos et al., 2010). These 
observations provide evidence of repressive methylation maintenance in 
mammalian cells through epigenetic means. 
There are some clues as to the inheritance of histone modifications; specifically, in 
terms of the localisation of histone marks across the genome. Genome 
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sequencing studies have been performed that show certain histone modifications 
are reliably and reproducibly found only in certain genomic locations, aligning 
themselves with features such as gene transcription start sites (TSSs) and 
heterochromatic regions including the centromere (Birney et al., 2007, Marks et 
al., 2009). For example, H3K4me3 is enriched at the TSS of genes throughout the 
genome, and is less densely distributed at intergenic loci (Guenther et al., 2007, 
Tian et al., 2011). This mark is inherited at gene promoters for developmental loci 
through the differentiation process, as a constituent part of the bivalent motif 
(Radman-Livaja et al., 2010, Sachs et al., 2013). 
1.6.4 Polycomb and trithorax motifs 
 
The methylation of H3K27 is affected by the action of the polycomb repressor 
complex PRC2 (Hansen et al., 2008, Pasini et al., 2010). This generally has the 
effect of compressing chromatin, along with its partner complex PRC1, which 
ubiquitylates histone H2A (Landeira et al., 2010). In mammals, this complex has 
antagonistic qualities to the trithorax group of proteins responsible for H3K4 
methylation (i.e. de-compression of chromatin) (Schuettengruber et al., 2009, 
Voigt et al., 2013).  Despite the fact that these two modifications have antagonistic 
properties, they are often found together at gene loci, rather than within intergenic 
DNA (Bernstein et al., 2006, Shin et al., 2012). This observation is theorised to be 
the basis of the bivalent mark. Bivalent loci are marked with both H3K4me3 (in 
some studies H3K4me2) and H3K27me3 in embryonic stem cells and in 
developing blastocysts (Bernstein et al., 2006, Sachs et al., 2013, Shin et al., 
2012). The genes that these modifications cover are associated with embryo 
development and differentiation, and as long as both marks are present, 
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transcription of these developmental genes is repressed (Bernstein et al., 2006, 
Mikkelsen et al., 2007). However, upon certain cues, these loci lose the 
H3K27me3 mark, and their expression is up-regulated (figure 1.7) (Sha, 2009).  
As a result, the cell is driven towards a differentiation pathway, and pluripotency is 
lost (Azuara et al., 2006, Jia et al., 2012). This describes a clear mechanism by 
which histone modifications affect gene transcription to bring about a change in 
cell phenotype. Although the tri-methyl K27 modification is lost, the H3K4me3 
mark could be said in this example to be a heritable epigenetic mark that also has 
an important functional role in regulating the development of cells (Azuara et al., 
2006). 
1.6.5 Inheritance of epigenetic information through differentiation 
 
Differentiation is an ideal model for the study of epigenetics, as it results in cells 
that are genetically identical to their predecessors, but with contrasting 
phenotypes. It also involves the dual nature of epigenetic marks, at the same time 
being heritable predictors of gene expression, and being influenced by external 
and environmental changes in order to alter gene expression to adapt. The 
bivalency paradigm highlights the possible resolution of this, by showing how 
some marks can remain constant as a heritable mark, and how others can be 
added or lost to confer a degree of transcription control to the epigenome 
(Bernstein et al., 2006, Mikkelsen et al., 2007, Sachs et al., 2013). This view of 
such a system is necessarily simplistic, although it does shed some light on how 
an epigenome-wide system of heritability and transcription control can occur within 
the same framework. Differentiation involves wide-ranging changes in the profile 
of gene expression, as not only do tissue-specific genes become up-regulated, but 
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Figure 1.7 Bivalent chromatin domains mark the promoters of
developmentally important genes in pluripotent ES cells. PRC2 and TrxG
proteins catalyze the tri-methylation of histone H3 on lysine 27 and 4,
respectively. PRC1 is also recruited to many of these genes and can mono-
ubiquitinylate histone H2A on lysine 119, a modification that is also thought to
be important for gene silencing, possibly through blocking RNAPII elongation.
As such, bivalent genes are said to be silent, yet poised for activation. H2AZ
is highly enriched in a manner that is remarkably similar to PRC2 and may
also be an important regulatory component at bivalent genes. Upon
differentiation, the bivalent histone marks can be resolved to monovalent
modifications in which the gene is “ON” or “OFF”. Bivalent domains can also
be maintained or newly established in lineage-committed cells. Taken from
Sha and Boyer, 2009.
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those genes responsible for maintaining pluripotency are concurrently silenced 
(Lengner et al., 2007). Profound changes through differentiation can also be 
observed in other vital processes such as the cell cycle (Andang et al., 2008, 
Chen et al., 2013a). 
Evidence for heritability of histone modifications has been shown in embryonic 
cells from as early as the 8-cell stage (Vermilyea et al., 2009). It has been shown 
that increasing the level of acetylation in the 8-cell stage embryo by use of HDAC 
inhibitors can lead to increased acetylation of histones for several cell divisions up 
to the blastocyst (ES cell) stage, confirming that altered epigenetic states can be 
heritable, even in early embryonic cells that are rapidly differentiating (Vermilyea 
et al., 2009). 
ESCs classically have an abbreviated cell cycle, particularly in G1 (Fujii-Yamamoto 
et al., 2005). After differentiation, this changes to include a much more obstinate 
G1/S checkpoint block (Chen et al., 2013a). The mechanism for bypassing part of 
the restriction point in ESCs is lost, and the up-regulation of cell cycle related 
genes have the effect of stalling cells for longer at G1 (Chen et al., 2013a).  What 
is less well known is how this process is controlled by epigenetic modifications. 
Bivalency offers one explanation, and as stated before, it is generally found at 
developmental loci (Azuara et al., 2006, Bernstein et al., 2006). There are other 
studies that have provided insight into certain epigenetic marks that have been 
observed to change in concert with each other upon differentiation (Serandour et 
al., 2011). However, there is less information on how the crucial processes of 
epigenetic modification and changes in the cell cycle are linked throughout 
differentiation. As the cell cycle is so central to the maintenance of pluripotency, 
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epigenetic processes are critical in contributing to this, and in particular to the G1/S 
block.  
The factors that maintain pluripotency are well-known and discussed above. Both 
Nanog and Pou5f1 genes are known to be involved with the maintenance of 
bivalent histone modifications (Bernstein et al., 2006, Adamo et al., 2011). This is 
critical to the control of pluripotency, as once the bivalent mark is lost; the cell will 
begin to differentiate. A mechanism has been elucidated whereby the levels of the 
bivalent histone modifications are kept in check by the action of an enzyme called 
Utf1 (Jia et al., 2012). This factor limits methylation of H3K27 and concurrently 
labels the underlying mRNAs for destruction, ensuring a balanced, or ‘poised’, 
state that maintains the pluripotency of the cell, and is down-regulated at the onset 
of differentiation (Jia et al., 2012). 
 
1.7 GENOMIC DISTRIBUTIONS OF HISTONE MODIFICATIONS 
 
The vast array of histone modifications present on eukaryotic chromatin can 
present a wealth of information to any chromatin-binding proteins that can read 
the histone/epigenetic code (Strahl and Allis, 2000, Turner, 2007, Turner, 2000). 
One of the important questions remaining in the field today is whether we can 
reach the breadth of knowledge required to be able to read the code ourselves, 
and even to manipulate it to prevent or hinder damaging conditions such as 
cancer. In order to properly answer this question, we must know the distributions 
of each chromatin modification in the epigenome. 
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Histone modifications are not deposited blindly across the entire genome; they are 
specifically targeted to various regions of chromatin depending on the function of 
the mark (Bloushtain-Qimron et al., 2009). For example, the H3K4me3 
modification can be found within gene-coding regions, particularly around the TSS 
of the gene (Guenther et al., 2007, Lloret-Llinares et al., 2012). The distributions of 
these histone modifications reveal much about their activities and interactions. As 
well as the example above, there are other histone modifications that are 
restricted only to densely packaged and transcriptionally inactive chromatin 
(Schotta et al., 2004, Gonzalo et al., 2005, McManus et al., 2006, Puschendorf et 
al., 2008). H3K9me3 can be found in abundance at the centromeres of 
mammalian cells, and also at non-coding and silenced sites within the 
euchromatic areas of the genome (Puschendorf et al., 2008, Alder et al., 2010).  
The changes in these distributions throughout differentiation can determine the 
lineage or fate of the cell (Breiling et al., 2004, Hathaway et al., 2012, Hattori et 
al., 2013). The upregulation of genes involved in lineage-specification, and the 
downregulation of genes involved in pluripotency maintenance are controlled by 
epigenetic processes, and so are the distributions of histone modifications 
changes. Some developmental genes are known to be regulated in clusters, for 
example the Hox clusters (Lewis, 1978, Durston et al., 2011). This makes it easier 
for genes in the cluster to be regulated all at once, so that a generally permissive 
or restrictive chromatin environment can be enforced upon the entire region. When 
development proceeds, the repressive histone modifications are removed and 
transcription and differentiation proceeds (Larson and Yuan, 2010, Kashyap et al., 
2011). This process has also been linked to control by bivalent motifs as described 
above (Kashyap et al., 2011). The dynamic and intricately controlled nature of 
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histone modifications throughout differentiation highlights the importance of the 
understanding of the distributions of critical histone marks throughout the genome 
and epigenome. 
 
1.8 AIMS 
 
In order to understand the effects and activities of histone modifications, we must 
first determine where they are, and how they change over time. In biological 
terms, time can be defined in terms of the number of cell divisions, and so histone 
modifications either remain stable throughout several cell divisions, or are re-
distributed as a response to environmental stimuli. The progress of differentiation 
involves wide-reaching changes to the expression profile of the cell, and so must 
involve some changes to the epigenetic landscape of the nucleus. In order to test 
these principles, I aim: 
- To determine the distributions of several key histone modifications in metaphase 
mouse embryonic stem cells, and crucially to find out whether these distributions 
change after differentiation, exploring one aspect of epigenetic heritability. 
- To produce a full epigenetic karyotype of a few of these histone modifications to 
correlate their distributions with specific chromosomes, and to compare and 
contrast activating and repressive histone modifications and their similarity to data 
for asynchronous cells. This will provide insight into another aspect of histone 
modification inheritance, the transition from interphase to metaphase. 
- To go further into the exploration of histone modification distributions by 
examining a more focused area of the genome, namely the Hox clusters. This will 
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allow the discrimination of histone marks at the single gene scale, leading to a 
comprehensive picture of chromatin environment at a discrete chromatin region. 
Cells will be separated into asynchronous and mitotic populations to probe the link 
between epigenetic modifications and the cell cycle. 
- To determine what epigenetic changes occur at the developmental gene cluster 
Hoxa during the differentiation process and whether these are also affected by the 
progression of the cell cycle. 
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2.     MATERIALS AND METHODS 
 
2.1 TISSUE CULTURE 
2.1.1 Tissue culture of embryonic stem cells 
 
CCE/R (Wild-type) and OS25 (Billon et al., 2002) murine embryonic stem cells 
were grown in gelatinised (0.1%, Sigma) T25 and T75 vented flasks (Sarstedt) at 
37oC in 5% CO2 in DMEM supplemented with the following: 
20% foetal bovine serum; 2mM L-glutamine; penicillin (100units/ml) /streptomycin 
(100µg/ml); 100x non-essential amino acids at 1% v/v, 125µM 2-mercaptoethanol 
(all Invitrogen) and leukaemia inhibitory factor LIF (ESGRO 1000 units/ml, 
Millipore).  
Cells were passaged once confluent, usually in a 1:6 ratio, every two days, and 
were supplemented with 50% new medium on the non-passage days. To 
passage, undifferentiated cells were trypsinised for 5 mins using 0.5% 
Trypsin/EDTA (Invitrogen) and centrifuged at 1200rpm for 5mins (MSE Mistral 2) 
in 15ml or 50ml centrifuge tubes (Falcon). The pellet was then resuspended in 
10ml of the above ES cell medium. Cells were then put into fresh gelatinised 
flasks. Harvesting of cells was accomplished by trypsinising as above and 
resuspending cells in 1xPBS (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM 
KH2PO4, 5mM Sodium Butyrate, pH adjusted to 7.4 (all Sigma)). The cell pellet 
was then washed twice in PBS by centrifugation (1200rpm/10min) and 
resuspended in PBS. 
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2.1.2 Tissue culture of differentiating cells and fibroblasts 
 
OS25 and CCE/R cells were encouraged to differentiate by trypsinising as above, 
and then plating them into 7cm non-adherent dishes (Sterilin) in the absence of 
LIF. Plates were incubated at 37oC in 5% CO2 and 50% media was replaced every 
day. Two days after plating, 1µM retinoic acid was added to further promote 
differentiation. Harvesting of cells was done by trypsinising for 3mins, then 
transferring to centrifuge tubes (Falcon), centrifuging at 1200rpm for 5 minutes 
and washing in PBS as above.  
Mouse embryonic fibroblasts were grown in gelatinised (0.1%, Sigma) vented 
flasks (Sarstedt) at 37oC in 5% CO2 in Dulbecco’s modified Eagle’s medium 
(DMEM, Invitrogen) containing: 
10% foetal bovine serum; 2mM L-glutamine; penicillin (100units/ml) /streptomycin 
(100µg/ml); 100x non-essential amino acids at 1% v/v and 125µM 2-
mercaptoethanol (all Invitrogen).  
2.1.3 Cryopreservation of cells  
 
Undifferentiated cells to be cryopreserved were harvested as above. After washing 
twice with ES cell medium, pellet was resuspended in FBS (Invitrogen) containing 
10% Dimethyl sulphoxide (DMSO, Sigma). This was then divided into 1ml aliquots 
in cryo vials (Sigma) and the vials placed in a freezing container (Mr. Frosty, 
Sigma) at -80oC overnight. The vials were then transferred into a Dewar 
containing liquid nitrogen at -196oC for storage. Cells brought up from liquid 
nitrogen storage were thawed at room temperature and then resuspended in 10ml 
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ES cell medium. This solution was centrifuged at 1200rpm for 10min (MSE Mistral 
2). The pellet was washed twice in ES cell or MEF medium and finally 
resuspended in 5ml. This was then added to a gelatinised T25 vented flask 
(Sarstedt) and kept in a CO2 incubator as above (37
oC, 5% CO2). 
2.2 FLOW CYTOMETRIC ANALYSIS OF CELL POPULATIONS 
 
Cells used for flow cytometry were trypsinised and harvested as above. Cells were 
fixed in 5ml ice cold ethanol and centrifuged at 800rpm for 10min (MSE 2000R). 
The pellet was washed three times in PBS and resuspended in 2ml PBS in 
polypropylene tubes (Falcon). An equal volume of 1xPBS/1% Triton X-100 
(Sigma) was added to disaggregate the cells, 20 µl RNase A and 20µl Propidium 
iodide (10mg/ml, Sigma) were added to stain the nuclei. The sample was analysed 
using a flow cytometer and its associated software (Beckman Coulter 
FACSCalibur). Gates were determined specifying the populations of 2n (G1 phase 
cells), 4n (G2/M phase cells) and 2-4n (S phase cells). Graphs were produced by 
plotting cell counts (y-axis) against fluorescence (x-axis). For an example of the 
resulting plot, see figure 2.1.  
 
2.3 CHROMOSOME IMMUNOFLUORESCENCE 
2.3.1 Isolation of nuclei and chromosome spreading  
5l colcemid (10µg/ml, Invitrogen) per ml of medium was added to cultured mouse 
cells (in 25cm3 tissue culture flasks). Cells were incubated at 37oC for 2½ hours 
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43% 35% 22%
Figure 2.1 FACS results from asynchronous differentiating (d4)
OS25 cells treated with Propidium iodide. The graph shows gating
for three distinct cell cycle populations. R5 refers to the G1
population, R4 to the S phase population, and R3 contains cells in
G2 and mitosis phase, as shown by the fluorescence (X-axis)
being nearly double that of the G1 cells (cell count on Y-axis).
Shown above the graph are the proportions of each population
relative to the total cell count.
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and shaken off. Cells were centrifuged at 1200rpm for 10 minutes at 4oC (MSE 
2000R), and then washed twice in ice-cold 1xPBS/ Sodium Butyrate pH 7.4. Cells 
were counted and then resuspended at 105 cells per ml in 0.1M KCl (at least 2 
biological replicate experiments). The suspension was left at room temperature for 
10 minutes, and then 2x104 cells were pipetted into a cytospin chamber attached 
to an ethanol-washed glass slide (VWR). The chamber was centrifuged at 
1800rpm (Thermo CytoSpin 4) for 10minutes at room temperature. The chamber 
was removed and the glass slide was immersed in KCM buffer (120mM KCl, 
20mM NaCl, 10mM Tris pH 8.0, 0.5mM EDTA, 0.1% v/v Triton X-100, all Sigma) 
for 10 minutes.  
2.3.2 Chromosome indirect immunofluorescence 
 
Primary antibodies (see table 2.1) raised in rabbit against specific histone 
modifications was diluted in 1% bovine serum albumin (BSA, Sigma) in KCM 
buffer, and 50l was then added onto the slide. Commercial antibody specificity 
data is shown in figures 2.2 and 2.3. In-house antibodies have been tested 
previously and demonstrated to be specific to target modified residues. The slide 
was humidified in the dark at 4oC for 1 hour. The slide was then washed twice in 
KCM for 10 minutes each. 50l goat anti rabbit FITC (diluted x50 in 1% BSA/KCM) 
was added, the slide was then humidified again for 1 hour. The slide was then 
washed twice in KCM and then immersed in 4% Formaldehyde in KCM for 10 
minutes exactly. The slide was then rinsed in distilled water and mounted on an 
ethanol-washed cover slip with 1µg/ml DAPI (Invitrogen) in Vectashield mounting 
medium (Vector Labs). The cover slip was sealed using nail varnish and the slide
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Antibodies used in 
immunofluorescence experiments
Antibody Dilution factor
H3K4me1 (in-house SAS cut) 100x
H3K4me2 (in-house SAS cut) 100x
H3K4me3 (in-house SAS cut) 100x
H3K9me1 (Abcam) 300x
H3K9me2 (Millipore) 400x
H3K9me3 (Millipore) 600x
H3K9ac (in-house SAS cut) 100x
H3K27me3 (Millipore) 600x
H3K27ac (Abcam) 300x
H4K12ac (in-house SAS cut) 400x
H4K16ac (in-house SAS cut) 200x
H4K20me3 (Abcam) 400x
Table 2.1 Sources and dilutions of antibody added to each 
reaction in the immunofluorescence procedure. Antibodies 
were diluted in 1% BSA in KCM buffer.
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Figure 2.2 Commercially acquired antibody specificity (Millipore):
A. Western Blot Analysis and Peptide Inhibition: Representative blot HeLa Acid
extract were resolved by electrophoresis, transferred to nitrocellulose and probed
with anti-dimethyl-Histone H3 (Lys9) (1:500, Lane 1) or preincubated with 0.4uM
Histone H3 peptide with following modifications: Lane 2: Linear non-modified, Lane
3: Branched non-modified, Lane 4: Branched trimethyl, Lane 5: Linear trimethyl,
Lane 6: Branched dimethyl, Lane 7: Linear dimethyl, Lane 8: Branched monomethyl,
Lane 9: Linear monomethyl Proteins were visualized using a goat anti–rabbit
secondary antibody conjugated to HRP and a chemiluminescence detection system.
B. Dot Blot Analysis: Dot-blot analysis demonstrating specificity of anti-H3K9me3 for
trimethyl Lys9 of histone H3. Synthetic peptides containing various histone
modifications (0-50 pmol) were spotted onto PVDF. The membrane was incubated
with a 1:100 dilution of a previous lot of anti-trimethyl-Histone H3 (Lys9), clone
6F12-H4, and processed for Western blotting.
C. Histone peptides with various modifications were probed with Anti-trimethyl
Histone H3 (Lys27) (1:500 dilution). Proteins were visualized using a Donkey Anti-
Rabbit IgG secondary antibody conjugated to HRP and a chemiluminescence
detection system. C11: KAAR[trimethyl-K]SAPA-C E10: KAAR[trimethyl-
K]SAPSTGGVKKC.
Figures and data taken from Millipore website: www.emdmillipore.com.
A
B
C
50 
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Figure 2.3 Commercially acquired antibody specificity (Abcam): Western blot
blocking experiments -
A. All lanes : Anti-Histone H3 (mono methyl K9) antibody - Lane 1 : Calf Thymus Histone Preparation
Nuclear Lysate Lane 2 : Human Histone H3 (unmodified ) Lane 3 : Human Histone H3 (mono methyl
K4) Lane 4 : Histone H3 (di methyl K4) Lane 5 : Human Histone H3 (tri methyl K4) Lane 6 : Human
Histone H3 (mono methyl K9) Lane 7 : Human Histone H3 (di methyl K9) Lane 8 : Human Histone H3
(tri methyl K9) Lane 9 : Histone H3 (mono methyl K27) Lane 10 : Human Histone H3 (di methyl K27)
Lane 11 : Human Histone H3 (tri methyl K27) Lysates/proteins at 0.5 μg per lane.
B. All lanes : Anti-Histone H4 (tri methyl K20) antibody at 1 μg/ml. Lane 1 : Human Histone H4
(unmodified ) peptide 2 : Human Histone H4 (unmodified ) peptide 3 : Human Histone H4 (mono
methyl K20) peptide 4 : Human Histone H4 (di methyl K20) peptide 5 : Human Histone H4 (tri methyl
K20) peptide
6 : Human Histone H3 (tri methyl K4) peptide 7 : Human Histone H3 (tri methyl K9) peptide Blocking
peptides at 1 μg/ml per lane.
C. Peptide Array against peptides to different Histone H3 modifications. Six dilutions of each peptide
are printed on to the Peptide Array in triplicate and results are averaged before being plotted on to a
graph. Results show strong binding to Histone H3 acetyl K27 peptide (ab24404), indicating that this
antibody specifically recognises the Histone H3 acetyl K27 modification. ab24404 - H3 acetyl K27
ab15591 - H3 acetyl K14 ab24003 - H3 acetyl K18 ab17163- H3 unmodified ab48359- H3 acetyl K23
ab41409 - H3 acetyl K36 ab15662 - H4 acetyl K12 ab16635 - H3 acetyl K9. Figures and data taken
from Abcam website www.abcam.com
A
B
C
51 
52 
 
was stored in a dark box. Slides were photographed using an Axioplan2 
microscope (Zeiss) at x100 magnification in Smartcapture software (Digital 
Scientific UK). Images were analysed using ImageJ (NIH) and SmartType (Digital 
Scientific UK) software. 
2.3.3 Fluorescence In Situ Hybridisation slide preparation 
 
5µl Fluorescence In Situ Hybridisation (FISH) mouse chromosome paint DNA 
probe (Cambio StarFISH) was added to 5µl StarFISH hybridisation buffer 
(Cambio) and denatured at 65oC for 10min, then incubated at 37oC for 2.5 hours. 
Cover slips were removed from previously immunostained slides, and were 
immersed in 70% formamide/SSC (0.3M NaCl, 0.03M sodium citrate, pH 8) at 
75oC for 10min. Slides were progressively dehydrated for 2min each in 75%, 90% 
and 100% methanol, and dried on a heating block. 10µl FISH probe was added to 
the slide and the cover slip was attached using rubber cement. The slide was 
humidified at 37oC overnight. The cover slip was carefully removed and the slide 
immersed in 1xSSC at 75oC for 30min. The slides were washed twice at room 
temperature in PN buffer [100 mM Na2HPO4, 50 mM NaH2PO4, 0.1% Triton X-100 
(v/v)] for 10min each, then 1µg/ml DAPI in Vectashield medium (Vector Labs) was 
added, and then a cover slip was applied and sealed. Images were obtained as 
above. Two biological replicates were performed, each slide containing many 
chromosome spreads so that n≥8 as reported above. 
2.3.4 Computational analysis of chromosome immunofluorescence 
 
To produce numerical results from the images obtained from the 
immunofluorescence procedure, ImageJ software was used (NIH). The freeform 
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line tool was used to trace a path along the selected chromosome arm, and the 
line was widened to fit as closely as possible the width of the chromosome, whilst 
still staying inside its boundaries. The software calculated the average FITC 
fluorescence at each pixel along the length of the chromatid. Another line was 
drawn in an empty section of the image in order to provide an average 
background reading. This value was subtracted from the other results, and then 
the results were normalised as a percentage of the maximum observed 
fluorescence for that image. Using this method, it was possible to gauge the 
changes in fluorescence across chromosome arms. This was repeated for each 
chromosome and chromosome arm under consideration (n= at least 4 
chromosomes, or 8 chromosome arms). The relative lengths of the chromosomes 
were normalised by using the NCBI Map Viewer to obtain the length of each 
chromosome in terms of base pairs. The data was then segmented into 10 
megabase tranches, so that values obtained for each pixel were allocated to a 
discrete data bin. This way, images of chromosomes displaying different physical 
lengths were normalised to the same genetic length. A histogram chart was 
produced from this data consisting of the mean relative fluorescence of a 
particular 10 megabase section of a chromosome represented by a bar, and the 
standard deviation between replicates represented by the error bars. This was 
then compared to publicly available NCBI sequence data, namely gene density, 
CpG density and repeat density. These were obtained by counting the number of 
genes, CpGs and repeats in each 10 megabase window and representing them as 
bars on a histogram in a similar way to my own data. Error bars are not present on 
these graphs, as they are taken from a single source (NCBI website, chromosome 
viewer). These sets of data cannot be compared statistically as there are 
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insufficient replicated to perform parametric statistical tests, and the use of non-
parametric tests would not yield statistically significant results.  
 
2.4 NATIVE CHROMATIN IMMUNOPRECIPITATION 
2.4.1 Chromatin preparation and purification for N-ChIP 
 
Cultured CCE/R cells were trypsinised (Invitrogen) and washed 3 times in ice cold 
1xPBS/Sodium butyrate. Cells were resuspended at 2x107 cells per ml PBS. The 
final cell pellet was resuspended in 1 x TBS (1mM Tris-HCl, 15mM NaCl, 3mM 
CaCl2, 2mM MgCl2 and 5mM sodium butyrate, all Sigma) at a concentration of 2 x 
107 cells per ml. An equal volume of 1% Tween40 (Sigma) diluted in TBS and 
1/200th of the volume 0.1M PMSF (Sigma) was added. The cell suspension was 
stirred on ice for 1 hour. The sample was homogenised using a hand operated, 
all-glass homogeniser with a tight pestle (Dounce). After 7 smooth strokes the 
homogeniser was placed on ice until the suspension cleared (usually 1-3 minutes). 
During the cooling/settling period, release of nuclei was checked by examining a 
small aliquot under the microscope in a standard counting chamber. 
Homogenisation continued until 75% of cells yielded intact nuclei. Following 
homogenisation, nuclei were centrifuged at 2000rpm for 10 minutes at 4oC (MSE 
2000R). Nuclei were resuspended in 1ml of 5% sucrose (Sigma)/TBS pH 7.4 with 
0.1mM PMSF and centrifuged at 2000rpm 10 minutes at 4oC (MSE 2000R). Nuclei 
were resuspended in 1ml Digestion buffer pH7.4 (0.32 M Sucrose, 50 mM Tris-
HCl (pH7.4), 4 mM MgCl2, 1 mM CaCl2, and 0.1 mM PMSF). The amount of 
chromatin was checked by measuring the A260 of an aliquot diluted 20-fold in 0.1% 
SDS (Sigma), using a light spectrometer (Amersham). Samples were centrifuged 
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at 2000rpm for 10 minutes at 4oC (MSE 2000R) and pellets resuspended to a 
chromatin DNA concentration of 0.5mg/ml and divided into 1ml aliquots in 
Eppendorf tubes. Chromatin was digested with micrococcal nuclease (Sigma) at 
50U per 500 µg chromatin for 5 minutes at 37oC. Digestion was stopped by 
addition of 20µl 0.5M EDTA (Sigma) (to a final concentration of 10 mM) and 
chromatin placed on ice for 5 minutes. Sample was centrifuged at 4000rpm for 5 
minutes (Fresco), supernatant (S1) was removed and kept on ice. Pellets were 
resuspended and combined in 500µl lysis buffer at pH7.4 (2 mM Tris-HCl (pH7.4), 
0.2 mM EDTA, 5 mM Na butyrate, 0.2 mM PMSF) per 1ml solution (if multiple 
micrococcal nuclease digestions had been performed; then in 1 ml final volume). 
Pellets were dialysed overnight at 4oC in dialysis tubing (Sigma) against 2 litres of 
lysis buffer, and the S1 fraction was kept at 4oC. Dialysed chromatin was 
centrifuged at 2000rpm for 10 minutes at 4oC (MSE 2000R). The supernatant was 
removed and place on ice (fraction S2). The pellet was resuspended in an equal 
volume of lysis buffer (fraction P). A260 of all samples was checked and distribution 
of chromatin between the three fractions was calculated. All samples were 
analysed by 1.2% agarose (Sigma) gel electrophoresis, to ensure that a 
nucleosomal ladder had been precipitated in the S1 and S2 fractions (figure 2.4). 
These fractions were the combined and the final chromatin concentration assayed 
by A260 measurement. 
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100bp 
DNA 
ladder
First 
elution
Second
elution
Pellet
Figure 2.4 Inverted UV photograph showing chromatin
resulting from the N-ChIP chromatin extraction procedure.
First elution (S1) and second elution (S2) display bands
equivalent to multiples of nucleosome lengths (~146-200bp),
material remaining in the pellet contains very few
oligonucleosomes. Chromatin was run out on a 1.2%
agarose gel, stained with ethidium bromide and viewed using
a transilluminator.
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2.4.2 Native chromatin immunoprecipitation: N-ChIP 
 
Antibodies were added to S1+S2 combined fractions in the quantities below (see 
table 2.2). Antibody solutions were added to 50µg unfixed chromatin and 
incubation buffer (50 mM NaCl, 20 mM Tris–HCl, pH 7.5, 20 mM Na butyrate, 
5 mM Na2EDTA, 0.1 mM PMSF) was added up to a final volume of 800µl. Half 
that amount of chromatin was added to 10µl pre-immune serum, as a non-specific 
control and made up to 400µl with incubation buffer. After overnight incubation on 
a slowly rotating platform (TAAB) at 4 °C, 200 μl (100µl for PI) pre-swollen protein 
A–Sepharose (50% v/v slurry, GE Healthcare) was added and the incubation was 
continued for a further 3 h at room temperature on a fast turntable (Bibby). The 
antibody–chromatin mixture was centrifuged at 13000rpm for 10 min (Thermo 
Fresco). Supernatant was removed using siliconised glass Pasteur pipettes 
(Appleton Woods) and added to 333µl phenol chloroform (25 parts phenol: 24 
chloroform: 1 methylbutanol) to constitute the unbound fraction. The protein A–
Sepharose pellet was resuspended in 1 ml wash buffer (50 mM Tris–HCl, pH 7.5, 
10 mM EDTA, 5 mM Na butyrate) containing 50 mM NaCl, transferred to 
siliconised 15ml CTs and layered onto 9 ml of the same buffer. After centrifugation 
at 2000rpm for 10 min at 4 °C (MSE 2000R), supernatant was removed and the 
pellet washed in 10 ml wash buffer containing 100 mM NaCl and again in 10 ml of 
wash buffer containing 150 mM NaCl. Samples were centrifuged at 2000rpm for 
10 minutes (MSE 2000R) and resuspended in 1ml wash buffer (with 150mM 
NaCl). Samples were transferred to siliconised Eppendorfs and centrifuged at 
13000rpm for 10 minutes (Thermo Fresco). Bound material was eluted from the 
protein A–Sepharose by addition of 250μl 1% SDS in incubation buffer and 
incubated for 15 min at room temperature on a fast turntable (Bibby). After 
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Antibodies used in 
N-ChIP experiments
Antibody Amount to add to 50µg
chromatin
H3K4me3 (in-house SAS cut) 100µl
H3K9me2 (Millipore) 10µl
H3K9ac (in-house SAS cut) 100µl
H3K27me3 (Millipore) 10µl
H3K27ac (Millipore) 10µl
H4K20me3 (Millipore) 10µl
Pre-Immune Control (in-
house from rabbit)
10µl
Table 2.2 Sources and amounts of antibody added to each 
reaction in the N-ChIP procedure.
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centrifugation at 13000rpm for 10 min (Thermo Fresco) the supernatant was taken 
and added to 333µl phenol chloroform. 250μl 1% SDS in incubation buffer was 
again added to the pellet After centrifugation at 13000rpm for 10 min (Thermo 
Fresco) the supernatant was taken and added to the bound fraction. An equal 
volume of incubation buffer (500µl) was added to the bound fraction to reduce the 
concentration of SDS to 0.5%. Unbound and bound fractions were vortexed and 
centrifuged at 2000rpm for 10 min (MSE 2000R) to separate the phases. 
Supernatant was removed and an equal volume of phenol chloroform added. 
Samples were vortexed and centrifuged at 2000rpm for 10 min (MSE 2000R). An 
equal volume of chloroform (24 parts chloroform: 1 methylbutanol) was added, 
vortexed/centrifuged as before, and the supernatant transferred to a 6ml 
polypropylene tube (Falcon). Finally the DNA was precipitated at −20 °C using 
100µl 4M LiCl (Sigma), 25µl glycogen (2mg/ml, Roche) and ice-cold ethanol 
(Fisher) up to 5ml. 
2.4.3 Verification of DNA following ChIP 
 
Samples were centrifuged at 3000rpm for 20 minutes (MSE 2000R). The pellet 
was air dried and resuspended in 200µl water, transferred to Eppendorfs and 
stored at       -20oC. PicoGreen analysis of the DNA concentration was performed 
by adding 2µl DNA to 98µl PicoGreen (Invitrogen) diluted 200-fold in TE buffer: 
1mM Tris-HCl pH 8.0, 0.1mM EDTA; in duplicate, and analysed using a 
spectrophotometer (Victor3 – Perkin Elmer). The percentage pull-down for each 
antibody was calculated for bound fractions based on a standard curve of known 
quantities of mouse genomic DNA, and unbound samples were diluted to the 
same DNA concentration as the bound fraction. 
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2.4.4 Analysis of N-ChIP samples by Real-time PCR 
 
PCR reactions were performed in triplicate on 384 well plates (ABgene), with 
mouse genomic DNA control and no template control. Primers (Invitrogen) were 
designed to specific regions of the mouse genome using Primer3 
(http://bioinfo.ut.ee/primer3 and http://www.ncbi.nlm.nih.gov/tools/primer-blast). 
Primers were designed to be specific to a single target sequence, produce a 
single dissociation curve peak, have an efficiency of 90-110%, and to have a 
melting temperature of 60 +/-2 oC (see table 2.3). Primers for the Hox cluster were 
targeted towards the promoters of all 10 Hoxa genes, the promoters of the 5’ and 
3’ flanking genes and upstream and downstream intergenic sequences (figure 
2.5). 0.5µl forward primer, 0.5µl reverse primer, 2µl sterile water and 5µl 2x 
Quantitect SYBR mastermix (Qiagen) were added to 2µl template DNA for each 
reaction. The plates were centrifuged and loaded onto the ABIPrism 7900 PCR 
machine (Applied Biosystems). PCR program was as follows: 95oC for 15mins; 
then 40 cycles of 94oC for 15 secs, 60oC for 30 secs and 72oC for 30 secs. A melt 
analysis consisting of 95oC for 15secs, 60oC for 15secs, then a 95oC melt gradient 
was performed to verify a single product. Analysis of the data was performed 
using the double delta Ct (cycle threshold) method of relative DNA quantification 
to compare bound with unbound fractions. This uses the time (in cycles) at which 
the fluorescence of the product bound to SYBR green reaches a threshold (that is 
set above the background fluorescence). As SYBR green increases in 
fluorescence by a factor of 20 when bound to double-stranded DNA, proper 
amplification of a target will result in a fluorescence signal higher than that of the 
background. Means of the three replicates are taken, and the unbound fraction 
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Mouse genomic DNA primer sets
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) Tm 
(oC)
Product 
length 
(bp)
Skap2
CGGGCAACGGTACAGGTGGC CGGAGCGTTCTGATTGGCGC 60 148
Evx1
GGAACTCGCTGCGCGCCTTA AGGTGTGGGCCTCGCTCGAA 60 143
Hoxa1
GCGCGTCACCTACACTGAG CGTGACTCTACCAGCCAATG 60 117
Hoxa2
TGAGGCGTTCCTTTCTGACT TGGCTGTCACATGATTGCTT 60 103
Hoxa3
CAGTTCCTGGAGCAGCCGCC CTGTCGCTTCGGCAGCCCAA 60 111
Hoxa4
TGGAGGGCCTCGAACCCTCG GCCCTGTTCCTGCCCACGTC 60 116
Hoxa5 
GATCGGCAGCTGACGGCCTC CGCTTCCGACCTCGGGCTTC 60 126
Hoxa6
ATTTGCTGCTGTCGCTTTTG CCCTCTGCAGGACTGTGATT 60 113
Hoxa7 
GGCCTGAGCAGTTTATGAGG CTTACCTTGCTGGGCTTCAG 60 129
Hoxa9 
AGCTGCGCGATCCCTTTGCA GTGTCCGCCCGGCAGAACAA 60 122
Hoxa10 
TCTTCTGGCCCATCAATACA CACTCCCAGTTTGGTTTCGT 60 101
Hoxa11 
TCAATTTCAACATCGGGTCA GAAGCGGATCCGTGAAGTAG 60 105
Hoxa13 
GCCAGTCCAAGGCCAAGGCA CGGAGGTTGGGAGGGGCAGT 60 118
Hoxa
upstream 
(intergenic)
TGGAGCTCAGTGTCGAGAGTGTGA ACTCCATGCTGTTGCCATATCTGC 58 160
Hoxa 
downstream 
(intergenic)
AACCCAAGTTGGCTGCCCCATC ACCCAGGCAAACGTTCGGAGTAA 60 137
Gapdh
TCCTGGGAACCATCACCCGGTC TGTGCACGCACCAAGCGTGT 60 94
Nanog
CCAATGTGAAGAGCAAGCAA CCCCCAAAAAGAGGCTTTAC 60 155
Pou5f1
CAACAGGCTTTGTGGTGCGA CAACCCTTAGGACGGGACCC 60 129
Table 2.3 Sequences, lengths and melting temperatures of
primers used during qPCR of material derived from ChIP
experiments
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Figure 2.5 Diagram of UCSC genome browser data showing the
positions of Hoxa genes within the Hoxa cluster on mouse
chromosome 6. Chromosome bands and base position are shown
above. Approximate primer positions are marked with a red P, and are
targeted to the 5’ promoter region for each gene.
P
P
P
P
P
P
PP
P
P
P
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value is subtracted from the bound fraction value. The negative of this value is 
then taken as a power of 2 to produce a relative enrichment value for that sample. 
A value above 1 indicates that the Ct value for the bound fraction is lower (i.e. 
earlier in the PCR, denoting higher initial copy number) than the unbound fraction, 
or that the bound fraction is enriched. In formula terms: 
ΔΔCt = 2-(Bound Ct – Unbound Ct) 
This allows the comparison of the amplification of DNA from bound to unbound 
fractions. Three biological replicates were performed, each with three technical 
replicates (triplicates). 
 
2.5 RNA EXPRESSION ANALYSIS 
2.5.1 Extraction of RNA from cultured cells 
 
CCE/R cells were cultured in Sterilin 7cm dishes and harvested every day for 7 
days. Cells were shaken off, washed x3 in PBS and the pellets frozen at -20oC. 
Cells were then thawed and resuspended in 600µl RLT buffer (Qiagen RNeasy 
Kit) and passed through a 21G needle 7 times. An equal volume of 70% v/v 
ethanol was added, and the suspension transferred to a centrifuge column 
(Qiagen). Samples were centrifuged at 13000rpm (Eppendorf MiniSpin) for 30 sec, 
flow through was discarded, and 700µl RW1 buffer (Qiagen) was added. Samples 
were centrifuged again at the same speed for 30s, flow through was discarded 
and 500µl RPE buffer (Qiagen) was added to the column. Samples were 
centrifuged again for 30s and flow through discarded. Another 500µl RPE was 
added and samples centrifuged for 2 minutes. Then, columns were placed in a 
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new collection tube and the samples centrifuged again for 1min. Columns were 
again placed in a new collection tube and 30µl RNase free water (Qiagen) was 
added. Tubes were centrifuged for 1 min, another 30µl of water was added, 
samples were centrifuged again for 1 min, and eluate was transferred to 
Eppendorf tubes. Product was run out on 1.2% agarose gel to check for the 
characteristic double band of RNA-associated ribosomes. 
2.5.2 Synthesis of cDNA and subsequent analysis by qPCR 
 
1µg of RNA was added to a PCR tube with 1µl oligo-dT (Invitrogen Superscript III 
kit), 1µl dNTP mix and made up to 13µl with water. Samples were heated at 65oC 
in a PCR block (MJ research) for 5 minutes, then cooled at 0oC for 1 min. 1µl DTT, 
1µl RNase inhibitor, 1µl reverse transcriptase and 4µl first-strand buffer were 
added, and the tube was heated at 50oC for 60min, then 70oC for 15min. 1µl 
RNase H was added, and the sample was heated at 37oC for 20min. Samples 
were diluted up to 100µl and stored at -20oC for later analysis using real-time PCR 
described above. Primers designed for cDNA analysis span exon junctions so that 
any residual genomic DNA is not amplified (see table 2.4). 
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Mouse cDNA (expression) primer 
sets
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) Tm 
(oC)
Product 
length 
(bp)
Skap2
GGCCCCTCTGATGGAAACCAGT GCTGAGCGCACACCACCGTT
60 141
Evx1
GGGGAGGCCAGGAGGAGGAG TCGGAGCCTGGCGCTTTGC
60 256
Hoxa1
AGTTGTGGTCCAAGCTATGGC ACTCTCCAACTTTCCCTGTTTTG
58 388
Hoxa2
CGACGCTTTCACACTCGACA TTTCCAGGGATTCTTTGTGGCC
60 273
Hoxa3
CCGCGGTCTGAAGGCTACGT CGTGACACTCCGCCGCCAAT
60 235
Hoxa4
CCACGTGAGCGCCGTCAACTCC GTGTGGGCGATCTCGATGCGG
60 150
Hoxa5 
CCACCACGGCGGGAAAAACT TCTGGGCCACCTATATTGTCGTG
58 240
Hoxa6
GTCCAACTCGGTCTTGGCCTGC TACACGGCACCCGCACAGGAATT
60 270
Hoxa7 
CTCGCAGAGAAGCGGCTACGG TCCTGTCGGGTCCTGAACTGCG
60 287
Hoxa9 
CGCTCTCCTTCGCGGGCTTAC GGCAGCCGGGTTATTGGGATCGA
60 242
Hoxa10 
TCCGGCACCCCTTCGTATTCA CGCCTTTGGAACTGCCTTGACT
58 180
Hoxa11 
GGTGGCTCCGGTGGCCAACG ATGCGGGACAGTTGCAGACGC
60 131
Hoxa13 
TCGGGGGTCCTGGCGAGTCG GGGAGACGACGTCGGGCAGAGT
60 162
Actb
CCACACCCGCCACCAGTTCG TACAGCCCGGGGAGCATCGT
60 112
Nanog
TCCTGGTCCCCACAGTTTGCC AGGCAGGTCTTCAGAGGAAGGGC
60 169
Pou5f1
TGGGCTAGAGAAGGATGTGG TGGGAAAGGTGTCCCTGTAG
60 118
Table 2.4 Sequences, lengths and melting temperatures of
primers used during qPCR of cDNA derived from expression
analysis experiments
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 3. RESULTS – CHROMOSOME IMMUNOFLUORESCENCE 
 
3.1 INTRODUCTION TO IMMUNOFLUORESCENCE RESULTS 
3.1.1 Inheritance of histone modifications 
 
One of the central assumptions of the theory of epigenetics is that epigenetic 
modifications must be replicated faithfully upon cell division; otherwise they would 
be transient bystanders in the mechanism of inheritance (Turner, 2000, Masumoto 
et al., 2011). However, the process and action of epigenetic inheritance and its 
link to the cell cycle have not yet been fully elucidated. The cell cycle is a crucial 
paradigm in the concept of inheritance as it is the basic unit of change for passing 
on cellular information to future generations. DNA sequences are replicated 
accurately through a single cell cycle, and are maintained throughout the lifetime 
of the organism and passed down vertically to survive for generations. It is thought 
that epigenetic marks, such as histone modifications, could behave in a similar 
way to provide a deeper layer of heritable information that can complement and 
interact with genetic sequences (Strahl and Allis, 2000, Turner, 2000, Guerrero-
Bosagna et al., 2010). I hope to probe the nature of histone modifications at the 
transition between cell cycles in order to better understand the nature of the 
inheritance of epigenetic information.  
3.1.2 Histone modifications at the interphase – mitosis phase transition 
 
The cell cycle model I am using in this study is the transition from interphase to 
mitosis phase in murine embryonic stem cells. Mitosis, and more specifically 
metaphase, is the period of the cell cycle characterised by highly condensed and 
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packaged DNA in chromosomes, the lack of a nuclear envelope, the formation of 
spindle fibres in preparation for cell splitting, and very low transcriptional activity 
(Konrad, 1963, Parsons and Spencer, 1997). This is useful for the study of 
epigenetics because it has been alleged that histone modifications are not truly 
epigenetic and are in fact merely indicators of gene transcription, controlled 
entirely by underlying DNA sequences (Singh et al., 2008, Yi and Richards, 2009). 
Therefore, breaking the link between transcription and histone modifications by 
performing experiments involving cells that are not transcribing genes is 
particularly useful. I used mouse ES cells, which display an unusually short cell 
cycle profile, characterised by short gap phases (Becker et al., 2007, Tarasov et 
al., 2008). I also used these cells as they can be differentiated into any intra-
embryonic cell type, providing a model for the behaviour of histone modifications 
through differentiation, another key insight into the wider question of epigenetic 
inheritance (Evans and Kaufman, 1981, Martin, 1981). 
3.1.3 Chromosomes under the microscope 
 
Metaphase is an ideal point to analyse the association of histone modifications 
with DNA through the cell cycle, as it is transcriptionally inert, a very short, discrete 
and specific phase of the cell cycle and one entirely concerned with passing on 
genetic information to daughter cells (Cohen and Deane, 1976, Parsons and 
Spencer, 1997). The chosen method to arrest cells in metaphase is by using a 
mitotic spindle microtubule poison, colcemid. Then, chromosome immunostaining 
is used to fluorescently label specific histone modifications on the surface of 
metaphase chromosomes (Terrenoire et al., 2010, Ding et al., 2012). This is 
analysed using a fluorescence microscope, which can distinguish regions of 
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higher and lower intensities of antibody staining. This method allows for a whole-
genome, single-cell analysis of the histone modification landscape at metaphase 
in mouse cells. The advantages of a single cell analysis method are that the effect 
of inter-cell noise giving unclear results is eliminated and that the entire 
epigenome of any given modification can be viewed at once (Terrenoire et al., 
2010). Another advantage is that using immunomicroscopy it is possible to gauge 
the progression of the cell cycle with remarkable precision. It is immediately 
obvious, for example, whether or not cells viewed using this technique are going 
through the initial stages of metaphase, a very discrete and short window in the 
cell cycle that has important implications as I have explained above. For the 
purposes of this study, the microscope was appropriate to discover the links 
between histone modifications and chromosomal regions. 
Previous studies using the immunofluorescence techniques probed the 
distributions of histone modifications in human cells (Terrenoire et al., 2010). This 
method relied on the technique of reverse-DAPI banding in order to identify 
chromosomes in the resultant karyotypes. This method is somewhat subjective 
and prone to error, as it relies on the operator to distinguish G-banding patterns 
that are very similar to each other and can be indistinct. The technique employed 
in this study involves attaching a chromosome-specific FISH (Fluorescence In Situ 
Hybridisation) tag to DNA in order to unequivocally identify each chromosome 
(Evans et al., 1991, Nagamachi et al., 2013). This can greatly improve the 
precision of the karyotype identification process and can therefore improve the 
confidence with which the epigenetic profile of that chromosome can be called. 
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3.1.4 Chromosome immunofluorescence was used to indicate specific 
histone modification distributions 
 
The chromosome immunofluorescence procedure involves purifying nuclei from 
cultured mouse cells and centrifuging them to release the chromosomes. 
Fluorescent-tagged antibodies indirectly bind to histone modifications H3K4me1, -
me2 and -me3; H3K9me1, 2, 3 and H3K9ac; H3K27me3 and H3K27ac; H4K12ac; 
H4K16ac and H4K20me3 were attached to the chromatin to distinguish modified 
from unmodified sections of the chromosomes. These marks were chosen in order 
to obtain results from different classes of modifications, including acetyl and 
methyl marks on both histones H3 and H4, and residues with multiple possible 
modifications, such as H3K4, H3K9 and H3K27. Another reason that these 
specific modifications were chosen is that they are associated with different 
activities within the nucleus. H3K4me3 and H3K27me3 are constituent parts of the 
bivalent mark, with transcription activating and repressing properties respectively 
(Bernstein et al., 2006, Schwartz et al., 2010). The bivalent mark is present on 
certain genes or gene clusters that change their expression patterns upon 
differentiation, where the repressive component of the mark is lost in order to 
promote expression of the associated gene (Bernstein et al., 2006, Shin et al., 
2012). Several other marks have reciprocal, concomitant or complementary 
actions, and so probing a wide range of histone modifications was necessary in 
order to form a more comprehensive picture of what the state of the epigenome is 
in eukaryotic cells. 
H3K4me1, 2 and 3 are closely associated with genes, and are densely distributed 
within gene-rich regions of the genome (Pekowska et al., 2011). However, each of 
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these marks aligns with a different part of the gene region. H3K4me1 was found to 
associate closely with enhancers (Pekowska et al., 2011), H3K4me2 is enriched 
across the bodies of genes (Lindahl Allen et al., 2009, Roudier et al., 2011) and 
H3K4me3 commonly associates with gene promoters (Guenther et al., 2007, 
Jiang et al., 2011, Lloret-Llinares et al., 2012). Marks such as H3K9me3 and 
H4K20me3, however, are often found in repeat-dense areas of the genome such 
as the centromere (Schotta et al., 2004, McManus et al., 2006, Puschendorf et al., 
2008). Acetyl marks on both histones are generally associated with relaxed 
chromatin and active transcription, due to their ionic charge-cancelling properties 
(Allfrey et al., 1964, Grunstein, 1997). There is a paucity of information as to 
precisely how these marks are maintained or if their genomic locations are altered 
after differentiation, or between cells of the same population.  
These studies were performed using mouse ES cell lines CCE/R and OS25, 
mouse embryonic fibroblasts (MEF), and OS25 cells during the first stages of 
differentiation. Two different cell lines were used to determine the variation of 
histone modification distributions within two different populations drawn from the 
same species. One of these cell lines (OS25) was differentiated for 7 days in order 
to assay the changes in epigenetic signature associated with loss of pluripotency, 
and concomitant lengthening of the cell cycle. MEFs were used to extend this 
study of developing cells into even more developed embryonic tissues, and again 
to provide another comparison between two different cell lines, this time for the 
differentiated state of embryonic cells. All cells used for these experiments were 
male, allowing the analysis of the almost entirely heterochromatic Y chromosome. 
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3.2 CHROMOSOME IMMUNOFLUORESCENCE AT METAPHASE 
3.2.1 Results of the immunostaining procedure for H3K4me1 and H3K4me2 
 
Chromosome spreads in figure 3.1 show that H3K4me1 is distributed across 
undifferentiated (d0) CCE/R chromosome arms in a non-uniform pattern, as 
denoted by the bands of green fluorescence contrasted against the red 
background depicting areas low in H3K4me1. The heterochromatic centromere 
and Y chromosome are unlabelled and so appear red. The X chromosome also 
appears paler than autosomes. This pattern of K4 methylation is also found on 
metaphase chromosomes from a different cell population; OS25 d0 cells. This is a 
separate transgenic cell line, as opposed to the wild-type CCE/R line, and yet 
displays the banding pattern of H3K4me1 just as clearly (figure 3.1). The 
centromeres, and the X and Y chromosomes are also distinguishable in spreads 
for the OS25 ES cell line. Chromosome spreads labelled with H3K4me2 show a 
very similar picture to those for H3K4me1. Antibody-stained bands show the areas 
of high K4me2 concentration, contrasted against areas with less H3K4me2. Both 
undifferentiated cell lines show a similar banding pattern and characteristic 
unstained centromeres. However, the X chromosome appears indistinguishable 
from other chromosomes in H3K4me2 spreads. The Y chromosome, on the other 
hand, is clearly visible in these spreads as an unstained small chromosome in 
both H3K4me1 and H3K4me2 experiments. This confirms the negative correlation 
between mono and di-methylated H3K4 and heterochromatic regions of the 
karyotype (Rudolph et al., 2007). 
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Figure 3.1 Photographs of chromosome spreads prepared using the
immunofluorescence protocol. Left panel shows chromosomes labelled
with FITC (pseudo-coloured green) attached to antibodies specific to
H3K4me1; right panel shows chromosomes labelled with H3K4me2.
Chromosomes were counterstained with the nuclear stain DAPI (red).
The cell types used were, in order from top to bottom; undifferentiated
CCE/R wild type mouse ES cells, undifferentiated OS25 ES cells, OS25
cells differentiated for 5 days, and mouse embryonic fibroblast cells
(MEF). The X and Y chromosomes, where clearly distinguishable, have
been highlighted with red arrows. Scale bar is shown in yellow.
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OS25 cells were then differentiated for 7 days and then chromosomes were 
analysed as before. Figure 3.1 shows that H3K4me1 has a reduced level of 
enrichment compared to that seen in d0 cells. H3K4me2 shows no noticeable 
changes in localisation after differentiation. In mouse embryonic fibroblast cells, 
however, both marks show a change from d0 OS25 cells to MEFs, with reduced 
FITC fluorescence for MEF cells indicating a lower general level of methylation. 
H3K4me2-rich bands appear less frequently and are less wide than those for the 
other three cell populations, whereas the H3K4me1 distribution shows that some 
chromosomes have remained strongly stained with FITC, and others have lost 
H3K4me1 as they display low FITC fluorescence (figure 3.1). Sex chromosomes 
from this study of XY mouse cells did not show any noticeable change from 
undifferentiated to differentiated cells for H3K4-me1 and –me2, but instead 
displayed maintenance of these histone modifications throughout the first 7 days 
of differentiation (figure 3.1). 
The two main chromatin structures, euchromatin and heterochromatin, can be 
distinguished by looking at -me1 and -me2 methylated H3K4 distributions. 
Constitutive heterochromatin, such as that found at the centromere or on a large 
proportion of the Y chromosome, is clearly highlighted in red in figure 3.1. Mono 
and dimethylated H3K4, as marks associated with active chromatin, do not 
colocalise with centric heterochromatin or the Y chromosome (Zhang et al., 2009). 
The absence of any flecks of green fluorescence at these regions indicates they 
are mainly free of these modifications. Interestingly, the X chromosome also 
appears to be poorly stained for H3K4me1, despite the presence of over 2000 
genes on the chromosome arm. This may represent epigenetic labelling of the sex 
chromosomes in order to distinguish them from autosomes, and possibly to 
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provide a mechanism of control for dosage compensation in mammals (Keohane 
et al., 1996, O' Neill et al., 2003, Rens et al., 2010, Dunlap et al., 2012). 
3.2.2 H3K4me3 chromosomal distribution at metaphase 
 
Although all levels of H3K4 methylation are associated with gene-rich regions, 
H3K4me3 is particularly closely aligned with gene transcription start sites (TSS) 
(Guenther et al., 2007, Lloret-Llinares et al., 2012) H3K4me3 shows a similar 
distribution pattern to H3K4me1/me2 on undifferentiated metaphase 
chromosomes in both cell lines, however this pattern is interrupted by the progress 
of differentiation, displaying a reduced level of fluorescence in d7 embryoid body 
cells, but then reverting to the d0 enrichment of the mark in MEF cells (figure 3.2). 
Images for d7 OS25 cells show a different distribution of H3K4me3, as the 
fluorescence appears less distinct and less easily recognisable as being banded. 
The Y chromosome is clearly unlabelled in all cell types as before, but the X 
chromosome appears not to be distinguishable from autosomes as in spreads for 
the H3K4me1 modification. Earlier studies analysed epigenetic modifications in  
differentiating asynchronous cells using molecular techniques such as ChIP on 
chip (ChIP coupled with microarray analysis) and ChIP-sequencing (Marks et al., 
2009, Furey, 2012). Results from these experiments show that there were few 
differences in H3K4 trimethylation between d0 and d10 female mouse embryonic 
stem cells. Autosomes from these two samples were particularly similar, and 
major differences were only found between the X chromosomes, as after 
differentiation one of these had become inactivated (Marks et al., 2009). This may 
be an indication of the differences between a microscopic and a molecular 
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Figure 3.2 Photographs of chromosome spreads prepared using the
immunofluorescence protocol. Left panel shows chromosomes labelled
with FITC (pseudo-coloured green) attached to antibodies specific to
H3K4me3; right panel shows chromosomes labelled with H3K27me3.
Chromosomes were counterstained with the nuclear stain DAPI (red).
The cell types used were, in order from top to bottom; undifferentiated
CCE/R wild type mouse ES cells, undifferentiated OS25 ES cells, OS25
cells differentiated for 5 days, and mouse embryonic fibroblast cells
(MEF). The Y chromosome, where clearly distinguishable, has been
highlighted with a red arrow.
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method, as the molecular method considers each gene or stretch of DNA 
individually, whereas the microscopic method considers the epigenetic state of a 
large region of DNA at once. As such, small changes in methylation of histones 
may appear insignificant in the analysis of single genes, but when these 
alterations are combined over a range of 10 megabases, the effect can be more 
easily picked up by use of immunofluorescence. 
It is known that all three K4 methyl marks are present in several different cell types 
throughout differentiation and development, although the levels of these marks 
can be regulated in order to produce different cell fate outcomes (Jiang et al., 
2011). These marks are often found in close proximity to each other, but can also 
have different distributions across the genome, as they are associated with 
separate components of genes and perform different functions. For example, in 
haematopoietic stem cells, it was shown that H3K4me1 occupied mainly internal 
regions of genes and intergenic spaces, as opposed to H3K4me3, which 
correlated strongly with gene promoter regions, with only a small proportion of the 
tri-methyl mark being present in intergenic or intra-gene regions (Cui et al., 2009, 
Jiang et al., 2011). This may explain the differences in the maintenance of these 
marks through differentiation, since the H3K4me3 mark may be actively 
maintained at many loci due to its tight association with transcription start sites, 
whereas H3K4me1 may be allowed to be lost at intergenic regions without 
affecting its function, the stability of the surrounding chromatin or resulting 
transcription. H3K4me2 is often distributed within coding regions of genes, as well 
as at the promoter (Morillon et al., 2005, Zhang et al., 2012). These data show 
that, at the chromosomal level, H3K4me2 is reduced in a similar fashion to K4me1 
on differentiation to embryonic fibroblasts (figure 3.1).  
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Despite the differences in the locations of the K4 methyl marks in genes, all three 
levels of methylation show banding at the undifferentiated stage (figures 3.1 and 
3.2). This reveals that these modifications are to some degree correlated and 
could reflect the association of methyl K4 with gene-rich regions, therefore 
sections of chromatin containing a relative abundance of genes would be 
expected to have higher levels of methylated K4. 
H3K4me3 also forms a bivalent mark with H3K27me3, which is assumed to 
influence the expression of genes involved in differentiation and development. 
This is thought to constitute a system of epigenetic control, and is a dynamic motif 
where one of the marks is lost at some point in order to alter gene transcription 
(Bernstein et al., 2006, Vastenhouw and Schier, 2012). It therefore provides an 
ideal model for the study of epigenetic change after differentiation. 
3.2.3 Distribution of H3K27me3 on mitotic chromatin 
 
Immunofluorescence data shows that trimethylation of lysine 27 on histone H3 is 
more widespread across the chromosome than for H3K4me3. Figure 3.2 shows 
that K27me3 is generally present across the entire chromosome arm, but still 
displays separate regions of higher and lower methyl K27 intensity. These bands 
are more subtly distinguished from the rest of the chromosome, but still reveal 
differences between genomic regions in the chromosome-wide distribution of 
H3K27me3. These differences persist up to at least the MEF stage of 
differentiation, as seen in Fig 3.2, showing that both the bivalent markers 
H3K4me3 and K27me3 display a variegated distribution across chromosome 
arms, and that they persist through metaphase and through differentiation. This 
observation indicates that the bivalent mark is continued at the chromosomal level 
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up to at least the embryonic fibroblast stage, and is evidence against a large-scale 
reorganisation of these two histone marks as a result of very early embryonic 
differentiation.  
These bivalent modifications are both distributed across the arms of autosomes. 
They are also distributed along the X chromosome in a pattern that is not easily 
distinguishable from the other chromosomes. This is supported by previous 
immunofluorescence studies which show that the female active X, as could be 
compared to the male active X, is indeed marked by both H3K4me3 and 
H3K27me3 in undifferentiated cells and after differentiation (O' Neill et al., 2008, 
Terrenoire et al., 2010). 
 3.2.4 Analysis of mouse chromosome spreads immunostained for 
methylated H3K9 
 
Methylation of histone tails on residues H3K4 and H3K27 are markedly enriched 
at and around genes (Barski et al., 2007, Schwartz et al., 2010). It is worthwhile, 
therefore, to analyse other residues that do not display this association, in order to 
probe the actions of modifications that have different localisations with respect to 
gene positions. Lysine 9 on histone H3 can, like K4, have up to three 
posttranslational methyl groups attached. These are generally linked to 
transcription repression, particularly di- and tri- methyl K9, and are spread 
throughout the genome, with the exception of H3K9me3, which shows an affinity 
for centric heterochromatin (McManus et al., 2006, Puschendorf et al., 2008). The 
functions of H3K9me1 are not fully known; however this mark, like H3K9me2, is 
distributed mainly within heterochromatin in plants (Naumann et al., 2005), but has 
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a more euchromatic distribution in animal cells and has been implicated in 
controlling transcription repression (Qi et al., 2010).  
Figure 3.3 shows that H3K9me1 and me2 show similar distributions, localising 
across the chromosome arms and not at the centromere. This pattern is 
maintained throughout differentiation, with no obvious regions of lower or higher 
staining intensity. As opposed to the K4 marks, these images reveal that at the 
chromosomal level, mono and di-methyl K9 are distributed evenly and consistently 
across the chromosome arms, suggesting that they are present both at gene-rich 
regions and in intergenic sequences. These results show that metaphase 
chromosomes show strong immunostaining for both H3K9me1 and H3K9me2. 
This is contrary to earlier findings in human HeLa cells, which suggested that 
these marks are almost undetectable at metaphase (Duan et al., 2008). 
As is the case for the repressive mark trimethyl H3K27, the X chromosome is 
indistinguishable from the autosomes for mono and dimethyl H3K9. This could 
indicate that repressive histone modifications are distributed on autosomes and X 
without special prejudice, therefore contrasting with the lack of activating methyl 
H3K4me3 on X. The Y chromosome is also stained with H3K9me1 and H3K9me2 
(figure 3.3), whereas the centromere is left unstained. This indicates that unlike 
the other marks under investigation, mono and dimethyl H3K9 distributions can 
discriminate between centric heterochromatin and Y chromosome 
heterochromatin. The distributions of these two marks remains unchanged through 
differentiation up to the MEF stage, as chromosome arms remain stained, 
whereas centromeres are still clearly distinguishable. This reflects the results from 
an earlier study that found that H3K9me2 levels did not change appreciably at the 
82 
 
H3K9me1
C
C
E/
R
 d
0
O
S2
5
 d
0
M
EF
O
S2
5
 d
7
H3K9me2
10µm Y
Y
Y
Y
82 
83 
 
Figure 3.3 Photographs of chromosome spreads prepared using the
immunofluorescence protocol. Left panel shows chromosomes labelled
with FITC (pseudo-coloured green) attached to antibodies specific to
H3K9me1; right panel shows chromosomes labelled with H3K9me2.
Chromosomes were counterstained with the nuclear stain DAPI (red).
The cell types used were, in order from top to bottom; undifferentiated
CCE/R wild type mouse ES cells, undifferentiated OS25 ES cells, OS25
cells differentiated for 5 days, and mouse embryonic fibroblast cells
(MEF).
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global level from stem cells to differentiated cells in humans (Lienert et al., 2011). 
H3K9me3 has previously been very closely linked with heterochromatin, and has a 
repressive effect on underlying DNA sequences (McManus et al., 2006, Alder et 
al., 2010). It is known that H3K9me3 is a marker of centric heterochromatin in 
differentiated cells, but recently it has been discovered that K9me3 is also 
associated with genic regions in ES cells and may have a role in the bivalent 
system of epigenetic gene regulation (Alder et al., 2010, Fodor et al., 2010). 
Although figure 3.4 shows that the intensity of the H3K9me3 signal is highest at 
the centromeres, there is also a general distribution across the arms of all 
chromosomes, confirming that H3K9me3 is widespread throughout the genome at 
the ES cell stage of development.  
H3K9me3 localises to centric heterochromatin, but also to the Y chromosome, 
only one of two modifications in this sample set to do so (figure 3.4). In 
undifferentiated CCE/R cells, the entire Y chromosome is stained with the anti-
K9me3 antibody, indicating that not only is this histone modification present in 
heterochromatic regions, but also is accessible to the antibodies used in the 
immunofluorescence technique. A similar pattern is evident for d0 OS25 cells 
(figure 3.4). The Y chromosome in this instance provides a good model for the 
link between histone modifications and underlying DNA sequence. The Y 
chromosome contains almost no coding genetic information and is largely a 
construct of condensed heterochromatin (Baumann 2008). Differentiated OS25 
cells display a different H3K9me3 distribution, as the mark is almost entirely 
confined to centromeric chromatin at this stage of differentiation. MEF cells, on the 
other hand, show H3K9me3 present on both centromeres and chromosome arms 
in a similar pattern to undifferentiated cells (figure 3.4). 
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Figure 3.4 Photographs of chromosome spreads prepared using the
immunofluorescence protocol. Left panel shows chromosomes labelled
with FITC (pseudo-coloured green) attached to antibodies specific to
H3K9me3; right panel shows chromosomes labelled with H4K20me3.
Chromosomes were counterstained with the nuclear stain DAPI (red).
The cell types used were, in order from top to bottom; undifferentiated
CCE/R wild type mouse ES cells, undifferentiated OS25 ES cells, OS25
cells differentiated for 5 days, and mouse embryonic fibroblast cells
(MEF). The Y chromosome, where clearly distinguishable, has been
highlighted with a red arrow.
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3.2.5 Prevalence of tri-methylation at H4K20 during metaphase 
 
These results have highlighted the different distributions of methyl marks on 
modified histone H3 residues and their associations with heterochromatin. To 
extend the investigation further, I chose another histone modification, this time on 
histone H4 to analyse the similarities and differences between epigenetic 
modifications at metaphase on different histone molecules. Like lysine 9 of histone 
H3, H4K20 methylation has also been linked with heterochromatic repression of 
chromatin (Schotta et al., 2004, Gonzalo et al., 2005), and both have been 
implicated as markers or effectors in the maintenance of heterochromatin. 
However, as shown in figure 3.4, the difference in H4K20me3 distribution 
between ES cells and differentiated cells is pronounced. Differentiated MEF cells, 
like for H3K9me3, show only centromeric staining on metaphase chromosomes. 
However, images for d0 ES cell spreads show that trimethyl K20 is present along 
the chromosome arms, and not at the centromere. Therefore, at some point during 
differentiation, the localisation of K20me3 within centric DNA has been reversed.  
3.2.6 Immunofluorescence of acetylated lysine residues on metaphase 
chromosomes 
 
Histone methylation is known to be a complex process involved in several nuclear 
processes, and is thought to be involved in many and diverse biochemical 
pathways and not simply the regulation of gene expression. Histone acetylation is 
thought to have a more direct, physical role in the relaxation of chromatin and so 
amplifying underlying gene transcription (Allfrey et al., 1964, Kouzarides, 2007). 
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Acetylation is also thought to be more dynamic, being added and removed from 
chromatin more rapidly than methyl marks (Allfrey et al., 1964, Waterborg, 1998). 
Therefore, the persistence of acetyl marks can be assayed by the technique of 
chromosome immunofluorescence. This can show whether or not acetylation can 
be maintained in the transcriptionally (and metabolically) inert metaphase. Results 
from figure 3.5 show that H3K9ac is distributed evenly across all chromosome 
arms for d0 CCE/Rs, but is absent from the centromere. This distribution holds 
true for d0 OS25 cells and through differentiation in d7 OS25s. MEF cells, 
however, show a subtle banding pattern for H3K9ac that was not detected during 
earlier developmental stages. This pattern resembles those found for methyl 
modifications such as H3K4me1, and may reflect a more targeted and specific 
pattern of H3K9 acetylation, among the background of a genome-wide 
deacetylation of lysine 9 after differentiation. Figure 3.5 shows that H3K27ac does 
display a banding pattern across chromosome arms in d0 CCE/R cells, and to a 
less pronounced extent in d0 OS25s as well. This can also be seen in 
differentiated MEF cells, although this acetyl mark also undergoes genome-wide 
deacetylation at this stage as denoted by the lack of widespread FITC staining. 
Two acetylated residues on histone H4, H4K12ac and H4K16ac show similar 
distributions in all cell types assayed. Acetylated H4 is ubiquitous on chromosome 
arms but not centromeres in undifferentiated CCE/Rs and OS25s, and in 
differentiated OS25s. In a similar fashion to H3K9ac, K12ac and K16ac appear to 
display variegated banding in MEF cells, and a generally lower level of FITC 
staining indicating less widespread acetylation at these residues.  
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Figure 3.5 Photographs of chromosome spreads prepared using the
immunofluorescence protocol. Far left panel shows chromosomes
labelled with FITC (pseudo-coloured green) attached to antibodies
specific to H3K9ac; centre-left panel shows chromosomes labelled with
H3K27ac; centre-right panel shows H4K12ac immunofluorescence; and
the far right panel displays chromosomes stained with anti-H4K16ac
bound to FITC. Chromosomes were counterstained with the nuclear
stain DAPI (red). The cell types used were, in order from top to bottom;
undifferentiated CCE/R wild type mouse ES cells, undifferentiated
OS25 ES cells, OS25 cells differentiated for 5 days, and mouse
embryonic fibroblast cells (MEF).
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3.2.7  Histone modifications present and absent at the Y chromosome 
The Y chromosome in mice is specific to males and contains very little gene 
coding information. It is also much smaller than the other chromosomes, and the 
only chromosome in mice that is not telocentric. It is mainly composed of 
heterochromatin and therefore has very little gene activity. Figures 3.1, 3.2 and 
3.4 show that the Y chromosome can sometimes be distinguished by the histone 
modifications that are either present or absent on the Y chromosome. The bivalent 
modifications H3K4me3 and H3K27me3 are not present on the Y chromosome, as 
shown in figure 3.2, neither are H3K4me1 and H3K4me2 (figure 3.1). All these 
modifications are associated with genomic features present in gene-rich areas of 
the genome and are not thought to be widespread in heterochromatic DNA. 
Figure 3.4 shows two more methylated chromatin residues, H3K9me3 and 
H4K20me3. Both are known to mark heterochromatic areas, which is reflected in 
results for undifferentiated cells in figure 3.4, showing fluorescence on the Y 
chromosome (Kouzarides, 2007; Puschendorf et al., 2008).  However, for both of 
these heterochromatic marks, their clear marking of the Y chromosome has been 
lost upon differentiation. This means that the transcriptionally inert Y chromosome 
is subjected to dynamic changes in histone modifications through differentiation. 
The epigenetic state of Y in undifferentiated cells as determined by figures 3.1-3.5 
is that it is depleted in H3K4 methylation of all kinds, and in H3K27me3. The Y 
chromosome is rich in H3K9me3 and H4K20me3, and is marked with acetyl 
modifications for H3K9, H3K27, H4K12 and H4K16 so that the Y is 
indistinguishable from other chromosomes. Y is visible as being depleted in some 
spreads for H3K9me2, but not in others, whereas the Y chromosome appears to 
be marked with H3K9me1 in d0 cells, but not in d7 differentiated cells, as shown in 
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figure 3.2. This could highlight a role for H3K9me1 in the marking of the Y 
chromosome specifically during the pluripotent phase of the embryo.  
3.3 FISH IDENTIFICATION AND KARYOTYPING OF CHROMOSOMES 
3.3.1 Building epigenetic karyotypes using FISH 
 
Having analysed several chromatin modifications, the bivalent markers of 
H3K4me3 and H3K27me3 both display quite different distributions on metaphase 
chromosomes and could be said to each have their own unique banding pattern 
on each chromosome. The bivalent marker is also a key player in the switching on 
and off of some genes during the process of differentiation, and so applying the 
chromosome immunofluorescence technique to cells at various stages of 
development allows insight into the changes in epigenetic markers upon 
differentiation, which according to these results are not visible at the chromosomal 
scale. To investigate these observations further, I undertook a novel epigenome-
wide study of the immuno-stained chromosome slides using FISH to identify each 
stained chromosome and so to align histone modifications with DNA sequence.   
Having undertaken to obtain snapshots of the epigenome for different histone 
modifications, I then endeavoured to analyse the banding patterns more precisely. 
This can only be done by classifying and identifying each of the immunostained 
chromosomes to align epigenetic with genetic information. Previously, reverse-
DAPI banding has been used in humans to identify each chromosome in a 
karyotype by selectively staining AT rich chromosome regions (Liu et al., 2006). 
However this is not a suitable technique under these circumstances as mouse 
chromosomes are physically shorter than in humans, and mouse chromosomes 
are not morphologically distinct enough to be classified by this method as 
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indicated by previous work in our laboratory. Therefore I employed a molecular 
technique, FISH, to unmistakeably identify each chromosome based on unique 
DNA sequences (Nagamachi et al., 2013).  Whole-chromosome FISH probes 
were used for each chromosome individually in order to build up a full karyotype of 
40 chromosomes for both H3K4me3 and H3K27me3 immunolabels. Histone 
modification fluorescence patterns can then be aligned with NCBI mouse genome 
data on gene density, repeats and CpG islands to determine the associations of 
these two marks with well-studied chromosomal features. By analysing the 
interface between genetic and epigenetic features, I will understand more about 
the positions of histone marks at the transcriptionally silent period of metaphase, 
and in turn about the nature of these marks with regard to future gene 
transcription and the cell cycle.  
Once a chromosome spread similar to those already shown has been produced, the 
slides are then washed to remove any residual fluorescence and then whole-
chromosome FISH DNA probes were used to hybridise specifically to a single 
chromosome (Cartwright et al., 2013). The only dyes remaining after the FISH 
procedure was complete were the DNA stain DAPI and the FITC label attached to the 
chromosome-specific FISH probe. Key to this process is that the chromosomes 
remain in the same position on the slide after FISH. Figures 3.6-3.10 show that OS25 
cells have highlighted chromosome pairs due to FISH fluorescence, which can identify 
chromosomes at the same locations as those already imaged using 
immunofluorescence. Using this method, it is possible to produce an epigenome 
karyotype of histone modifications by immunofluorescence. This was previously 
difficult, as traditional methods of karyotyping rely on linking banding patterns to the 
physical size of chromosomes (Liu et al., 2006, Terrenoire et al., 2010). 
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Figure 3.6 Left panel shows previously immunostained chromosome spread
having been treated with FISH probes for chromosomes 1 and 2 (green)
counterstained with DAPI (red). Right panel shows the original spread showing
FITC staining for either H3K4me3 or H3K27me3 antibodies (green) also
counterstained with DAPI. Green arrows indicate the locations of the target
chromosome within the spread. Scale bar indicates 10µm.
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Figures 3.7-3.10 – H3K4me3 FISH Chromosome paints. Left panel shows
previously immunostained chromosome spread having been treated with
FISH probes for chromosomes 1-19, X and Y (autosomes and Y
chromosome in green, X chromosome shown in red) counterstained with
DAPI (red). Right panel shows the original spread showing FITC staining
for antibodies (green) also counterstained with DAPI. Green arrows
indicate the locations of the target chromosome within the spread. Scale
bar indicates 10µm.
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3.3.2 FISH identification of chromosomes already assayed for H3K4me3 
association 
 
The combined results from individual FISH probes of each chromosome stained 
with H3K4me3 are displayed in figure 3.11, showing a complete mouse 
epigenome. The entire panel of chromosomes is shown, each one next to an 
ideogram showing approximate relative fluorescence across the chromosome, and 
an ideogram showing the G-banding pattern of each chromosome showing AT rich 
areas in darker colours. G-banding is a long-standing method for distinguishing 
human chromosomes, and is analogous to the reverse-DAPI method used in 
some studies (De Arce et al., 1982, Terrenoire et al., 2010). Almost every 
chromosome has a unique pattern of K4me3 staining that distinguishes it from the 
others, and each replicate of a chromosome shows a similar pattern to its 
counterparts (figures 3.12-3.14). Approximate patterns are shown beside the 
photos of chromosomes and are compared to G-banding patterns on the 
corresponding ideogram. The Y chromosome is also unstained, but is easily 
distinguished by its small size and unique morphology. The global snapshot of the 
H3K4me3 distribution in mouse shows a clear preference for certain chromosomal 
areas over others in most chromosomes. This also confirms that each 
chromosome has a specific and unique pattern that can identify it in terms of its 
H3K4me3 landscape. 
3.3.3 Relationship between the H3K4me3 epigenome and genomic features 
 
H3K4me3 banding does not closely correspond to G- banding, as seen on figure 
3.11. These banding techniques highlight areas of DNA that are AT-rich, and do 
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Figure 3.11 Karyotype of OS25 ES cells showing the H3K4me3 epigenome. Chromosomes
were first immunostained with FITC (green) labelled antibodies to H3K4me3 and
counterstained with DAPI (red), then washed and labelled with FITC-DNA probes specific
for each chromosome. These were captured separately under a fluorescence microscope
and aligned with their respective ideograms (university of Washington).
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Figures 3.12-3.14 Replicates of chromosome staining by
immunofluorescence. Chromosomes 1-19, X and Y were identified by
FISH, cut out from the chromosome spread and aligned together on a
single page. Four replicates for each separate chromosome indicate the
reproducibility of the technique.
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not always correspond to gene-poor or gene-rich areas, and so it can be said that 
this mark does not correlate closely with AT density on metaphase chromosomes. 
The exception to this is chromosome 13, where H3K4me3 is depleted at regions 
of heavy Giemsa staining (figure 3.11). To more closely analyse the significance 
of the bands of histone modifications on metaphase chromosomes, I analysed 
sequence data directly and aligned features of the genome with the epigenetic 
karyotype obtained from this study. Data include gene density, CpG island density 
and repeat density. H3K4me3 has been found to exist mainly at promoter regions, 
and so these histone modifications may be aligned with gene-rich regions. 
Similarly, H3K4me3 has been found to colocalise to sequences containing a high 
proportion of CpG islands, which are also associated with genes and are largely 
absent from intergenic loci (Bird, 1986, Cross and Bird, 1995, Illingworth et al., 
2010). Repeat sequences are found throughout the genome in both intergenic and 
genic sequences, and even centric heterochromatin and telomeres. However, 
some stretches of DNA contain more repeats than others, and the longer satellite 
repeats found in intergenic sequences and heterochromatin mean that these 
regions contain comparatively fewer repeats than gene-rich regions, which have 
shorter but more numerous repeats (Singer, 1982). 
Figure 3.15-3.17 shows results obtained from the karyotype data, aligned with 
NCBI sequence data. The fluorescence has been converted into a numerical 
value that is relative to the maximum and minimum fluorescence seen in that 
chromosome spread. Values for FITC emittance (Y-axis) for FISH labelled 
chromosomes (at least 4 chromosomes per value) were obtained by analysing the 
relative brightnesses of pixels along each chromosome using computer software. 
These were normalised to the background brightness and displayed as a 
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percentage of the maximum emittance. The results were organised into 10 
megabase windows in order to reflect the resolution of the microscope images. 
Chromosome emittance was compared to NCBI data, which was also delineated 
into 10 megabase windows. High percentage values indicate strong fluorescence, 
whereas low values indicate regions of sparse FITC staining. Analysis using this 
technique has produced a graph displaying the entire mouse genome in the form 
of a line chart. Included in the appendix are histograms which reflects the banding 
pattern of each individual chromosome in a graphical form. Error bars have been 
included in the appendix to denote the standard deviation between replicates and 
indicate the reproducibility of the data, but have been omitted from the line graphs 
so as to not obstruct the view.  
The genome-wide picture of the correlation between H3K4me3 enrichment and 
the genomic features analysed here show a close relationship. For the majority of 
the genome, the lines representing H3K4me3 enrichment and gene density, CpG 
density and repeat density are very close to each other. Often peaks are found in 
the same position on the chromosome, and patterns of H3K4me3 enrichment are 
mirrored by the genomic features. Looking closely at the data, chromosome 5 has 
a fluorescent region at the telomere end of the chromosome, as shown in the 
photograph in figure 3.11, and a more subtle, smaller, region of fluorescence near 
the centromere. This is reflected in the FITC emittance graph below, which shows 
the highest fluorescence between 120 and 153 megabases from the centromeric 
end of the chromosome, and a small elevation in fluorescence between 40 and 60 
megabases relative to surrounding chromatin. The alignment of these data with 
genomic features such as gene, CpG and repeat densities show a clear 
correlation (figures 3.15-3.17). Gene density on chromosome 5 is relatively higher 
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in a 20Mb window between 20 and 40Mb from the centromere. This may 
correspond to the high FITC emittance shown at 40-60Mb due to the not strictly 
linear nature of chromosomes on glass slides. There is also a clear elevation in 
gene density at the telomere end of the chromosome, from 110-150Mb, which also 
correlates with increased FITC emittance. CpG island and repeat density also 
show peaks on chromosome 5 at this 110-150Mb region of increased FITC 
emittance, confirming that gene density is closely related to H3K4me3 incidence 
on this chromosome. 
Data in figures 3.15-3.17 and in the appendix show that the H3K4me3 
distribution throughout much of the genome corresponds closely with CpG island, 
gene and repeat-dense sequences. Chromosomes 2, 3, and 4 show similar 
profiles for FITC emittance and all three genomic features, with peaks in these 
coinciding in most cases. The peaks are slightly offset from each other, perhaps 
reflecting the fact that chromosomes on glass slides are non-linear and will be 
stretched or compressed in some areas over others. For all of the chromosomes 
in this study there is a strong correlation between peaks in FITC emittance and 
peaks in CpG islands, repeats and gene density, showing that the similarities in 
distribution patterns among these graphs reveal that H3K4me3 maintains its 
association with gene-rich areas of DNA even at the metaphase chromosome 
stage. The strongest FITC correlation among the literature sequence data sets is 
with CpG islands, evidenced by data for chromosome 2, which shows a K4me3 
peak corresponding to a peak in CpG density, but no associated peak in gene 
density (figures 3.15-3.16 and appendix).  
Some exceptions to the close relationship between H3K4me3 and these genomic 
features can be found on chromosomes 8 and 14 (figures 3.15-3.17 and 
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appendix). Data for these two chromosomes shows a fairly constant and 
moderate level of H3K4me3 enrichment across these chromosomes. However, 
the three genomic features under investigation do not correlate with this pattern. 
Both gene density and repeat density have pronounced peaks at chromosome 8 
that are not reflected in the H3K4me3 data or in the NCBI data for CpG island 
density. This could indicate that H3K4me3 is preferentially deposited at CpG 
islands, which coincide in many cases with gene and repeat dense areas of the 
genome. However, the same is not the case for chromosome 14, which shows a 
distinct peak in density for all three genomic features that is not reflected in the 
epigenetic H3K4me3 distribution. One possible explanation for this observation is 
that the region in which CpG island density and gene density increases, but 
H3K4me3 remains low, contains several variable T-cell receptor gene loci. It 
would be important for these regions to contain CpG islands so that expression of 
these vital variable regions would not be silenced by DNA methylation, and this 
would also clearly be a region of high gene density. However, the embryonic cells 
have not been poised for T-cell expression yet and so are likely to not mark these 
sites for activation using H3K4me3. Taken as a whole, therefore, these data, in 
most cases, support the association of H3K4me3 with genes, repeats and CpG 
islands, which fits in with the tight association of trimethyl K4 with gene promoters 
and TSSs as a marker of active gene expression (Pekowska et al., 2011).  
The relatively pale stained chromosomes 1, X and Y all show a uniform 
distribution of gene density and do not have pronounced regions of higher and 
lower density of any of these three genomic features. This is reflected in the FITC 
emittance data, showing a relatively uniform distribution across the chromatid 
arms (figure 3.11 and appendix). The comparison between chromosomes 1 and 
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2 is particularly reflective of this, as despite having 15 megabase pairs more DNA 
than chromosome 2, chromosome 1 contains only 1944 genes, 729 fewer than its 
shorter counterpart (NCBI, 2013). These data show that trimethyl K4 levels are 
equivalent along the length of chromosome 1, and significantly lower than at 
regions on chromosome 2. This may indicate that genes are spread more evenly 
along chromosome 1, having no clusters of high gene density. Alternatively, 
chromosome 1 may simply lack the high-density H3K4me3-rich regions that 
account for a large proportion of genes on chromosome 2, and therefore has 
fewer genes as a result. The clustering nature of H3K4me3 banding could indicate 
that certain sections of the genome can be functionally agglomerated by 
recruitment of chromatin-binding proteins to areas of high methylation. These 
high-density areas may be activated at the same time, or be located close to each 
other for efficient transcription factor and Pol II recruitment. It is already known that 
there are gene clusters such as Hox clusters that contain functionally related 
genes, often marked with histone modifications in a similar pattern, in the case of 
Hox; this is with the bivalent markers of H3K4me3 and H3K27me3 (Soshnikova 
and Duboule, 2009, Kashyap et al., 2011). 
3.3.4 Analysis of H3K27me3 distribution on metaphase chromosomes 
 
Tri-methyl H3K27, as already described, has a more widespread distribution 
across the genome than H3K4me3 (figure 3.2). This is also true at the gene level, 
whereas K4me3 is situated at the promoter and TSS of the gene, K27 methylation 
covers the entire gene and environs in a block of methylated chromatin (Pauler et 
al., 2009). However, despite the repressive action of H3K27me3, it is still 
distributed in gene-rich euchromatin (figure 3.18). Figures 3.11 and 3.18 show 
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Figure 3.18 Karyotype of OS25 ES cells showing the H3K27me3
epigenome. Chromosomes were first immunostained with FITC (green)
labelled antibodies to H3K27me3 and counterstained with DAPI (red),
then washed and labelled with FITC-DNA probes specific for each
chromosome. These were captured separately under a fluorescence
microscope and aligned with their respective ideograms (university of
Washington).
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that the areas of low H3K27me3 density are less prominent than those for 
trimethyl K4, or alternatively that the less stained areas of the chromosome are 
only slightly poorer in trimethyl K27 than the more strongly stained loci; i.e. the 
bands are weaker. Whereas chromosomes stained with the H3K4me3 antibody 
displayed usually two or three bands of dense staining per chromosome, 
H3K27me3-stained samples show only two, one or even no clear bands on ES 
cell chromosomes (figure 3.18). There are also several chromosomes, such as 
chromosome 2, which have no clear banding pattern at all, and are blanketed by 
FITC fluorescent molecules, except at the centromere (figure 3.18). The FITC 
emitting sections of chromatin for H3K27me3 are also longer and cover more of 
the chromosome than the trimethyl K4 bands. However, H3K27me3 still shows 
preferred localisation to certain chromosomal regions over others, and the same 
process of FISH probe labelling can be used to identify each chromosome labelled 
with H3K27me3 and therefore construct an epigenetic karyotype describing the 
distribution of this mark across the metaphase genome.  
The full karyotype of H3K27me3 labelled chromosomes is shown in figure 3.18. 
FISH slides used to construct these are shown in figures 3.19-3.22, with 
replicates of chromosomes shown in figures 3.23-3.25. These pictures show that 
the H3K27me3 epigenome contains pronounced biases towards some sections of 
the genome. The resulting banding pattern can be analysed as before against 
genomic data, and H3K4me3 epigenome data (figure 3.7). It is less clear where 
the boundaries of H3K27me3 bands lie, by the very nature of antibody 
fluorescence, but still a pattern can be assigned to the H3K27me3 distribution at 
metaphase, as boundaries between densely and sparsely fluorescent areas are 
still visible. By analysing the numerical fluorescent values extracted from these 
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Figures 3.19-3.22 – H3K27me3 FISH Chromosome paints. Left panel
shows previously immunostained chromosome spread having been
treated with FISH probes for chromosomes 1-19, X and Y(autosomes and
Y chromosome in green, X chromosome shown in red) counterstained
with DAPI (red). Right panel shows the original spread showing FITC
staining for H3K27me3 antibodies (green) also counterstained with DAPI.
Green arrows indicate the locations of the target chromosome within the
spread. Scale bar indicates 10µm.
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Figures 3.23-3.25 Replicates of H3K27me3 chromosome staining by
immunofluorescence. Chromosomes were identified by FISH, cut out from
chromosome spread and aligned together on a single page. Four replicates for
each separate chromosome indicate the reproducibility of the technique.
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slides, it is possible to ascertain a clearer picture of the H3K27me3 distribution in 
ES cells than is possible by eye. 
3.3.5 Banding patterns for H3K27me3 on identified chromosomes  
 
The H3K27me3 banding pattern shows some similarities with the pattern for 
H3K4me3. One of the more clearly banded chromosomes in the H3K27me3 
karyotype is chromosome 16, which contains a high-density region of FITC 
emittance near the centromere (corresponding to a gene-rich area), and a low-
density region towards the telomere (figures 3.25, 3.26 and 3.27). This is 
analogous to the pattern seen for H3K4me3 on figure 3.11, suggesting that this is 
a region containing a high number of both trimethylated K4 and K27, perhaps a 
region with several bivalent genes or gene clusters. Clearly, however, for two 
marks which display very different banding patterns and distributions at 
metaphase, there are many instances where they do not line up together and one 
mark is found without the other. In keeping with its more widespread pattern of 
distribution, large clusters of K27me3 can be seen, for example on chromosome 2, 
which encompasses several of the more discrete, thin bands of trimethyl K4. This 
suggests that trimethyl H3K27 is deposited more broadly and persists more widely 
at metaphase than its tightly banded neighbour H3K4me3. This is most evident on 
chromosome 2, which shows K27 FITC emittance all across its arms, but K4 
staining only in two bands at opposite ends of the chromosome arms (figures 
3.18 and 3.23).  
Other chromosomes appear to show similar banding patterns, such as 
chromosome 5 (figure 3.23, 3.28 and 3.29), which shows two distinct regions of 
high H3K27me3 banding intensity, separated by a region of weak staining. 
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Figure 3.28 Histogram showing the relative fluorescence (%) of secondary
antibodies against H3K4me3 (green) and H3K27me3 (red) histone
modifications across mouse chromosome 5.
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Figure 3.13 Alignment of A. H3K4me3 and B. H3K27me3 FITC emittance data from
chromosome 5 with genomic features. Shown here are the NCBI data for C. genes, D.
CpG islands and E. repeats in 10 megabase windows. Error bars denote standard
deviation between replicates
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However, after analysis of several replicates of FITC-labelled chromosomes, there 
is a distinct difference between the distributions of the two bivalent marks. The 
peak at ~40Mb from the chromosome 5 centromere is prominent in H3K4me3, 
H3K27me3 and in genomic features; however at the telomere end of the 
chromosome, a peak in trimethyl K4 and in gene density is not reflected by a peak 
in K27me3. On the contrary, trimethyl K27 staining is reduced markedly at the 
telomere end of the chromosome. Unlike results seen for many of the other 
chromosomes, this reveals a portion of the genome where H3K4me3 and 
H3K27me3 do not appear to co-localise at the same concentrations.  
Similarly, histone modification distribution patterns on chromosome 6 appear 
identical, but upon further analysis they have subtle differences (figures 3.18, 
3.30 and 3.31). The karyotype for H3K27me3 shows that chromosome 6 appears 
to be stained across the entirety of the chromosome arms; however analysis of 
this data using the mathematical method described earlier results in a more 
detailed picture being obtained (figures 3.30 and 3.31). In this case, a peak in 
H3K4me3 at 50-70Mb correlates with gene density but not with CpG island 
density; whereas the FITC emittance histogram for H3K27me3 shows a gradual 
increase from the centromere to the telomere that more closely resembles the 
sequence data for CpG islands. This may highlight a divergence in the 
associations of these marks with genomic features. Whereas peaks in gene 
density and CpG island density often, quite logically, overlap; there are a few 
occasions where a lone peak in one of these sequence features can provide 
insight into what sequence feature is really correlated to which histone 
modification, and how closely epigenetic features follow underlying sequences.  
133 
 
0
10
20
30
40
50
60
70
80
F
IT
C
 e
m
it
ta
n
c
e
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Distance from centromere (Mb)
Distribution of histone modifications on 
chromosome 6 of OS25 cells d0
H3K4me3
H3K27me3
Figure 3.30 Histogram showing the relative fluorescence (%) of secondary
antibodies against H3K4me3 (green) and H3K27me3 (red) histone
modifications across mouse chromosome 6.
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Figure 3.31 Alignment of A. H3K4me3 and B. H3K27me3 FITC emittance
data from chromosome 6 with genomic features. Shown here are the NCBI
data for C. genes, D. CpG islands and E. repeats in 10 megabase windows.
Error bars denote standard deviation between replicates
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These observations highlight the diversity of the data and the amount of 
information that can be extracted from an epigenetic karyotype of the entire mouse 
genome. The relationship between histone modifications and DNA sequence is 
not fully understood, and further investigation into the links between genetics and 
epigenetics is warranted in order to discover the mechanisms involved in 
maintaining this delicate balance in eukaryotic systems. 
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 4. RESULTS – NATIVE CHROMATIN IMMUNOPRECIPITATION 
4.1 INTRODUCTION TO N-CHIP RESULTS 
4.1.1 Epigenetic control of differentiation 
 
Epigenetic processes are thought to be at the heart of the progress of 
differentiation. The production of a multitude of different cell types from a single 
progenitor is due to the epigenetic profiles of those resultant cells being different 
enough from each other that they have their own individual identity, or gene 
expression profile (Niwa, 2007). This is programmed not by their genetic sequence 
(which for all these cells are identical) but by their various histone modifications 
and DNA methylation patterns, for example. Although it has been implied that the 
bivalent markers H3K4me3 and H3K27me3 are part of the mechanism that alters 
gene expression on differentiation, it is not known exactly how these modifications 
change during differentiation, and what role other modifications have in this 
process (Bernstein et al., 2006, Khromov et al., 2011, Vastenhouw and Schier, 
2012). This presents an opportunity to investigate the link between histone 
modifications and gene expression more closely, as any predictive properties that 
the epigenetic marks may have can be probed by assaying these marks over a 
period of time whilst cells are differentiating. To discover what association histone 
modifications have with gene expression over the time of the differentiation 
course, it was desirable to assay the gene expression of ES cells over a period of 
seven days. To determine how these marks change through the cell cycle, two cell 
populations were used; an asynchronous population and one treated with 
colcemid to stall cells at the G2 and M phase transition (Kleinfeld and Sisken, 
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1966, Muntion et al., 2012). Using these two populations of cells allows the 
determination of the effect of the shift in gene expression between S phase and M 
phase of the cell cycle.  
Figures 4.1 and 4.2 show the cell cycle profiles for asynchronous and metaphase 
cells between 0 and 7 days of differentiation. The asynchronous population 
displays a classical stem cell distribution, with a large proportion of cells in S 
phase, and at least as many cells in G2 as in G1. Over the period of the time-
course the profile begins to change, as a greater proportion of cells become 
stalled in G1, and the percentage of cells in S and G2 phases reduces. At d7 the 
cell cycle profile more closely resembles a differentiated cell than an ES cell, with 
a large peak in cell numbers at the G1 phase, followed by a smaller G2 peak, and a 
lower proportion of S phase cells. Figures 4.1 and 4.2 show that colcemid-treated 
cell samples all contain a majority of cells in G2 or M phase, far in excess of those 
found in the asynchronous samples at every timepoint. 
4.1.2 Hoxa, pluripotency and histone modifications 
 
The Hoxa cluster of genes is responsible for regulating the vertebral segmentation 
of the developing embryo and for controlling the early differentiation of the 
mammalian embryo (Lewis, 1978, Durston et al., 2011). The cluster is organised 
so that each gene is arranged on the chromosome in order of how early in 
development it is expressed. As such, the cluster acts as a block of many genes, 
which is evident in its epigenetic signature, often displaying a histone modification, 
i.e. H3K27me3 being present throughout the cluster (Kashyap et al., 2011). The 
Hox clusters represent an ideal model of study into the process of epigenetic 
changes through differentiation as it has a well-defined on-off switch at an early 
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Figure 4.1 Graphs showing the DNA content of asynchronous and
colcemid-treated CCE/R cells fixed with acetone and stained with
propidium iodide. 2N cells (G1) are distributed within R5, 4N G2 and
mitotic cells within R3, and S phase cells within R4. Percentage of cells in
each population are also shown. D1-3 represents 1-3 days of
differentiation, i.e 1-3 days after the removal of LIF. D0 cells are
undifferentiated.
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36% 38% 26%
36% 34% 30%
20% 41% 39%
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17% 27% 56%
17% 27% 56%
16% 26% 58%47% 35% 18%
46% 37% 17%
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43% 35% 22%
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Figure 4.2 Graphs showing the DNA content of asynchronous and
colcemid-treated CCE/R cells fixed with ethanol and stained with
propidium iodide. 2N cells (G1) are distributed within R5, 4N G2
and mitotic cells within R3, and S phase cells within R4.
Percentage of cells in each population are also shown. D4-7
represents 4-7 days after the removal of LIF.
Asynchronous
Colcemid-
treated
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stage of differentiation. The temporally expressed nature of each of the Hoxa 
genes also provides a further insight into the epigenetic signature that is 
associated with a future, past or present expression profile. 
Hoxa genes generally present a bivalent motif at the transcription start site (TSS). 
This is the co-incident trimethylation of H3K4 and H3K27, and is often found at 
lineage-specific genes required after differentiation (Bernstein et al., 2006, 
Vastenhouw and Schier, 2012). It is currently unknown to what extent these 
domains are critical in the control of differentiation, but it is theorised that the 
repressive H3K27me3 mark inhibits transcription of these lineage specific genes 
at the undifferentiated stage, and then that this mark is lost during differentiation to 
leave the underlying H3K4me3 histone modification to promote expression of the 
genes at the appropriate time (Bernstein et al., 2006, Khromov et al., 2011). As 
Hox genes fit into the category of developmentally regulated genes, it will be 
interesting to find out what epigenetic motifs occur at this locus before and after 
differentiation of embryonic stem cells. 
Pluripotency can be thought of as a poised state whereby an embryonic stem cell 
remains uncommitted to any particular developmental path. This state is controlled 
by a few key genes and transcription factors like Oct4 (Pou5f1), Nanog and Sox2 
(Boyer et al., 2005, Mikkelsen et al., 2007). These proteins bind enhancers of 
most genes required for maintaining the pluripotent state, and also promote their 
own and each other’s transcription to maintain a positive-feedback loop (Whyte et 
al., 2013). A reduction in expression of these factors, usually due to environmental 
cues both extrinsic and intrinsic, leads to rapid differentiation and loss of 
pluripotency.  
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4.2 RNA EXPRESSION OF ES CELLS THROUGH DIFFERENTIATION 
4.2.1 Analysis of ES cell expression changes through differentiation at the 
Hoxa cluster 
 
Asynchronous cells were grown without LIF for seven days and sampled at the 
same time on each day during that period. Retinoic acid was added to the cells at 
d2, in order to stimulate differentiation of the stem cells and to encourage Hox 
expression (Chen and Gudas, 1996, Bami et al., 2011, Kashyap et al., 2011). 
Some cells were incubated with colcemid for 24hrs before harvesting, and some 
were left untreated as an asynchronous control group. RNA was extracted and 
reverse-transcriptase PCR was used to determine the levels of transcript for 
genes in the Hoxa cluster. This cluster was used as it is known to display higher 
levels of expression after differentiation, and it has also been found to be marked 
with the bivalent histone modifications H3K4me3 and H3K27me3, giving it a 
known identity as a differentiation-regulated gene cluster (Bernstein et al., 2006, 
Kashyap et al., 2011).  
Data from figure 4.3 shows that at day 0, expression of all genes in the Hoxa 
cluster is extremely low compared to the expression of the housekeeper gene β-
actin. As shown by previous studies, the expression of Hox cluster genes is 
switched off in ES cells because the homeobox proteins are not needed until later 
in the differentiation process (Dolle and Duboule, 1989, Durston et al., 2011). 
Therefore, it is likely that this level of expression is due to spurious transcription 
and that these genes are effectively silent. Some of the genes in this cluster show 
consistently elevated expression compared to the others on all eight days included 
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Figure 4.3 Real-time expression levels of Hoxa cluster genes in day 0 to day 7
differentiating CCE/R cells. A shows expression levels (y-axis) of Hoxa genes (x-
axis) relative to ß-actin in asynchronous cells. B. Expression of Hoxa genes in
colcemid-treated metaphase cells. Error bars show the standard error of the mean
between three biological replicate experiments
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in this study. For example, Hoxa 1, 4 and 5 are enriched over any of the other 
Hoxa genes, and is particularly evident in the case of Hoxa1 versus Hoxa11, 
indicating that the former group may be beginning to be expressed over the 7 day 
period of the time-course, whereas the latter group remain inactive. Hox genes are 
normally classified in order of activation, i.e. Hoxa1 would be first expressed 
before Hoxa2, and so on (Durston et al., 2011). In accordance with this dogma, 
these results show that Hoxa1 is rapidly expressed soon after the differentiation 
process had begun, as the enrichment increases from d0 to d1, then increases to 
peak at day 5 after LIF withdrawal, a value nearly 100 times higher than the 
baseline.  
The fact that Hox expression increases quickly after addition of retinoic acid (RA) 
at d2 is a well-known feature of the RA response in ES cells (Kashyap et al., 
2011), however the increase in expression of Hoxa genes such as Hoxa1 before 
RA has been introduced is unexpected and occurs well before the physiological 
requirement of the gene products. The relatively low levels of many Hoxa 
transcripts, even after d2, may indicate that the increase is not high enough to be 
effective in vivo, however it may point to a mechanism whereby a gradual build-up 
of transcript throughout differentiation may result in a positive feedback switch 
being turned on. 
In contrast to other genes in the cluster; Hoxa2 expression is only slightly enriched 
after 3 days of differentiation and maintains this low level of expression for the rest 
of the time-course. Activation of Hoxa genes occurs most frequently at day 3, with 
examples including Hoxa2, 3, 4, 5, 7, 9, 10 and 13, corresponding to 24h after RA 
was introduced into the cell culture medium. These genes display fluctuating 
levels of expression relative to each other; however they all share the 
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characteristic of an obvious leap in transcript levels between days 2 and 3. Hoxa6 
shows a drop in gene transcription after 5 days, which is also reflected in several 
other Hoxa genes, indicating that there is only a small window in which the peak in 
Hoxa gene expression is maintained, and that the effects of the RA have begun to 
wear off. This may indicate a small artificial response to RA that increases 
expression slightly in otherwise completely silent Hoxa genes. 
4.2.2 Comparison between asynchronous and G2/M stalled cell expression 
 
The replication fork of the synthesis phase disrupts the histone modification 
landscape, and so in order to investigate fully the potentially altering effect of the 
cell cycle, it was desirable to analyse expression data before and after this point. 
The asynchronous population represents the “before synthesis” sample, as the 
majority of its cells are in G1 or S phase. The colcemid-treated population contains 
mostly G2 and M phase cells (figures 4.1 and 4.2), and is ideal for studying the 
expression of genes between DNA replication and cell division. G2/M expression is 
shown in figure 4.3, which shows that Hoxa genes are expressed at roughly 
equivalent levels both before and after S phase. Some of the expression patterns 
from the asynchronous population are retained in G2/M, such as genes Hoxa1, 4 
and 5, which display the highest levels of expression, and Hoxa2, 3, 10 and 11, 
which maintain particularly low levels of RNA transcript. The timings of 
transcription activation differ somewhat, however, as is evident in results for 
Hoxa1. The activation of this gene is evident in the G2/M stalled populations, 
showing a large increase in enrichment between d2 and d3. Expression goes on 
to peak at d5, the same day as the asynchronous population, and at a similar 
enrichment value.  
145 
 
The data shown here confirm that for many of the genes in the Hoxa cluster, there 
is no great difference between expression in asynchronous populations and for 
G2/M stalled populations. This means that any difference in epigenetic marks 
between pre-synthesis and post-synthesis chromatin would be due to the 
mechanisms of chromatin maintenance and not fluctuations in gene expression. It 
also suggests that any disruption in the epigenetic landscape that occurs at S 
phase does not contribute to a transient up- or down-regulation of gene 
transcription activity.  
Another striking feature of these data is the low levels of enrichment of all of these 
Hox genes relative to the housekeeping gene β-actin. Even the highest level of 
expression of any Hox gene during the time-course was less than a tenth of the 
level of actin transcription. This may be because only small numbers of Hox 
transcript are necessary to complete its function of binding to DNA and to affect 
transcription of differentiation-related genes. In other words, more copies of β-
actin RNA are needed as its product is required at all times throughout the cell in 
order to maintain its cytoskeleton. A gene such as Hox is needed only transiently, 
and perhaps not in such large quantities as actin, in order to fulfil its function. This 
is reflected in the expression results for the two pluripotency genes Nanog and 
Pou5f1. Both genes are involved with the maintenance of the undifferentiated 
state in ES cells and both are down-regulated once the cell begins to differentiate. 
This is reflected in these data that show a pronounced drop in Nanog expression 
in asynchronous cells at d3, and in Pou5f1 expression at d2, and then further at 
d5. The enrichment of Pou5f1 is lower than Nanog throughout the time-course 
despite its vital role as a nuclear transcription factor; however a clear pattern of 
transcription down-regulation is still visible. This suggests that either fewer copies 
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of Oct4 are required to maintain its functionality, or that the Pou5f1 mRNA is more 
stable than that of Nanog and produces more copies of the protein from each 
mRNA molecule.   
4.2.3 Expression of housekeeping and Hoxa neighbouring genes from d0 to 
d7 
 
In order to examine whether the expression patterns of Hoxa are replicated in the 
surrounding chromatin environment, figure 4.4 also shows expression of Skap2 
and Evx1, genes which are adjacent to the Hoxa cluster. Expression of Skap2 is 
constant throughout differentiation, as expected for a housekeeping gene 
(Shimamura et al., 2013). Evx1 expression is at a consistently low level throughout 
the time-course as shown by the values of enrichment relative to Beta-actin. 
Neither of these boundary genes shows any response to retinoic acid and so 
remains representative of loci close to Hoxa whose expression is not affected by 
differentiation during this time-course. 
After having analysed the expression of genes within a developmentally-regulated 
gene cluster, I then went on to assay the association of various histone 
modifications with these sequences to determine whether or not the changes in 
gene expression are influenced or predicted by the epigenetic background of the 
chromatin. 
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Figure 4.4 Real-time expression levels of day 0 to day 7 differentiating CCE/R
cells, both untreated and cells treated for 24h with 5µl/ml colcemid. A.
Expression of pluripotency-related genes. B. Expression of Hoxa cluster-
neighbouring genes. D0-d7 represents days that cells were cultured in the
absence of LIF (1µM retinoic acid added at d2). Real-time enrichments are
relative to ß-actin transcript levels as determined by real-time PCR. Error bars
show the standard error of the mean between three biological replicate
experiments
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4.3 HISTONE MODIFICATIONS IN ES CELLS 
4.3.1 Analysis of histone modification enrichment by chromatin 
immunoprecipitation 
 
Epigenetic information must be reconstituted after every cell cycle in order to be 
maintained as a heritable mark (Turner, 2007). The two critical phases that histone 
modifications must pass through are mitosis phase and synthesis phase. Mitosis 
phase, as described previously, presents a problem for the enzymatic 
maintenance of histone marks as transcription is silenced during mitosis and 
chromatin has a reduced accessibility to enzymes, so any modifications present 
on chromatin at this time would have to survive the compression and subsequent 
relaxation of chromosomes associated with M phase.  
Synthesis, or S phase, represents another obstacle for the maintenance of 
epigenetic marks, because information must be copied from the old chromatin 
strand to the new. The mechanism by which this occurs is not fully understood, but 
it is thought that new histones go through a specific sequence of modifications that 
culminate in the correct marks being maintained on both sets of chromatin. 
However, it is not known whether this process occurs exactly faithfully, or at what 
time in the cell cycle the epigenetic profile is reconstituted. It is also not known 
whether the distributions or positions of these histone modifications are shifted at 
some point during the cell cycle, or if marks are quickly and accurately deposited 
onto new chromatin. To establish this, I analysed the genetic locations of histone 
modifications in cells which had been stalled in G2/M phase, and compared them 
with asynchronous cells. This was done by using the N-ChIP technique with 
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antibodies to histone modifications H3K4me3, H3K27me3, H3K9me2, H3K9ac, 
H3K27ac and H4K20me3. 
4.3.2 Enrichment of histone modifications at Gapdh, Nanog and Pou5f1 
 
Figure 4.5 shows the level of enrichment of 6 different histone modifications on 
the housekeeper gene Gapdh and the pluripotency genes Nanog and Pou5f1 in 
both asynchronous and G2/M CCE/R cell populations. H3K4me3 enrichment does 
not change between asynchronous and G2/M samples, either at Gapdh or Pou5f1. 
H3K4me3 increases at G2/M at Nanog, however, and methylation of this mark at 
Nanog is higher than both Pou5f1 and Gapdh. This reflects the high level of 
Nanog expression seen in figure 4.4, especially with respect to Pou5f1. All three 
of these genes are expressed in ES cells, and so the repressive mark H3K27me3 
is depleted at all three marks, a state which does not change through the cell 
cycle. The repressive mark H4K20me3 is also depleted at these promoters, 
although H3K9me2 does show a moderate level of enrichment at all three loci. 
These histone modifications also do not change in enrichment as the cell cycle 
progresses. Although H3K9ac is enriched above the unbound fraction at each of 
these loci, this mark does appear to be reduced in the G2/M population, as shown 
in figure 4.4. This shows a reduction in H3K9ac at Gapdh, Nanog and Pou5f1 in 
the colcemid-treated cells as opposed to asynchronous cells. Nanog again 
displays a higher enrichment of this activating mark than Pou5f1, reflecting its 
increased transcription. This relationship is reversed, however, for another acetyl 
mark H3K27ac, which displays a greater level of enrichment at Pou5f1 rather than 
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Figure 4.5 Enrichment of DNA extracted from ChIP pulldowns with A.
H3K4me3 B. H3K27me3 C. H3K9me2 D. H3K9ac E. H3K27ac and F.
H4K20me3 antibodies. Asynchronous denotes undifferentiated asynchronous
CCE/R cells, G2/M indicates the same cells treated for 6 hours with 5µl/ml
colcemid. Primers used are specific for the promoters of the metabolic gene
Gapdh and the pluripotency-related genes Nanog and Pou5f1. Activating
marks are highlighted in green, repressive marks in red. Error bars show the
standard error of the mean between three biological replicate experiments
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Nanog. This might indicate that H3K27ac is less directly reflective of expression 
levels. Gapdh, Nanog and Pou5f1 all show enrichment of H3K27ac and no clear 
differences between asynchronous and G2/M cells can be determined for this 
histone modification. 
4.3.3 Enrichment of H3K4me3 and H3K27me3 across the Hoxa cluster 
 
Results from Figure 4.6 show that H3K4me3 is not distributed evenly across the 
entire Hoxa cluster in either asynchronous or G2/M cells. Firstly, it is clear that 
there are no significant differences between the asynchronous and G2/M samples 
across the cluster. Upstream of Hoxa1, trimethyl K4 shows a very low level of 
enrichment, revealing not only that it is depleted in intergenic sequences, but also 
that some gene promoters – in this case the housekeeper Skap2 – are not marked 
by elevated H3K4me3 levels despite the relatively high expression of Skap2 in 
these cells (figure 4.4). 
Trimethyl H3K4 is enriched at Hoxa1 compared to the unbound fraction control. 
However, at Hoxa2, the level of K4me3 enrichment is much lower. This reflects 
the future expression patterns of these two genes, as Hoxa1 is expressed after d2 
of differentiation whereas transcript levels of Hoxa2 are not raised significantly 
throughout the time-course. This pattern is carried through into Hoxa3 and Hoxa4, 
which show low and high levels of K4me3 respectively, corresponding to their low 
and high future expression in differentiating ES cells. The association between the 
level of expression and the level of methylated H3K4 continues through the rest of 
the Hox genes, as H3K4me3 enrichment drops from Hoxa4 to Hoxa5, and drops 
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Figure 4.6 Enrichment of DNA extracted from ChIP pulldowns with A. H3K4me3 and B.
H3K27me3 antibodies. Asynchronous denotes undifferentiated asynchronous CCE/R cells, G2/M
indicates the same cells treated for 6 hours with 5µl/ml colcemid. Primers used are in and
adjacent to the HoxA cluster on mouse chromosome 6. Primers are specific for the promoter of
the labelled gene except for upstream and downstream primers which are complementary to
intergenic sequences. C. Diagram of genome browser data showing the relative positions of Hoxa
genes and neighbouring genes within the Hoxa cluster on mouse chromosome 6. Gene positions
not to scale. Error bars show the standard error of the mean between three biological replicate
experiments
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further across Hoxa6, 7, 9, 10 and 11, before rising at Hoxa13. There is not a 
perfect correlation between Hox gene activity and H3K4me3 enrichment, as the 
transcription of Hoxa7 is much greater than that of Hoxa9, which is not reflected in 
the ChIP data that shows Hoxa7 as being the most trimethyl K4-depleted gene 
among the cluster. Another observation is that Hoxa11 shows enrichment in this 
histone modification that is equivalent to several other genes in the cluster, 
whereas shown in figure 4.3 is the clear repression of Hoxa11 transcription at 
each day sampled compared to every other Hox gene. There is not a simple 
relationship between transcription and histone methylation, although these data do 
reveal a strong link implying H3K4me3 increases as a pre-emptive mark, as future 
transcription of underlying DNA increases.  
Intergenic sequences both upstream and downstream of the Hoxa cluster have 
very low enrichments (figure 4.6); however, the closest genes on each side of 
Hoxa differ in their enrichment of trimethyl K4. Evx1 has an enrichment of several 
times the unbound in both asynchronous and G2/M populations and is equivalent 
to some Hox genes like Hoxa9, whereas enrichment for Skap2 is less than 1, 
indicating a depletion of H3K4me3 at that site. This indicates that Evx1, a 
developmentally regulated gene, shows a similar enrichment of H3K4me3 to Hoxa 
genes, whereas Skap2, a housekeeping gene, does not (Dush and Martin, 1992, 
Fujioka et al., 2003). 
Data from N-ChIP experiments using H3K27me3 antibodies reveal more about the 
epigenetic landscape of the Hoxa cluster in ES cells. Again, the enrichment of this 
mark does not change significantly between asynchronous and G2/M phase cells, 
with the possible exception of Hoxa5. This gene has a small enrichment in 
H3K27me3 in G2/M compared to the asynchronous population. This is also 
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reflected in the results for H3K4me3, which show another slight increase. This 
difference is not reflected in the expression data, which shows a steady level of 
detected transcript between asynchronous and G2/M cells. In fact, the expression 
time-course for Hoxa5 shows a particularly close congruence between 
enrichments at each sampled day between both sets of cell populations. 
Therefore, any difference in the levels of histone modifications is not governed by 
changing expression, and vice versa.  
Another striking feature of the H3K27me3 data is that it appears to complement 
the results obtained for H3K4me3. That is to say that genes at which H3K4me3 is 
enriched, are simultaneously depleted in H3K27me3. This is particularly evident 
for Hoxa1, which is greatly enriched in H3K4me3, but only slightly enriched in 
H3K27me3. Many other studies have noted the co-existence of H3K4me3 and 
H3K27me3 at Hox promoters, although this data shows a more nuanced picture of 
the epigenetic state of the promoters in ES cells (Bernstein et al., 2006, Hattori et 
al., 2013). Enrichment of both these marks relative to unbound fractions suggest 
that the bivalent motif is present, yet the predominance of trimethyl K4 as opposed 
to K27 reflects a predictive permissive chromatin environment that is confirmed by 
the elevated Hoxa1 expression after differentiation relative to other genes in the 
cluster. This relationship can also be found inversely at genes Hoxa2 and Hoxa3. 
These genes have low transcription relative to Hoxa1, and also show low levels of 
H3K4me3 and high levels of H3K27me3 relative to Hoxa1. Data from these 
experiments imply that the bivalent domain does not involve an undifferentiated 
state characterised by equal levels of trimethyl K4 and K27, but rather that at 
bivalent loci both modifications are often present, but with one or the other mark in 
clear prevalence over the other, determining its transcriptional output. The outlying 
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DNA sequences also reveal information about the bivalent mark. The intergenic 
sequences are devoid of both modifications, confirming the association of these 
marks with gene-promoter regions and not intergenic DNA (Bernstein et al., 2006, 
Roudier et al., 2011). Both marks are also depleted at Skap2, a gene which is 
expressed in these cells but which is not thought to be related to the process of 
differentiation. Evx1, on the other hand, contains both H3K4me3 and H3K27me3 
and is more heavily enriched in H3K27me3. This pattern is similar to the level of 
modifications present at Hoxa2, and like this gene, Evx1 shows a low level of 
expression at day 0. Evx1 is also closer in terms of locus to the Hoxa cluster than 
Skap2, however both the upstream and downstream regions between the cluster 
and these outlying genes show depletion of histone modifications, confirming that 
these observations are not due to a motif from the Hoxa cluster indiscriminately 
spreading to outlying genes, but that another discrete bivalent mark has been 
deposited on Evx1 to influence its epigenetic signature. Bivalency is thought to 
play a major role in the control of differentiation, and indeed Evx1 is a gene which 
has been implicated in the repression of transcription related to the control of the 
differentiation process (Dush and Martin, 1992, Fujioka et al., 2003). So in a 
sense, the bivalent mark can distinguish the Evx1 gene that is differentiation 
related from Skap2 that isn’t, therefore implicating epigenetic factors in predictively 
marking, or even determining, the behaviour of underlying genes by the 
combination of histone modifications on chromatin. 
As ever, the number and variety of epigenetic modifications means that a simple 
pattern of one modification influencing gene transcription alteration is too 
simplistic. The pattern of expression for undifferentiated cells found here, however, 
does intimate a strong relationship between bivalent modification enrichment and 
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gene expression in the Hoxa cluster. The pattern of high trimethyl K4 and low 
trimethyl K27 is shared by Hoxa1 and Hoxa4, whereas the reverse pattern is 
evident for genes Hoxa2, 3, 6, 7, 9, 10 and 11. Hoxa13 shows only a slight 
enrichment in H3K4me3 compared to H3K27me3, and Hoxa5 shows a unique 
distribution of trimethyl K27. The incongruous results obtained for Hoxa5 may 
reflect its unusual position at the confluence of several transcription units in the 
Hox cluster (Coulombe et al., 2010). This may result in the epigenetic signature of 
this locus being more complex or perhaps differently organised than the other Hox 
loci. This may represent a gap in the bivalently controlled Hox cluster whereby 
future Hoxa5 expression is regulated by some other means. 
Despite the expression profiles of Hoxa4 and Hoxa5 being very similar, these two 
genes show differences in their enrichments of histone modifications. Methylation 
at H3K4 is lower at Hoxa5 than Hoxa4, and H3K27me3 is higher. However, a 
more obvious feature of these data is that both histone marks show increased 
enrichment at G2/M at the Hoxa5 locus. In asynchronous cells, the levels of 
H3K4me3 and H3K27me3 are equivalent, whereas at G2/M the increase in 
H3K4me3 enrichment is overtaken by a larger increase in H3K27me3. At G2/M 
then, the chromatin environment at Hoxa5 would appear to be repressive, despite 
the high enrichment of H3K4me3. However, this shift in chromatin modifications 
does not affect expression at all, as Hoxa5 expression is equal between 
asynchronous and G2/M in undifferentiated cells and in cells at every stage of 
differentiation during the sampled time-course. It is possible that the information 
encoded by these histone modifications extends to more than simply gene 
expression and that the increase in the bivalent mark seen at G2/M could signal an 
as yet unidentified pathway to interact with this section of chromatin, perhaps to 
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assist with some cell cycle-related aspect of the differentiation process. 
Alternatively, histone modifications at Hoxa5 may be selectively deposited later 
than those of other genes, perhaps owing to its transcriptional complexity, 
therefore appearing to be enriched in G2 or M phase compared to the rest of the 
Hoxa cluster (Coulombe et al., 2010).  
4.3.4 Histone modifications at H3K9 at Hoxa gene promoters 
 
The bivalent mark is well-known to be found at certain developmental loci, but 
these loci, as well as others, have a variety of histone modifications that are 
deposited and removed to maintain a fine balance of epigenetic markers that have 
some control over gene expression as well as a plethora of other cellular 
processes. Other common marks include modifications on lysine 9 of histone H3, 
methylation of which is known to be associated with transcription repression and 
heterochromatin (Puschendorf et al., 2008, Alder et al., 2010). H3K9me2 in 
particular has been linked to deactivating expression of underlying genes (Rea et 
al., 2000). K9 acetylation, on the other hand, is commonly associated with 
activating neighbouring expression and is often found at the promoters and bodies 
of active genes (Agalioti et al., 2002). 
Figure 4.7 shows that the distributions of two histone modifications on H3K9 are 
very different. H3K9me2 enrichment is constant across the entire Hoxa cluster, 
remaining at a value of around 1 to indicate an average or low prevalence of this 
histone mark across this region. H3K9me2 enrichment also shows no significant 
differences between G2/M and asynchronous populations. Acetylated H3K9, 
however, shows great variation between genes in the Hoxa cluster, and between 
G2/M and asynchronous cell populations. High levels of acetyl-K9 throughout the 
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Figure 4.7 Enrichment of DNA extracted from ChIP pulldowns with A. H3K9ac and B. H3K9me2
antibodies. Asynchronous denotes undifferentiated asynchronous CCE/R cells, G2/M indicates
the same cells treated for 6 hours with 5µl/ml colcemid. Primers used are in and adjacent to the
HoxA cluster on mouse chromosome 6. Primers are specific for the promoter of the labelled gene
except for upstream and downstream primers which are complementary to intergenic sequences.
C. Diagram of genome browser data showing the relative positions of Hoxa genes and
neighbouring genes within the Hoxa cluster on mouse chromosome 6. Gene positions not to
scale. Error bars show the standard error of the mean between three biological replicate
experiments
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Hoxa cluster could explain the exclusion of the methyl modification from this 
residue.  At every locus studied apart from Skap2 and the downstream intergenic 
sequence, acetyl K9 enrichment was greater in the asynchronous population than 
in the G2/M sample. This included the upstream intergenic region as well as all 
Hoxa genes and the related outlying gene Evx1. Unlike the H3K4me3 mark, 
H3K9ac enrichment does not correlate consistently with gene expression, as 
Hoxa5 acetyl-K9 levels are low despite high expression, and the Hoxa11 locus is 
highly acetylated (in asynchronous cells) and yet is not expressed in ES cells.  
The frequency of K9 acetylation changes between Hoxa cluster genes in both 
G2/M and asynchronous cells, from high enrichment at Hoxa4 and Hoxa13 
(asynchronous), to low enrichment at Hoxa10 (asynchronous). Results for G2/M 
cells fluctuate even more significantly, as some genes show enrichment in 
H3K9ac, such as Hoxa1, 2, 3, 4, 6 and 13, and some show no enrichment or even 
depletion in acetylation; i.e. Hoxa5, 7, 9, 10, 11 and Evx1. Genes such as Hoxa9 
show a switch from strong enrichment in the asynchronous population to depletion 
in G2/M. These incidences of the loss of acetylation in G2/M may be due to the 
rapid turnover of acetyl marks in chromatin. As mitosis phase begins and 
chromatin becomes less accessible to HAT enzymes, it becomes more difficult for 
acetyl marks to be deposited (Patzlaff et al., 2010). Therefore, acetyl marks may 
be lost in G2/M cell populations more quickly than methyl marks. This process may 
be the reason behind the reversion at many loci to background levels (i.e. 
enrichment between 0.5 and 2) of H3K9ac. This also has implications for 
epigenetic inheritance, as not only would histone modifications need to be re-
established after DNA replication, but also be reinstated after mitosis.  
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4.3.5 H3K27ac and H4K20me3 distributions at Hoxa 
 
In order to investigate modifications on other residues and other chromosomes, I 
then studied the histone modifications H3K27ac and H4K20me3. I studied K27 
acetylation as a counterpoint to methylation on the same residue, as in the case of 
H3K9, to investigate further whether two modifications on the same histone tail 
residue can be enriched. As is shown in figure 4.8, H3K27ac enrichment is at a 
constant level of between 0.5 and 2 times the unbound control fraction across the 
entire Hoxa cluster and surrounding DNA. As such, there is no evidence of a co-
localisation of acetyl and methyl marks on H3K27. The levels of acetyl-K27, unlike 
those of acetyl K9, do not change between G2/M and asynchronous populations, 
as they show no difference to background (unbound) levels of this modification in 
both samples, so no specific acetylation has taken place.  
I analysed the distribution of H4K20me3 to find out if modifications on another 
histone would show a different pattern to those of histone H3. I also chose this 
modification as earlier chromosome immunofluorescence data showed that there 
was some association of this normally heterochromatic mark with euchromatin 
across all chromosome arms in ES cells. However, in keeping with its link with 
heterochromatin, H4K20me3 was found to be heavily depleted across most of the 
Hoxa cluster. A few loci show enrichments of around 1.0, such as Hoxa6 and 
Evx1, but for many loci the values were well below 0.5-fold of the unbound. On the 
whole, asynchronous populations and G2/M cells did not differ, but exceptions 
such as Hoxa2, 6 and 7 show a definite preference for H4K20me3 in the G2/M 
population. One explanation for this occurrence is that in some cases H4K20me3 
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Figure 4.8 Enrichment of DNA extracted from ChIP pulldowns with A. H3K27ac and B.
H4K20me3 antibodies. Asynchronous denotes undifferentiated asynchronous CCE/R cells, G2/M
indicates the same cells treated for 6 hours with 5µl/ml colcemid. Primers used are in and
adjacent to the HoxA cluster on mouse chromosome 6. Primers are specific for the promoter of
the labelled gene except for upstream and downstream primers which are complementary to
intergenic sequences. C. Diagram of genome browser data showing the relative positions of Hoxa
genes and neighbouring genes within the Hoxa cluster on mouse chromosome 6. Gene positions
not to scale. Error bars show the standard error of the mean between three biological replicate
experiments
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is deposited at G2 phase as part of the process involved in cell division. Once its 
function is completed, the mark is removed and a subsequent depletion of the 
mark is found during G1/S. The fact that even the elevated levels of H4K20me3 at 
G2/M is not significantly above the background, however, suggests that these 
marks are not specifically deposited on these loci after DNA synthesis, and 
removed after G2/M phase as part of the normal nuclear checking procedure 
characteristic of the eukaryotic cell cycle. 
These results show clear differences between methyl and acetyl marks on histone 
H3, possibly highlighting their respective persistence through the cell cycle. The 
link between histone modifications and gene expression has been shown to be 
much stronger for the bivalent epigenetic markers H3K4me3 and H3K27me3 than 
for the marks H3K9me2 and H3K9ac. This could be due to the fact that the Hoxa 
cluster is transiently expressed during differentiation and the bivalent marker is 
closely linked to this process, perhaps so much as to be the defining epigenetic 
motif in order to drive expression. 
 
4.4 HISTONE MODIFICATIONS IN DIFFERENTIATING CELLS 
4.4.1 Dynamics of histone modifications through early embryonic 
differentiation 
 
To fully investigate the distributions of histone modifications at Hoxa, I went on to 
repeat these N-ChIP experiments in differentiated cells for those modifications 
which showed enrichment at the Hoxa cluster, i.e. H3K4me3, H3K27me3 and 
H3K9ac. I used the time point of 5 days after LIF removal, because this was the 
point at which expression of Hoxa genes was highest, making it an ideal time to 
163 
 
analyse the behaviour of histone modifications during differentiation and their 
relation to gene expression. 
4.4.2 Histone modifications at Gapdh, Nanog and Pou5f1 after 
differentiation 
 
Figure 4.9 shows the changes in H3K4me3, H3K27me3 and H3K9ac between an 
undifferentiated and a d5 differentiated cell population. Methylation of H3K4me3 
has increased slightly at Gapdh after differentiation, but has decreased markedly 
at Nanog and Pou5f1, reflecting the drop in transcription of these two pluripotency 
genes. There is also a simultaneous increase in H3K27me3 at Nanog and Pou5f1 
after differentiation, although the level of the repressive mark does not rise above 
the unbound fraction. H3K27me3 remains at a similar level at Gapdh at both d0 
and d5. H3K9ac shows large changes between undifferentiated and differentiated 
cell populations, undergoing deacetylation from d0 to d5 as shown in figure 4.9. 
Although H3K9ac is enriched at all three loci, there has also been a change in 
how H3K9ac is transmitted through the cell cycle. At d0, acetylation at H3K9 
decreases at G2/M. At d5, however, the mark is stably enriched between both cell 
populations. Nanog has also become the least acetylated of the three genes, from 
being the most acetylated at d0. This is most likely to be a reflection of the drop in 
expression of Nanog and Pou5f1 during the first five days of differentiation. 
4.4.3 Bivalent histone modifications after differentiation at the Hoxa cluster 
 
Figure 4.10 shows the results of N-ChIP experiments from ES cells and 
differentiated cells for both bivalent histone modifications H3K4me3 and 
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Figure 4.9 Enrichment of DNA extracted from ChIP pulldowns with A+B. H3K4me3 C+D.
H3K27me3 and E+F. H3K9ac antibodies. Asynchronous denotes undifferentiated asynchronous
CCE/R cells, G2/M indicates the same cells treated for 6 hours with 5µl/ml colcemid. Primers
used are specific for the promoters of the metabolic gene Gapdh and the pluripotency-related
genes Nanog and Pou5f1. Panels on the left display results obtained from an undifferentiated cell
population, panels on the right represent data from cells sampled after 5 days of differentiation.
Error bars show the standard error of the mean between three replicate experiments
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Figure 4.10 Real-time enrichment (Bound/Unbound) of DNA extracted from ChIP
pulldowns. Data shown is from asynchronous CCE/R cells. A shows results obtained with
H3K4me3 antibody from undifferentiated cells (red), and from cells differentiated for 5 days
(green). B shows results obtained with H3K27me3 antibody from undifferentiated and d5
differentiated cells . Primers used are targeted to promoters for genes in and adjacent to the
HoxA cluster on mouse chromosome 6. Primers are specific for the promoter of the labelled
gene except for upstream and downstream primers which are complementary to intergenic
sequences. Error bars show the standard error of the mean between three biological
replicate experiments
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H3K27me3 across the Hoxa cluster. Data for trimethyl K4 shows that methylation 
here has increased from day 0 to d5 at each gene promoter across the Hoxa 
cluster. Figure 4.9, however, shows that K4 methylation decreased at pluripotency 
genes in the same cell populations. Although H3K4me3 levels remain low at 
sequences upstream of the cluster, the Hoxa genes themselves show clear 
enrichment of K4me3 compared to the d0 samples. Hoxa1 shows an increase in 
enrichment from d0 to d5, and an even larger increase in the G2/M population, 
representing a doubling in the concentration of trimethyl-K4 at this locus at G2/M. 
Hoxa2, one of the Hox genes with the lowest level of H3K4me3 at d0, shows a 
large increase in this mark after five days of differentiation. Methylation at K4 
shows an increase between d0 and d5 populations at Hoxa3 and similar increases 
can be found at every Hoxa gene in the study, as well as at Evx1.  
The highest fold increases in H3K4me3 occur at genes that have low levels of 
enrichment in the undifferentiated cell population, the most drastic of these being 
the increase at Hoxa10 from d0 to d5. This represents a shift in the epigenetic 
signature to a state that is strongly associated with promoting underlying gene 
transcription. The mechanism of bivalency suggests that one of the two marks 
becomes dominant after differentiation, negating the effect of the other. These 
data suggest that H3K4me3 is increasing in prevalence after 5 days of 
differentiation and thereby creating a more active chromatin environment, 
therefore fuelling the increase in transcription seen during the course of the 
expression study. 
The increase in methylation seen within the Hoxa cluster is not indiscriminate, 
although Hoxa1 and Hoxa4 still show the highest enrichment of H3K4me3 in the 
cluster, methylation at other genes has risen by varying extents. Hoxa5, for 
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example, is highly enriched at d0, more so than for Hoxa6. However at d5, the 
pattern was reversed and Hoxa6 displays higher levels of methyl K4. Hoxa5 may 
represent the exception once again to the general distribution of H3K4me3 at the 
Hoxa cluster, as enrichment at this locus does not greatly increase upon 
differentiation, and in fact in the metaphase sample the H3K4me3 enrichment is 
decreased. Expression of Hoxa5 and Hoxa4 follows the same pattern throughout 
the 7 days of differentiation; however the histone modification profiles at these two 
genes are very different, perhaps due to the unique nature of Hoxa5. This tells us 
that complex epigenetic regulation processes are occurring that are very discretely 
and specifically targeted to sections of chromatin without affecting neighbouring 
sequences. The rise in methylation of H3K4 at Hoxa4 is not spread to Hoxa3 or 
Hoxa5, making the difference in epigenetic signatures between these genes even 
more pronounced. Therefore, it is likely that K4 chromatin modifying enzymes 
exert careful control over the epigenetic fate of these genes and regulate each 
individually rather than depositing methyl marks over a large area of chromatin in 
order to facilitate decondensation of chromatin. This would also explain the rise in 
K4 methylation at most genes in the Hoxa cluster, and the simultaneous decrease 
in H3K4me3 at Skap2, Nanog and Pou5f1.  
Since the bivalent mark is linked to differentiation, and Hoxa is known to be 
activated during the course of cell development, one might expect the level of the 
repressive mark H3K27me3 to be reduced during this process (Kashyap et al., 
2011). Indeed, as shown in Figure 4.10, most Hoxa cluster genes undergo 
demethylation at lysine 27 after 5 days of differentiation. Again, there are 
exceptions, this time Hoxa9 and 10, which show no marked change in H3K27me3 
between undifferentiated and d5 cells. Unlike the pattern shown in H3K4me3, the 
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levels of trimethyl K27 relative to other genes in the cluster remain unchanged. 
The marks relatively high in K27me3 in d0 cells remain high after differentiation, 
but with a reduced enrichment over the unbound fraction. This trend is only 
bucked by the particularly high enrichment of K27me3 found at Hoxa5 in G2/M 
stalled cells, which is lost nearly entirely after differentiation to render the 
asynchronous and G2/M populations equal within this sample. Again, this could 
indicate that Hoxa5 alone is not developmentally regulated by the bivalent 
chromatin signature and is controlled instead by other histone modifications, or 
other epigenetic regulators entirely. This could challenge the notion that the Hox 
cluster represents one regulatory region of chromatin and that all underlying 
genes are affected by the same epigenetic mechanisms.  
This evidence points towards a reorganisation of chromatin during the process of 
differentiation with respect to the composition of the bivalent mark. Not only is the 
more repressive H3K27me3 mark reduced as differentiation progresses, but the 
more permissive histone modification H3K4me3 is up-regulated, with the main 
effect of increasing expression of Hoxa genes after the removal of LIF. It should 
be noted that although enrichment of H3K27me3 has been reduced after 
differentiation, it is still enriched above background levels at most Hox loci and 
significantly above levels at other genes such as the housekeepers Gapdh and 
Skap2, and pluripotency genes Pou5f1 and Nanog (figures 4.9 and 4.10). These 
pluripotency genes have been shown to lose their associations with H3K4me3 
after differentiation, however they do not show a concomitant increase in 
H3K27me3 deposition, as one might expect given results for Hoxa genes. The 
difference here is that the pluripotency genes are not thought to be associated 
with a bivalent histone modification mark, and so are not regulated in the same 
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way as those genes in the Hoxa cluster. They do still appear to be epigenetically 
regulated, however, as the loss of H3K4me3 after differentiation points to control 
of transcription through epigenetic means. It may be that the expression of these 
genes are controlled simply through K4 methylation, or that some other repressive 
modification is playing the part of H3K27me3 in another bivalent motif, or that this 
process is controlled by a complex variety of factors which do not conform to any 
simple linear relationship. 
4.4.4 H3K9ac enrichment through differentiation and the cell cycle 
 
The epigenetic code could potentially include hundreds of separate chromatin 
modifications that combine to influence cell phenotype (Strahl and Allis, 2000, 
Turner, 2000). Keeping this in mind, I looked at another histone modification 
outside of the bivalent paradigm, and studying acetylation through differentiation 
rather than methylation. As previously discussed, acetylation is thought to have a 
more direct influence on chromatin structure by disrupting bonds within histone 
molecules to allow access to transcription factors and DNA binding enzymes 
(Allfrey et al., 1964, Marushige, 1976, Grunstein, 1997). I therefore investigated 
histone 3 lysine 9 acetylation in day 5 differentiated cells as opposed to ES cells. 
Figure 4.11 shows that the distribution of this mark changes drastically as 
differentiation progresses, and that the persistence of this mark through the cell 
cycle is also more stably maintained.  
Results in the asynchronous population show that in the Hoxa cluster, H3K9ac is 
consistently depleted in d0 G2/M cells compared to an asynchronous population. 
However, after differentiation, the difference between G2/M and asynchronous 
cells is equalised, and H3K9ac is maintained at a constant level at each locus 
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Figure 4.11 Real-time enrichment (Bound/Unbound) of DNA extracted from
ChIP pulldowns. A shows results obtained with H3K9ac antibody from
asynchronous CCER cells, B from CCER cells treated with colcemid (G2/M).
Red bars denote undifferentiated cells, green bars represent cells differentiated
for 5 days in the absence of LIF. Primers used are in and adjacent to the HoxA
cluster on mouse chromosome 6. Primers are specific for the promoter of the
labelled gene except for upstream and downstream primers which are
complementary to intergenic sequences. Error bars show the standard error of
the mean between three biological replicate experiments
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throughout the cell cycle. This is due not only to a reduction in the enrichment of 
K9ac in asynchronous cells, but also to an increase in acetylation in G2/M-specific 
cells. Hoxa1, for example, showed an asynchronous enrichment at d0, dropping 
markedly in G2/M in the undifferentiated sample. After differentiation, these values 
equalised at an intermediate level. Hoxa2, on the other hand, does not show a 
great depletion of H3K9ac from asynchronous d0 to d5 cells, but does show an 
increase in acetyl K9 in the G2/M population. This pattern is also true for Hoxa5 
and Hoxa7. All other members of the Hoxa cluster display a trend of equalising, 
whereby acetylation is reduced in the asynchronous population, but increased for 
the G2/M population. These results can be explained by the reconciliation of two 
distinct processes. Firstly, the process of differentiation appears to have negated 
the effect of the cell cycle on the maintenance of the H3K9ac mark. The reduction 
of K9ac in the G2/M population in d0 cells can be attributed to the loss of 
acetylation during mitosis phase, although there is still widespread H3K9ac 
enrichment, as shown in figure 4.7 and in chromosome pictures (figure 3.5). The 
process of differentiation profoundly affects the nature and timings of the cell 
cycle, and also has the effect of increasing the doubling time of affected cells. As 
a result, cells spend a lot more of their time being stalled in the gap phases rather 
than going through mitosis. Therefore, the loss of acetyl marks at metaphase 
would represent an even more transient event in the cell cycle of a differentiating 
cell, and would therefore not greatly affect the results obtained from a G2/M 
population. This is accompanied by a simultaneous down-regulation of the 
H3K9ac modification, as evidenced by the reduction in acetylation on many of the 
Hoxa genes after 5 days of differentiation. The increase in H3K4me3 at the same 
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time may render the activating H3K9ac mark redundant, and so Hoxa chromatin 
becomes less acetylated as a result. 
Considering these experiments as a whole, the data lends further weight to the 
theory that histone modifications can be predictive of gene expression, as seen by 
the results of the H3K4me3 ChIP experiment at the Hoxa cluster (figure 4.6). 
These data also show that the differentiation process alters the epigenetic 
landscape at key developmentally-regulated genes such as Hoxa to create a more 
permissive chromatin environment (figure 4.10), underlining the importance of 
dynamic epigenome control during key cellular processes. 
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5. ANALYSIS OF DATA IN THE CONTEXT OF PREVIOUS STUDIES 
5.1 THE HOXA CLUSTER IN THIS AND PREVIOUS STUDIES 
5.1.1 Hoxa in undifferentiated mouse ES cells 
 
This chapter shows the data described in the previous chapters compared side by 
side with other similar studies involving embryonic cells. This comparison is 
between studies using undifferentiated murine embryonic stem cells, showing 
ChIP results against the H3K4me3 histone modification within the Hoxa cluster. 
The datasets shown in table 5.1 were chosen as they study mouse embryonic 
cells, using ChIP-sequencing to obtain results for H3K4me3 and H3K27me3 
enrichment across the mouse genome. This should allow a comparison to be 
made with my own data. All results have been normalised to the highest 
enrichment found in that data set, in order to easily compare different sets of data. 
Figure 5.1 shows the variation between experimental datasets and why 
normalisation is necessary. The enrichment of H3K4me3 is highest in all literature 
studies at Hoxa1, as in the original data shown in black. There is good agreement 
among all studies at the Hoxa2 and Hoxa3 loci, which all show low enrichment of 
H3K4me3. The amount of variability between studies of this nature is evident at 
Hoxa4, as is shown in figure 5.2. My data shows a high enrichment of H3K4me3 
at Hoxa4 of over half the Hoxa1 level, whereas the literature data shows an 
enrichment anywhere between 10% and 40% of the enrichment of H3K4me3 at 
Hoxa1. In one study (#307605), the level of H3K4me3 is fairly consistent between 
Hoxa2, a3 and a4, whereas in all the others, the enrichment of H3K4me3 
increases between Hoxa3 and Hoxa4.  
Results for Hoxa5 are also not consistent, with several studies showing low 
enrichment of H3K4me3, and others including mine showing a higher incidence. 
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Table 5.1 Table showing the characteristics of datasets used in Chapter 5. GSM
accession numbers are shown in the first column, and antibodies used, cell line and cell
type, ChIP method and sequencing resolution are also shown.
Accession Antibody Cell line Cell type ChIP method Read resolution
307605 H3K4me3 
Abcam 8580
V6.5 ES cell 
undifferentiated
X-ChIP 25bp with 300bp 
window
307618
Abcam 8580
V6.5 ES cell 
undifferentiated
X-ChIP 25bp with 300bp 
window
307148
Abcam 8580
V6.5 ES cell 
undifferentiated
X-ChIP 25bp with 200bp 
window
535982 Abcam 8580 E14Tg2A ES cell 
undifferentiated
X-ChIP Unspecified: 250bp 
window
651193 H3K4me3 
Millipore 
07-473
E14 ES cell 
undifferentiated
X-ChIP 25bp with 300bp 
window
686992 H3K27me3 
Upstate 
07-449
129Sv-
C57Bl/6
ES cell 
undifferentiated
X-ChIP 25bp with 200bp 
window
686993 Upstate 
07-449
129Sv-
C57Bl/6
ES cell 
undifferentiated
X-ChIP 25bp with 200bp 
window
686994 Upstate 
07-449
129Sv-
C57Bl/6
ES cell 
undifferentiated
X-ChIP 25bp with 200bp 
window
487549 Upstate 
07-449
C6 ES cell 
undifferentiated
X-ChIP 25bp with 200bp 
window
307608 H3K4me3 
Abcam 8580
129SvJae 
x C57BL/6
Mouse embryonic 
fibroblast MEF
X-ChIP 25bp with 300bp 
window
279934 Abcam 8580 MCV6 MEF X-ChIP 25bp with 300bp 
window
279936 Abcam 8580 MCV6 MEF X-ChIP 25bp with 300bp 
window
279938 Abcam 8580 MCV8 MEF X-ChIP 25bp with 300bp 
window
279942 Abcam 8580 MCV8.1 MEF X-ChIP 25bp with 300bp 
window
307609 H3K27me3 
Upstate 
07-449
129SvJae 
x C57BL/6
MEF X-ChIP 25bp with 300bp 
window
397409 H3K27me3 
in-house
LF2 ES cell d10 
differentiated
X-ChIP 25bp with 300bp 
window
397411 H3K27me3 
in-house
E14 ES cell d10 
differentiated
X-ChIP 25bp with 300bp 
window
279937 Upstate 
07-449
MCV6 MEF X-ChIP 25bp with 300bp 
window
279939 Upstate 
07-449
MCV8 MEF X-ChIP 25bp with 300bp 
window
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Figure 5.1 Graph to show the mean enrichments of A H3K4me3 and B H3K27me3 across
the 4 Hox clusters in mice. Shown on the x-axis are the GSM accession numbers of the
ChIP-seq datasets. The y-axis shows the level of enrichment of each modification.
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Figure 5.2 Graphs showing my original data compared with several datasets obtained
from previous studies in the literature. Original data is shown in black, literature data is
shown in green. NCBI GSM numbers are shown in the legend to denote the datasets. A
shows the H3K4me3 distribution in undifferentiated mouse cells, B shows the H3K27me3
distribution; both histone modifications were analysed at Hoxa cluster gene promoters. All
data were normalised to the maximum of that dataset, shown by a value of 1.0, so that
comparisons may be made between data
A
B
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Enrichment of H3K4me3 at Hoxa6 is less variable, with all results coming between 
10-20% of the maximum. Hoxa7 results are also quite consistent, with all studies 
reporting a low enrichment of H3K4me3. Hoxa9 is where the greatest difference 
between my results and the literature results lies. My results show an enrichment 
of H3K4me3 of between 10 and 20% of the maximum enrichment, whereas the 
literature studies all show low enrichments of less than 5% of the maximum. 
Hoxa10 shows low enrichment for all studies, as does Hoxa11, with moderately 
good agreement between the data. Hoxa13 shows fairly high enrichment in my 
data, which is reflected in some studies, although enrichment is very low in others. 
Results for the two genes that surround the Hoxa cluster show large differences 
between my data and those in previous studies. There is an extremely low 
enrichment of H3K4me3 at Evx1 in all previous studies. However, in my study, the 
enrichment is higher, at around 15-20% of the maximum. Conversely, enrichment 
of H3K4me3 at Skap2 is particularly high in several literature datasets, some even 
approaching the same level of H3K4me3 as at Hoxa1, but is extremely low in my 
data.   
As has been noted already in this study, the distribution of H3K27me3 across the 
Hoxa cluster generally opposes the distribution of H3K4me3. This is also reflected 
in figure 5.2, which shows a much lower relative enrichment of H3K27me3 at 
Hoxa1 than H3K4me3. My data is analogous to literature studies, which also show 
an enrichment of H3K27me3 at Hoxa1 at below 1/3 of the maximum enrichment 
across the cluster. The amount of H3K27me3 enrichment increases in Hoxa2 and 
then again to a maximum at Hoxa3 in my data. This agrees with the previous 
studies, two of which also have maxima at Hoxa3. This affirms the association of 
Hoxa2 and Hoxa3 with low H3K4me3 and high H3K27me3 levels. Hoxa4 shows 
178 
 
high H3K4me3 enrichment in my study, and relatively low enrichment in literature 
data. H3K27me3 is lower in all studies, as shown by the falls in enrichment levels 
in figure 5.2. H3K27me3 is maintained at a high level throughout the rest of the 
Hoxa cluster, in contrast to H3K4me3, which is generally low from Hoxa5 to 
Hoxa13 in literature datasets. The bordering genes Evx1 and Skap2 have 
opposing H3K4me3/H3K27me3 levels in the literature studies. For example, 
H3K27me3 is enriched at Evx1 but not at Skap2, whereas H3K4me3 is enriched 
at Skap2 but not at Evx1. This conflicts with my data, which shows a low level of 
H3K4me3 at Skap2, and not such a great difference between H3K4me3 and 
H3K27me3 at Evx1. Such a clear difference between datasets is somewhat 
surprising, given that these two genes are not part of the Hoxa cluster proper, and 
also that Skap2 in particular is a housekeeping gene and should not be subject to 
a great deal of expression regulation since it is required to be ‘always-on’. 
Interestingly, the literature data agrees with mine is so far as the H3K27me3 is 
enriched at negligible levels in d0 cells.  
5.1.2 Hoxa in differentiated mouse ES cells 
 
Figure 5.3 shows the distribution of H3K4me3 across the Hoxa cluster in 
differentiated cells. It is immediately clear that there is more variation between 
literature datasets, and also my own data, than there is for ESCs. For example, 
GSM307608 shows a similar enrichment of H3K4me3 at Hoxa1 to my study, and a 
very low level at Hoxa2, well below the value shown for my data. GSM279934, 
however, has low enrichment of H3K4me3 at Hoxa1, and a high enrichment at 
Hoxa2; the highest anywhere in the Hoxa cluster for that dataset. My data shows 
the highest enrichment of H3K4me3 differentiated cells occurring at the Hoxa4 
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Figure 5.3 Graphs showing my original data compared with several datasets obtained
from previous studies in the literature. A shows the H3K4me3 distribution in differentiated
mouse cells, B shows the H3K27me3 distribution; both histone modifications were
analysed at Hoxa cluster gene promoters. All data were normalised to the maximum of
that dataset, shown by a value of 1.0, so that comparisons may be made between data
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promoter. However, the literature data consistently show a low level of enrichment 
at this locus. This is again the case for Hoxa5-13, with the exception of Hoxa11, 
which shows a high level of enrichment in several studies. However, my data 
show varying levels of H3K4me3 enrichment, but always at a higher relative level 
than those shown in the literature studies. Results for Skap2 and Evx1 are similar 
to the undifferentiated data, and once again the literature data disagrees with the 
results of my study.  
Literature data for the distribution of H3K27me3 across the Hoxa cluster in 
differentiated cells is widely variable. The five different samples shown in figure 
5.3 show differences at many Hoxa loci. Firstly at Hoxa1, each dataset is different 
to the next; some showing high H3K27me3 enrichment, others showing moderate 
enrichment, and one displaying very low enrichment. My data shows low levels of 
H3K27me3 in d5 differentiated cells, agreeing with one study but not others. At 
Hoxa2 a similar picture can be seen, whereby my study agrees with two literature 
samples in denoting modest enrichment of H3K27me3 at this locus, but not other 
studies. This pattern continues throughout the Hoxa cluster, whereby literature 
datasets do not agree, with the exception of Skap2 H3K27me3 enrichment, which 
is consistently very low in all literature datasets and my own data. The amount of 
variation between datasets has been represented in figures 5.4 and 5.5 by error 
bars denoting standard deviation between studies. The error bars show that the 
variation between studies is greater when looking at differentiated cells rather than 
undifferentiated embryonic stem cells. This is most likely due to the fact that the 
embryonic stem cell is a very well-defined stage in the development of the cell, 
and has been standardised to some degree between laboratories. Studies 
employing ChIP-sequencing to look at histone modifications in more differentiated 
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Figure 5.4 Re-interpretation of figure 5.2, showing the literature data mean as a single
bar, and error bars to denote standard deviation of the results in order to represent the
variation between studies. A shows enrichment of H3K4me3 across the Hoxa cluster in
undifferentiated mouse cells. B shows enrichment of H3K27me3 at the Hoxa cluster, also
in undifferentiated cells.
182 
 
 embryonic cells may differ widely in their culture methods and differentiation paths 
of the studied cultures. There is also greater variation among H3K27me3 d0 
results when compared to H3K4me3 d0; however my results follow the literature 
pattern of H3K27me3 methylation closely, indicating that the methylation pattern 
found in this study is reflective of previous datasets obtained in other laboratories.  
The correlation between my data and literature data is not as strong for d0 
H3K4me3 as for d0 H3K27me3, and there are several clear differences in figure 
5.4 between the mean literature values and my results. However, the patterns of 
methylation of H3K4me3 appear similar. For example, although there is a 
difference at Hoxa4 between datasets in figure 5.4, it is still the second-most 
enriched site in the Hoxa cluster after Hoxa1 in literature studies, whereas my data 
shows Hoxa1 and Hoxa4 being more equal in H3K4me3 enrichment, both above 
any other Hoxa gene promoter. In fact, the differences between these datasets 
would be reduced considerably by the omission of the Hoxa1 bar. Hoxa1 has a 
very high relative enrichment to the other 10 Hoxa genes in the literature data. 
The normalisation of the data to the highest signal has caused the enrichment at 
other loci to appear low by comparison. The reason why Hoxa1 is relatively higher 
in the literature data is not clear, although it may be due to the use of differing cell 
lines, or possibly the use of ES cells that have been split through many more 
passages, causing more cells to begin differentiating and upregulating expression 
of the Hox genes. 
5.1.3 Comparison between literature studies and original study 
 
These analyses have shown that there is a strong basis to support the observation 
that my original data is supported by previous datasets for undifferentiated ES 
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cells. Data for H3K27me3 are particularly similar between literature and original 
studies, with only minor differences. Data for H3K4me3 is also correlated between 
original and literature sets, although there are more clear differences than for 
H3K27me3, the pattern of H3K4me3 methylation across the Hoxa cluster is 
broadly the same (figure 5.4). This, as has previously been mentioned, indicates 
a pre-establishment of histone modification in anticipation of the Hoxa cluster 
being transcribed after differentiation.  
The data shown here for differentiated cells shows a large amount of variation 
between both the literature datasets themselves, and also my original dataset 
(figure 5.5). There is little clear correlation between previous studies and my own, 
especially for H3K4me3 data. The difficulty in analysing these datasets together 
comes from the differences between populations of differentiated cells. My study 
used d5 differentiated embryonic stem cells from the CCE mouse lineage. As no 
ChIP-seq studies have been done using this exact cell line looking at H3K4me3 
and H3K27me3, studies using other types of differentiated embryonic cells have 
been analysed. Clearly, this can include a variety of cell lines, and even methods 
of differentiation and so therefore it is not surprising that a wide amount of 
variation has been observed. However, it remains the case that an inverse 
relationship can be found at most Hoxa loci between H3K4me3 and H3K27me3 
enrichment. The highest H3K27me3 enrichment in figure 5.5 can be found at 
Hoxa2, a3, a7 and a10 in the literature data, and at Hoxa3, a7, a9, a10 and a11 in 
my original data. All of these genes show low H3K4me3 enrichment in 
undifferentiated cells, although literature data shows that Hoxa2 and a3 are 
enriched with H3K4me3 in differentiated cells, and my data indicates a high level 
of H3K4me3 at Hoxa9 and a10. Referring back to figure 4.10, it is apparent that 
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Figure 5.5 Re-interpretation of figure 5.3, showing the literature data mean as a single
bar, and error bars to denote standard deviation of the results in order to represent the
variation between studies. A shows enrichment of H3K4me3 across the Hoxa cluster in
undifferentiated mouse cells. B shows enrichment of H3K27me3 at the Hoxa cluster, also
in undifferentiated cells.
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the absolute enrichment of H3K27me3 has decreased after differentiation at most 
Hoxa loci, but not at Hoxa9 and a10, whereas H3K4me3 has greatly increased at 
the same loci. This is not the case in the literature data shown in figure 5.5, which 
shows that H3K4me3 at Hoxa9 and a10 remains at negligible levels. The means 
of the literature datasets indicate that rather than an inverse correlation between 
H3K4me3 and H3K27me3 being present (as it is at d0) in differentiated cells, there 
are concomitant high levels of both marks at Hoxa1, a2, a3 and a11. However, the 
variation between studies as shown by the large error bars in figure 5.5 suggests 
that inter-sample disagreement may be skewing the results. 
Figure 5.6 shows a direct comparison between H3K4me3 and H3K27me3 levels 
at each Hoxa locus, both in my data and in literature studies. Presenting the data 
in this way, it is clear that the relationship between these two marks is similar in 
both datasets, and that my data (for d0 cells at least) corroborates earlier studies. 
The clear predominance of H3K4me3 over H3K27me3 at Hoxa1 and Hoxa4 is 
visible for original and literature data, as is the reverse relationship at Hoxa2, a3, 
a6, a7, a9, a10 and a11. At Hoxa13, levels of these two marks are broadly 
equivalent in my data, and also in literature data. There is a difference between 
the two sets of data at Hoxa5, where my study shows equivalence between the 
relative levels of H3K4me3 and H3K27me3, whereas the literature data shows a 
higher level of H3K27me3. However, the error between literature experiments 
shows that the overall levels of H3K4me3 and H3K27me3 could be more similar 
than the graphs suggest. As described earlier, the Hoxa border gene Skap2 has a 
clear enrichment of H3K4me3 and negligible amounts of H3K27me3 in the 
literature studies that is not reflected in my own data, which shows low enrichment 
of both marks. This difference could be caused by the use of two 
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Figure 5.6 Graphs to show the relationship between H3K4me3 (blue) and H3K27me3
(red) in d0 undifferentiated mouse ES cells. A shows enrichment of H3K4me3 and
H3K27me3 in studies described in this thesis. B shows enrichment of H3K4me3 and
H3K27me3 in studies performed in other laboratories, where data is available publicly.
Error bars show the standard deviation between studies.
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different techniques, ChIP-sequencing for the literature data, and targeted real-
time PCR for my data. 
The close similarity between my data and previous studies for the enrichment of 
H3K4me3 and H3K27me3 in undifferentiated mouse embryonic stem cells 
confirms that the bivalent model for the control of expression of developmentally 
regulated loci is too simplistic. These data point towards a more sophisticated 
mechanism of epigenetic control that carefully regulates the expression of these 
genes, and also marks chromatin based on the future expression of the underlying 
gene sequences. As shown earlier, the expression of Hoxa genes once induced 
using retinoic acid is not a linear process. Hoxa1 and Hoxa4 are two genes that 
are quickly and strongly upregulated after differentiation cues have been 
introduced. This is reflected in the chromatin landscape for the Hoxa cluster at d0 
even before cells have started to differentiate, showing the predominance of 
permissive chromatin marks (H3K4me3) over restrictive ones (H3K27me3). This 
implies that these histone modifications are marking particular genes, so that 
further down the differentiation line, the transcription machinery can recognise, 
with the assistance of chromatin-binding proteins, which genes are to be activated 
first.  
5.2 APPLYING CHIP-SEQ ANALYSIS TO OTHER GENES AND CLUSTERS 
5.2.1 Analysing other Hox clusters using literature data 
 
As shown above, hypotheses drawn from differentiated datasets are likely to be 
unreliable; however, the data for undifferentiated cells are similar enough to 
support a hypothesis that an inverse relationship exists between H3K4me3 and 
H3K27me3 at the Hoxa cluster and perhaps at other developmentally-regulated 
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sites as well. This hypothesis can be tested by applying this observation to 
genomic areas other than the Hoxa cluster, such as at other Hox clusters like 
Hoxb, c and d. 
Figure 5.7 shows the results obtained from the same literature datasets as above, 
this time looking at the three other Hox clusters. These clusters of Hox genes are 
similar to Hoxa in that they determine rostral-caudal axis patterning in developing 
embryos. From the ChIP-seq data displayed here, it appears that the Hoxd1 gene 
has been marked for early expression, due to the relative dominance of the 
H3K4me3 signal over H3K27me3. This appears similar to the Hoxa1 histone 
modification profile seen in figure 5.6. However, Hoxb1 does not display this 
motif, showing a relatively low H3K4me3 enrichment. The enrichment of H3K4me3 
over H3K27me3 is also less pronounced for the first Hoxc gene in the cluster, 
Hoxc4. There are genes in each cluster that show a greatly enriched H3K4me3 
residue accompanied by a low level of H3K27me3 trimethylation, although they 
are at different positions within the cluster. Hoxb7, and to a lesser extent Hoxb9, 
show such a pattern. Hoxc13 is also heavily methylated at H3K4me3 relative to 
the rest of the cluster, although its H3K27me3 remains low. These observations 
could indicate that the four Hox clusters are regulated by the bivalent signature 
differently or perhaps during separate stages of the organism’s development.  
The three Hox clusters shown in figure 5.7 show very different profiles of 
H3K4me3 and H3K27me3 enrichment. Hoxb shows an accumulation of 
H3K27me3 mainly in the middle of the cluster, at Hoxb3, b5 and b6, whereas 
H3K4me3 is enriched at Hoxb7 and b9. The Hoxc cluster shows a more moderate 
level of enrichment of both H3K4me3 and H3K27me3, as in many places both 
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modifications are enriched to roughly the same degree. There is an excess of the 
H3K4me3 mark on Hoxc13, and an excess of H3K27me3 on Hoxc6 and c8 
however, which could denote targeted epigenetic marking. 
Hoxd genes appear to be more generally marked with H3K27me3, with most 
genes showing a relatively high level of this mark, and a low level of H3K4me3. 
This is not the case at Hoxd1, which shows preferential H3K4me3 enrichment, or 
at Hoxd3, which shows relative equivalence between the two marks. This may 
indicate that, unlike Hoxb and Hoxc clusters, Hoxd may be regulated in a similar 
way to Hoxa. Expression data from other studies confirm that Hoxd1 and Hoxd3 
are expressed earlier and more strongly than other genes in the cluster after 
retinoic acid activation (Zha et al., 2012). Histone modifications may have a part to 
play in this process by foreshadowing the increase in expression by increasing the 
ratio of H3K4me3 to H3K27me3 at Hoxd loci. As differentiation, or retinoic acid 
activation of Hox, continues, the more distal Hoxd genes will become higher in 
H3K4me3 methylation and become epigenetically poised for expression. This 
same process could occur for Hoxb and Hoxc, but the characteristic epigenetic 
signature may become apparent later in the differentiation process than for Hoxa 
and Hoxd. The presence of the bivalent marks at all Hox clusters imply that this 
mechanism could be used to regulate the expression of these genes, although this 
has not yet been proven. 
5.2.2 Analysis of other developmental genes using ChIP-seq 
 
To explore the role of the two bivalent histone modifications H3K4me3 and 
H3K27me3, I have analysed the public ChIP-seq data for other genes not related 
to Hox clusters, namely Pou5f1 and Nanog, two key regulators of pluripotency, as 
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well as Shh and Foxd4, which are genes that have important functions during 
embryonic development (later than the ES cell stage). Figure 5.8 shows results 
from my study for Pou5f1 and Nanog, as well as literature study data for these two 
genes as well as Shh and Foxd4. It is clearly shown that both the pluripotency 
genes are rich in H3K4me3 methylation at their promoters, whereas H3K27me3 is 
almost entirely absent from these loci, in both literature and my original datasets. 
As d0 ES cells require these genes to be expressed to maintain pluripotence, a 
strongly permissive chromatin environment is required. 
Shh and Foxd4 are developmental genes that are required during embryo 
development, but have functions different to those of Hox genes (Huangfu and 
Anderson, 2006; Moody, et al., 2013). Results from figure 5.8 show that both of 
these genes display a high level of H3K27me3 enrichment, coupled with a low 
frequency of H3K4me3. This confirms a repressive chromatin environment at d0, 
consistent with its lack of expression. However, these genes do not display the 
bivalent characteristic of some of the Hoxa and Hoxd genes, which are markers 
for future expression of those genes at later developmental stages. Bivalency is 
clearly a specialised characteristic of some developmental loci, which is used to 
carefully control gene expression in developing vertebrates. A simple on/off 
switch, such as is required to down regulate pluripotency genes after 
differentiation, does not appear to involve both bivalent histone modifications as a 
precursor to cessation of transcription in these genes. 
The data in the literature shown above have shown a good level of agreement 
with the results I have obtained myself (figure 5.4), and therefore some 
confidence can be applied to the literature data shown for other genes and gene 
clusters. Considering all the data analysed within this chapter, it seems that the 
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Figure 5.8 Graph to show the relationship between H3K4me3 (blue) and H3K27me3 (red)
in d0 undifferentiated mouse ES cells. A shows enrichment of H3K4me3 and H3K27me3
in data from chapter 4 of this study. B shows results from literature studies performed in
other laboratories, where data is available publicly. Error bars show the standard deviation
between studies.
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bivalent mark is present specifically at developmentally regulated sites that are yet 
to be expressed in embryonic cells. The bivalent mark does not occur at the 
heavily transcribed Pou5f1 and Nanog loci, key pluripotency markers, but does 
occur at all four Hox gene clusters. However, there is little overlap between 
H3K4me3 and H3K27me3 at Shh and Foxd1, other loci that are up regulated after 
differentiation. This could indicate that bivalency is specific to individual sites and 
are not the exclusive mechanism by which differentiation-triggered transcriptional 
control is exerted. Certainly, the bivalent profiles across the four Hox clusters are 
very different, and it is evident that each cluster has its own unique bivalent 
signature (figure 5.7). This could reflect the differences between the clusters with 
regard to the timing of expression during the developmental process, as well as 
the physiological necessity for the levels of the protein products of those genes to 
be translated in the developing embryo. The epigenetic profile of the Hox clusters, 
however, are clearly distinguishable from the state of bivalent marks H3K4me3 
and H3K27me3 at other loci such as Shh, Foxd1, Pou5f1 and Nanog. These loci 
show either one or the other mark in abundance, but not both together. This 
observation supports the association between a bivalent motif and the regulation 
of differentiation. 
5.3 COMPARISON OF CHIP-SEQ AND IMMUNOFLUORESCENCE 
 
Having demonstrated that ChIP data in this study are comparable to ChIP-
sequencing data in other literature studies, I have also compared the chapter 3 
immunofluorescence data to these datasets. However, unlike the data in chapter 
4, which are mostly derived from asynchronous cell populations, 
immunofluorescence data are all taken from metaphase-specific cell populations. 
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As ChIP-seq experiments are performed on asynchronous cells in these datasets, 
by comparing these to my own data, it is analogous to comparing metaphase cells 
with asynchronous cells with a tiny proportion of cells in metaphase. Other notable 
differences between these experiments are that immunofluorescence is performed 
on unfixed chromatin, whereas all ChIP-seq data here use formaldehyde-fixed and 
sonically sheared DNA-histone fragments, eventually sequencing 200-300 base 
pair fragments fragments using sliding-window analysis to produce 25bp 
resolution maps. This technique has the potential to introduce bias into the 
experiment, as it has been previously shown that using X-chip can cause 
artificially strong signals for interactions in regions of low nucleosome density 
when using ChIP-seq (Schwartz, et al., 2005). However, figure 5.9 shows the 
enrichment of H3K4me3 across four different mouse chromosomes, both before 
and after ES cell differentiation. The patterns seen in these graphs closely 
resemble the karyotypes seen in figures 3.11-3.14 and the histone modification 
genome maps in figures 3.15-3.17. For example, the region at c. 50Mb on 
chromosome 5 shows low H3K4me3 enrichment in the ChIP-seq data; this 
corresponds with the fluorescence data, which also shows a lack of H3K4me3 
enrichment as evidenced by the lack of fluorescence in this region. Similarly, 
chromosomes 7 and 16 also have regions of low H3K4me3 density that 
correspond to low fluorescence in the immunofluorescent karyotype, at c. 70 
megabases from the centromere on both chromosomes. However, the graph for 
chromosome 1 illustrates the difference between data obtained by ChIP-seq and 
that from immunofluorescent techniques. Data from figure 3.11-3.12 suggests that 
chromosome 1 does not have any large chromosomal areas of intense H3K4me3 
density. The analysed graphs shown in figures 3.15-3.17 show a low level of 
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Figure 5.9 UCSC browser data showing ChIP-seq results for ES cells (upper – accession
GSM307605) and embryonic fibroblasts (lower – accession GSM307608). The data bars
indicate the level of enrichment of H3K4me3 throughout A - mouse chromosome 1, B –
chromosome 5, C – chromosome 7, D – chromosome 16. Chromosome ideograms and
scale bar is shown above
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fluctuation of fluorescence, with an increase in fluorescence at the chromosome 1 
telomere end. Figure 5.9 shows the same general picture, with H3K4me3 
enrichment fluctuating to a small extent from the mean, with an increase in density 
at the telomere end. However, these fluctuations are more well-defined than those 
shown in figure 3.15, and may correspond to functional areas of the genome. 
These comparisons are again obfuscated by the differences in techniques used, 
as ChIP-seq measures genetic distances between epigenetic features in base 
pairs, whereas the immunofluorescence technique measures physical 
chromosomal distances, which often does not reflect the distance in base pairs. 
This may cause some heavily fluorescent areas on chromosomes to appear in a 
different genetic location on the epigenomic map, either because the physical 
chromosome molecule has been compressed or relaxed at various regions within 
it, causing a distortion in the results. 
Also shown in figure 5.9 are graphs showing the H3K4me3 distributions across 
chromosomes in differentiated embryonic fibroblasts. On the whole, it appears that 
there are no major differences in the H3K4me3 distributions on this scale. 
However, a closer inspection of the data reveals that there are subtle differences 
in the enrichment of H3K4me3 at certain loci. For example, at 50 megabases from 
the chromosome 7 centromere, there is a double peak of strong H3K4me3 
enrichment in the ES cell chart. However, after differentiation into fibroblasts, this 
has changed to a single peak. The leftmost peak has reduced H3K4me3 
methylation after differentiation at this locus. This shows a specific response and a 
targeted change in epigenetic state caused by the progress of differentiation. 
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6.  DISCUSSION 
6.1 THE MOUSE EPIGENOME 
6.1.1 Histone modifications and their maintenance in metaphase 
 
One of the major current focuses in the field of molecular biology is the question of 
what the precise role of epigenetic marks is, and how they are maintained. Many 
theories have been suggested as to why the varied array of epigenetic 
modifications have arisen, but a definitive model for the establishment, 
maintenance and effect of these has not so far been achieved. These questions 
have potentially critical importance in our understanding of how eukaryotes 
organise not only their gene expression patterns, but also their diversely 
differentiated cell types. Much work has been done on the relationship between 
histone modifications and gene expression, and the effects and functions of many 
of these modifications are known (Rea et al., 2000, Schotta et al., 2004, McManus 
et al., 2006, Guenther et al., 2007, Pauler et al., 2009, Wen et al., 2009, Pasini et 
al., 2010, Pekowska et al., 2011, Zhang et al., 2012). Some important studies 
have also inquired into the fundamental nature of the marks themselves. Where 
are they located (Bernstein et al., 2006, Guenther et al., 2007, Puschendorf et al., 
2008, Marks et al., 2009)? How are they maintained (Breiling et al., 2004, Francis, 
2009, Francis et al., 2009, Vermilyea et al., 2009)? How are they re-established 
after replication (Groth et al., 2007, Scharf et al., 2009)? And how do they interact 
with each other (Forneris et al., 2005, Zippo et al., 2009, Kowenz-Leutz et al., 
2010)? 
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The first part of this study shows that during metaphase, histone modifications 
maintain individual and discrete distributions across the epigenome, and that 
some of these distributions change upon early embryonic differentiation (figures 
3.1 - 3.5). These distributions show that many histone modifications are persistent 
enough to be maintained even during the dense packaging of chromatin found at 
metaphase. It has also been shown that the chromosome painting method can 
lead to a robust and illuminating epigenomic karyotype, showing a single-cell at-
once epigenome (figures 3.7 and 3.11). 
6.1.2 Investigating the epigenome of Mus musculus 
 
With the completion of the Human Genome Project in 2003, the field of molecular 
biology can be thought of as being in the post-genomic era (Venter et al., 2001). 
Whole-genome sequencing is now a relatively routine affair, and the focus of 
research is now more to do with what those DNA sequences mean, what they 
code for, and how they are expressed in vivo. The latter question has a lot to do 
with the positioning and interactions of epigenetic modifications in eukaryotes. 
Histone modifications have been linked with influencing transcription since the 
1960s (Allfrey et al., 1964). However, the evidence of how they function and 
interact with the genome is not as advanced as the knowledge we have around 
DNA and the features of the genetic code. This is understandable, as there are 
known to be many different histone modifications, unlike the four bases found in 
DNA, and more and more are being discovered (Bannister and Kouzarides, 2011, 
Arnaudo and Garcia, 2013). There are several initiatives currently proceeding with 
the aim of closing that gap in knowledge between genome and epigenome, and to 
produce a map of epigenetic signatures such as histone modifications similar to 
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that of the genome map (Birney et al., 2007). This will have an enormous and 
profound impact on the field of biology, as not only the DNA sequence of a region 
will be known, but also the chromatin environment in which it lies, as well as other 
features such as potential chromatin-binding protein sites, higher-order chromatin 
structures, and permissiveness towards transcription could be determined. In 
order to further this end, this study has undertaken to examine the distributions of 
several different histone modifications in undifferentiated and differentiated mouse 
cells. 
6.2 GLOBAL DISTRIBUTIONS OF HISTONE MODIFICATIONS AT 
METAPHASE 
6.2.1 Distribution and inheritance of H3K4me1 and H3K4me2 at metaphase 
 
The results shown in chapter 3 describe the distributions of histone modifications 
on histones H3 and H4 across mouse metaphase chromosomes. Maintenance of 
histone marks is a process that has not yet been fully elucidated or explained. It is 
evident; however, that although a general reduction in H3K4me1 can be seen, 
H3K4me1 is maintained throughout differentiation at many loci during metaphase 
from ES cells to MEFs (figure 3.1). This mark is thought to be generally 
permissive of transcription, with a particular affinity to enhancer motifs (Heintzman 
et al., 2007, Heintzman et al., 2009). The low metabolic activity and reduced 
accessibility of enzymes to chromatin characteristic of metaphase could have 
implied that maintenance of histone modifications may be compromised. However, 
persistence of histone modifications at metaphase has already been 
demonstrated in humans, and it is shown to be true here in mice as well 
(Terrenoire et al., 2010). The intransigence of the H3K4me1 mark at some loci 
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through differentiation could mean that gene enhancers, which correlate with 
increased H3K4me1, maintain their chromatin signature (figure 3.1). This is 
supported by a recent study showing that H3K4me1 occupies the same proportion 
of the genome both in ES cells and ectodermal cells, although the authors do 
suggest that H3K4me1 is enriched at specific loci after differentiation, which could 
explain the apparent depletion of H3K4me1 in other genomic areas, relative to the 
increase in H3K4me1 at enhancer-rich sequences (Gifford et al., 2013). The 
supposedly permissive environment conferred by H3K4 methylation could be 
conserved at enhancers throughout the developmental process, leaving control of 
the on-off switch of transcription to chromatin motifs closer to the TSS, such as 
H3K4me3 (Guenther et al., 2007, Lloret-Llinares et al., 2012). This theory is given 
added weight by the results showing a reduction in H3K4me2 prevalence in MEF 
cells at metaphase (figure 3.1). H3K4me2 is more directly correlated with 
transcription activity than H3K4me1, and in this context seems more likely to be 
influenced by the changing expression profile of the cell population (Heintzman et 
al., 2007, Zhang et al., 2012). 
The distributions for both marks H3K4me1 and me2 show that centromeres and 
the Y chromosome are nominally free of these modifications (figure 3.1). The 
association between actively transcribed chromatin and methylated H3K4 would 
suggest that these marks would not be widespread in this region (Pekowska et al., 
2011). These results show that the centromeres and Y chromosome are entirely 
free of methylated H3K4, confirming that heterochromatin has a unique epigenetic 
makeup, and that it is not affected by histone methylation at H3K4 (figures 3.1 
and 3.2). One of the striking features of these pictures for mono and dimethyl 
H3K4 is the high contrast between stained and unstained areas, producing 
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discrete bands of FITC fluorescence. This indicates that these marks are targeted 
to specific regions of chromatin, and are not maintained in other areas, perhaps 
due to a low level of underlying transcriptional activity.  
6.2.2 Distribution of H3K4me3 through differentiation 
 
H3K4me3 has for a long time been considered a marker for active transcription 
(Kouzarides, 2007, Karlic et al., 2010). This modification is widespread in the 
promoters of genes, and marks developmental loci, with H3K27me3, as a bivalent 
epigenetic signature (Bernstein et al., 2006, Sachs et al., 2013). Images shown 
here reveal the genome-wide reduction in H3K4me3 upon differentiation of OS25 
cells (figure 3.2). Some of the strongly fluorescent bands seen in undifferentiated 
OS25s are retained after differentiation. However, for the majority of bands, 
fluorescence is reduced and bands appear smaller and thinner. This could 
indicate that a large-scale demethylation of H3K4me3 has occurred, whereby the 
cell responds to the stimuli involved in the differentiation process by switching off, 
or de-poising, large sections of chromatin through demethylation of H3K4me3. 
The sections that remain fluorescent, or rich in H3K4me3, may be the genes 
specific to the neural lineage, which this method of differentiation favours (Bami et 
al., 2011). This is supported by data in figure 4.10, which shows a specific 
increase in H3K4me3 at Hox loci after differentiation, but not at intergenic 
sequences. This could lead, with more knowledge about the distribution of these 
modifications, to identification of genomic regions based on epigenetic signature. 
For example, the telomeric end of chromosome 4 contains several genes related 
to neural development, and so it is possible that the strong H3K4me3 band that 
can be seen in figure 3.2 on the chromosome just below the Y chromosome is 
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indicative of chromosome 4 (NCBI, 2013). Indeed, figure 3.7 confirms that the 
telomeric end of chromosome 4 (this time clearly identified by FISH) is indeed 
labelled with H3K4me3 in undifferentiated cells. However, this pattern of 
widespread loss of H3K4me3 is not evident for the cultured MEF cells. The 
inherent differences between MEF cells and differentiated OS25 ES cells may 
provide an explanation for this finding. MEF cells are embryonic fibroblast cells 
that can be maintained in culture, and so have a stable phenotype. OS25 cells in 
this study have been differentiating for seven days, and are undergoing rapid 
changes in gene expression and cell identity (Glover et al., 2006). This entails 
major shifts in the epigenetic landscape. A mechanism can be imagined whereby 
a widespread demethylation event occurs at non-developmental and intergenic 
loci during development, causing pluripotency genes to be down-regulated and for 
cells to quickly differentiate (figure 3.2). A more targeted and specific epigenetic 
identity is established by the altering of histone modifications and other epigenetic 
marks (figure 4.10). This could be evident here, whereby the MEF cells have 
already gone through the loss of pluripotency and have regained a stable 
epigenetic environment. This may even resemble the pattern it has lost for 
H3K4me3, but there will be crucial differences in other epigenetic modifications 
that identify the cell as differentiated. 
6.2.3 Inheritance of repressive chromatin marks through differentiation 
 
The other side of the bivalent coin is the repressive histone modification 
H3K27me3. This is known to be closely associated with H3K4me3 at 
developmental loci in undifferentiated cells (Bernstein et al., 2006, Sachs et al., 
2013). The photos shown here corroborate this finding, as H3K27me3 is present 
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across the majority of the genome, therefore intersecting with many of the bands 
already observed for H3K4me3 (figure 3.2). This modification is stable throughout 
development up to and including the MEF stage. Taken together with the data for 
H3K4me3, it seems more likely that H3K27me3 is more heritable than H3K4me3 
for the majority of the genome, and that H3K4me3 is lost (Kaneda et al., 2011). 
Whether H3K4me3 is lost simply in the intergenic or non-coding regions cannot be 
determined from immunofluorescence, but these results do point to the 
preferential genome-wide preservation of some marks such as H3K27me3 over 
H3K4me2/me3 through the process of differentiation (figures 3.1 and 3.2). At 
specific developmental loci, H3K27me3 decreases after differentiation and 
H3K4me3 increases (Figure 6.1), but it seems here that for the majority of the 
genome, this is not the case (Bernstein et al., 2006). Although the two marks are 
components of the bivalent mark, they are not solely associated with that function. 
H3K27me3 acts independently of H3K4me3 to form broad areas of inactive 
chromatin, as well as interacting with other modifications to regulate chromatin in 
other mechanisms (Pauler et al., 2009, Schwartz et al., 2010). This could explain 
how H3K27me3 is more widespread throughout the genome than H3K4me3. 
Histone methylation on H3K9 is also maintained through differentiation (fig 3.3). 
Both H3K4me1 and –me2 retain their genome-wide distributions from ES cells 
through to differentiating and differentiated cells, displaying a general level of 
heritability throughout many cell cycles. There does however seem to be a 
redistribution of H3K9me3 between d0 and d7 OS25s (figure 3.4). This mark is 
abundant at centromeric chromatin, but by d7 the chromosome arms have 
become denuded of H3K9me3. There are proven links between H3K9me3 and 
centric DNA, however the ES cell epigenetic state shown in these pictures 
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Figure 6.1 ChIP-seq data from ENCODE and UCSC mouse genome browser. 
H3K4me3 and H3K27me3 signals derived from ChIP experiments on 
undifferentiated ES cells (blue) and differentiated liver cells (yellow).
A. H3K4me3 ChIP-seq enrichment at Hoxa cluster in liver cells
B. H3K27me3 ChIP-seq enrichment at Hoxa cluster in liver cells
C. H3K4me3 ChIP-seq enrichment at Hoxa cluster in inner mass (ES) cells
D. H3K27me3 ChIP-seq enrichment at Hoxa cluster in inner mass (ES) cells
204 
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suggests that there is an additional widespread role for H3K9me3 in 
undifferentiated cells (Puschendorf et al., 2008, Alder et al., 2010). In a similar 
fashion to H3K4me3, the MEF photo in figure 3.4 shows some H3K9me3 present 
on chromosome arms in contrast to the image for d7 OS25 cells. Again, the 
quickly changing phenotype of the differentiating cells may provide an explanation 
for this (Glover et al., 2006).  
6.2.4 Shift in epigenomic distribution of H4K20me3 after differentiation 
 
The most evident differences between undifferentiated and differentiated cell 
histone modification distributions can be seen for the H4K20me3 mark (figure 
3.4).  This has often been linked to heterochromatic and centromeric DNA in past 
studies; however, this association is shown here to be dependent on the 
developmental stage of the cell. At the ES cell stage it is clear that centromeres 
are free of H4K20me3. The chromosome arms display areas of high and low FITC 
fluorescence to indicate that this modification is distributed preferentially in certain 
sections, but these sections are present across the entire karyotype. On 
differentiation, even after only seven days, this distribution is totally inverted so 
that chromosome arms are now free of H4K20me3, but centromeres are now 
labelled with this modification (figure 3.4). A reorganisation of chromatin in this 
manner could indicate that H4K20me3 has a role in the maintenance of 
pluripotency, as the widespread distribution of this mark is evident in ES cells but 
not in differentiated cells. The compartmentalisation of H4K20me3 into 
centromeres after differentiation may represent a mechanism for marking the 
changes in gene expression and phenotype of the cell after loss of pluripotency. 
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Interestingly, the Y chromosome is clearly labelled on undifferentiated spreads for 
H4K20me3, but indistinguishable (i.e. unlabelled) from autosomes in differentiated 
samples (figure 3.4). This shows in essence the same pattern as for the other 
chromosomes, in that the distribution of H4K20me3 is reversed after 
differentiation. However, the H4K20me3 mark is present on the mainly 
heterochromatic Y chromosome in ES cells, but not within heterochromatic 
centromeres. After differentiation the opposite is true, signifying that the trimethyl 
H4K20 mark can be used to distinguish centric from Y chromosome 
heterochromatin in ES cells and confirming the observation that centric chromatin 
has a unique epigenetic signature that is not shared by other, similar, 
heterochromatic regions (Haldar et al., 2011, Honda et al., 2012). 
6.2.5 Distribution and transmission of acetylated histone residues through 
differentiation 
 
Acetylated histones are associated with promoting transcription of underlying DNA 
(Allfrey et al., 1964, Marushige, 1976, Agalioti et al., 2002). These modifications 
are widespread in ES cells in figure 3.5, showing a uniform distribution across the 
chromosome arms in metaphase spreads from the ES cell stage through to d7. 
This shows strong maintenance of all these acetyl marks through differentiation, 
even when other methyl marks have been lost (figures 3.1 and 3.5). Images for 
MEF histone acetylation however, show a decrease in the abundance of all acetyl 
marks. The fact that all acetyl marks are lost at the same time, even acetyl marks 
on different histone molecules, indicates that a general mechanism of 
deacetylation is occurring at the majority of genomic loci. The acetylation signature 
of ES cells may have been altered by the MEF stage, although it is still possible 
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that acetylation remains at key areas of the genome, most likely at gene-rich 
regions, and is lost at non-coding sections of chromatin and at pluripotency-
related genes or other genes no longer required by the cell. One theory resulting 
from these images could be that ES cells contain acetylated chromatin at 
transcriptionally inactive sequences, whereas by the time cells have differentiated 
into MEFs, the chromatin signature at these silent sites has become more 
deacetylated and therefore restrictive, although expression is not affected (figures 
4.3 and 4.11). Certainly, this data suggests that there are several acetylated 
residues that undergo a large scale redistribution event at some point between 
day 7 of differentiation from ES cells and the differentiated MEF cell stage. 
 
6.3 ALIGNMENT OF THE GENOME AND EPIGENOME 
6.3.1 Linking the epigenome to the genome for H3K4me3 and H3K27me3 
 
The metaphase chromosome immunofluorescence data already discussed has a 
lot to say about the distributions of histone modifications at this discrete portion of 
the cell cycle in various embryonic cell types. In order to put this data into a proper 
context, I compared these results to already available resources derived from 
publicly available sequence data (NCBI, 2013). This requires a link to be 
established between immunofluorescence and DNA sequence, which is provided 
by FISH identification of chromosomes already labelled with histone modification 
specific antibodies (figure 3.6). The epigenome karyotypes for H3K4me3 and 
H3K27me3 have been presented here, in a similar fashion to that already 
published for human chromosomes (Terrenoire et al., 2010). The characteristic 
banding pattern seen previously for H3K4me3 is again evident, and can be used 
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to construct ideograms based not on G banding patterns, but on 
immunofluorescence patterns (figure 3.7). This creates clear distinctions between 
areas on chromosomes, and suggests that these modifications are specific and 
directed towards specific genetic features, which are themselves concentrated 
preferentially on some areas of the chromosome over others, creating bands of 
high H3K4me3 content (figures 3.2 and 3.7).  
The implications of these observations can be explored by aligning the data with 
NCBI sequence data for mouse chromosomes (figures 3.9 and 3.10). These were 
organised into 10Mb windows in order to reflect the resolution of the chromosome 
immunofluorescence procedure. The strong correlation between H3K4me3 and 
gene density, CpG islands and repeats show that there is compelling evidence to 
support the theory that H3K4me3 is preferentially targeted to genes, and is less 
abundant in areas of low gene density. This supports previous research that found 
strong links between gene promoters and H3K4me3 deposition (Kouzarides, 
2007, Karlic et al., 2010, Tian et al., 2011). 
The distribution of H3K27me3 at first glance seems to be more widespread across 
the genome than that for H3K4me3 (figure 3.2). However, after analysis in the 
same way as above, the distributions for these two marks are actually quite similar 
(figures 3.11, 3.12, 3.13). The peaks in H3K4me3 abundance overlap with peaks 
of H3K27me3 abundance, signifying that these two marks are often found 
together in ES cells, agreeing with previous studies (Bernstein et al., 2006, Jiang 
et al., 2011, Sachs et al., 2013). Although it seems in figure 3.2 that the 
repressive mark is more widespread, FISH data suggests that the areas of specific 
H3K27me3 increases do coincide with H3K4me3 peaks, and may be rich in 
developmental loci, as is the case for chromosome 6 at 50-60Mb (figure 3.13).  
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6.3.2 Co-methylation of H3K4me3 and H3K27me3 throughout the mouse ES 
cell genome 
 
This study has provided new insight into the behaviour of histone modifications in 
metaphase ES cells. The relationship between H3K4me3 and gene-rich regions of 
chromatin has been confirmed, and also that this relationship remains even into 
metaphase (figure 3.2). A reproducible karyotype has been produced that has 
made the sorting of H3K4me3 bands into specific and recognised regions of the 
genome possible (figure 3.7). This epigenome karyotype may also be able to 
predict gene density, CpG island density, and repeat density, as it has been 
shown that these features have a close relationship with H3K4me3 enrichment 
(figures 3.9 and 3.10). H3K27me3 has been shown to coincide in many cases 
with H3K4me3-rich chromosomal areas, and both are enriched at the 
chromosomal locus of the Hoxa cluster (figures 3.7 and 3.11). This karotype 
denotes H3K27me3-rich bands as being less well-defined than those for 
H3K4me3, due to a high general genomic background level of H3K27me3 as 
shown in photographs taken after immunofluorescence, as well as in ChIP seq 
data (figures 3.2, 3.10 and 6.1). There is evidence for specific deposition or 
maintenance of both H3K4me3 and H3K27me3 at the same loci, as shown by the 
analysed data of chromosomes in figures 3.13 - 3.15. 
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6.4 HISTONE MODIFICATIONS IN THE HOXA CLUSTER 
6.4.1 Histone modifications at interphase and G2/M at the Hoxa cluster 
 
Results obtained from immunofluorescence studies have provided information 
about the distributions of histone modifications through differentiation and how 
they are aligned with DNA sequence features. To investigate further the nature 
and distributions of histone marks with regard to genetic features, I used 
chromatin immunoprecipitation to focus more closely on the relationships between 
histone modifications and genetic features through differentiation and the cell 
cycle (O' Neill and Turner, 2003). In order to prove or disprove any links between 
histone modifications and gene expression, I assayed expression of ES cells 
between day 0 and day 7 of a differentiation time-course by RNA extraction and 
subsequent qPCR. One of the central focuses of these experiments was the 
chromatin environment around the Hoxa cluster, and its expression in 
differentiating cells. As shown in figure 4.3, the expression of several Hoxa genes 
change rapidly upon cell differentiation as a response to retinoic acid, as 
previously reported (Chen and Gudas, 1996, Bami et al., 2011). Interestingly in 
this study, Hoxa1, 4 and 5 have all been up-regulated after d2, whereas Hoxa2 
and 3 have remained silent. This contradicts the classical Hox cluster theory that 
genes are activated in chromosomal order from 1 to 13, although other studies 
have also suggested non-colinearity for other Hox clusters (Carroll, 1995, 
Soshnikova and Duboule, 2009). The expressions of pluripotency-related factors 
such as Pou5f1 and Nanog have also fallen after at least 5 days of differentiation, 
confirming the loss of pluripotency for d5, d6 and d7 cells (figure 4.4). The 
expression of colcemid-stalled cells was also measured, allowing comparison 
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between G2/M and asynchronous populations. This leads on from the 
chromosome immunofluorescence study that showed histone modifications persist 
at metaphase in mouse cells. Interestingly, results from figure 4.3 show that there 
are no major differences in Hoxa expression between these two populations, 
indicating that expression after synthesis is equivalent to expression before 
synthesis and therefore that the Hoxa genes are not cell-cycle regulated.  
6.4.2 Histone acetylation changes rapidly through the cell cycle in ES cells 
 
The expression results led to the decision to use d5 differentiated cells as the 
sample for differentiated cells for N-ChIP experiments. A comparison was also 
made between asynchronous cells and colcemid-stalled cells to gauge whether 
histone marks were maintained at the G2/M stage, or lost relative to an 
asynchronous population. Firstly, it is evident that on the whole, there are few 
differences between asynchronous cells and metaphase cells in terms of histone 
modifications (figures 4.5 – 4.8). Hoxa5 has slightly higher enrichments of 
H3K4me3 and H3K27me3 in the metaphase population, however the greatest 
differences between asynchronous and G2/M histone modifications can be seen in 
results for H3K9ac (figure 4.7). This shows a lack of transmission of the acetyl 
mark from S phase to G2. It has been demonstrated that this is a cell-cycle specific 
mechanism whereby H3K9 is deacetylated and subsequently tri-methylated (but 
not di-methylated, as seen in figure 4.7) in preparation for mitosis (Park et al., 
2011). Rather than being lost after synthesis, it is likely that H3K9ac is intentionally 
and specifically removed from histone tails at G2/M in preparation for chromatin 
condensation (Park et al., 2011). The images obtained from immunofluorescence 
using antibodies for H3K9ac in figure 3.5 show abundant H3K9ac at metaphase, 
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however it is not possible to compare this to pre-mitotic chromatin using the 
immunofluorescence technique. These observations highlight the extra layers of 
information that are extracted by focusing, or ‘zooming in’ the investigation into the 
Hoxa cluster by the use of chromatin immunoprecipitation. 
 
6.5 BIVALENCY AT HOXA THROUGH DIFFERENTIATION 
6.5.1 The bivalent mark is dynamically regulated at the early stages of 
differentiation at the Hoxa cluster 
 
The bivalent mark has been found to occupy promoters of genes involved in the 
control of differentiation (Bernstein et al., 2006, Jiang et al., 2011, Vastenhouw 
and Schier, 2012). However, it is not clear how H3K4me3 and H3K27me3 levels 
change with respect to each other throughout differentiation. Hox genes represent 
an ideal model to explore this, as they are silent in ES cells, but show up-
regulation at the onset of differentiation (figure 4.3) (Dolle and Duboule, 1989). 
The pattern of enrichment of these histone modifications at the ES cell stage gives 
a revealing picture of how the bivalent mark contributes to the overall state of the 
chromatin, and how it relates to expression of the underlying genes (figures 4.3 
and 4.6). All Hox genes are silent at d0; however an enrichment of H3K4me3 is 
present at Hoxa1 and Hoxa4, with a commensurate lack of H3K27me3 enrichment 
(figure 4.6). This shows that the permissive chromatin environment inferred by a 
strong bias towards the activating bivalent mark H3K4me3 is established before 
the expression of Hoxa1 at d3 onwards. This shows a chromatin state predictive of 
future gene expression, and that two of the three most highly expressed Hox 
genes at d5 can be distinguished in this instance from the silent genes, based on 
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undifferentiated epigenetic signature, or in other words by determining part of their 
histone codes (figure 4.6). 
6.5.2 Bivalency as a key regulator of developmental expression 
 
Bivalency is thought to provide a poised state of chromatin whereby a gene’s 
expression can be up-regulated after differentiation by the loss of the repressive 
half of the mark H3K27me3 (Bernstein et al., 2006). This data, however, supports 
a more nuanced view of the bivalent mark. Both marks are enriched across the 
entire Hoxa cluster, supporting the theory that the two histone modifications are 
present at developmental loci in ES cells (figure 4.6) (Sachs et al., 2013). The 
relative levels of the two marks seem to be indicative of future gene expression; so 
rather than a digital mechanism whereby the loss of the H3K27me3 modification 
results in an increase in expression, a bias towards the deposition of H3K4me3 
and removal of H3K27me3 results over time in a switching-on of the associated 
gene. Graphs comparing d0 and d5 ChIP results for the two bivalent marks 
support this theory (figure 4.10). After five days of differentiation, the CCE/R cell 
population has switched on Hoxa1 and Hoxa4 expression (figure 4.3). The 
profiles of the bivalent marks at d5 reveal that these loci have been affected by 
increased H3K4me3 and decreased H3K27me3 enrichment. This may indicate a 
mechanism of histone modification controlled gene expression whereby a build-up 
of H3K4me3 and a depletion of H3K27me3 eventually cause a threshold to be 
breached and a switch in gene expression to occur. Alternatively, a progressive 
deposition of H3K4me3 may cause increased signalling to chromatin binding 
proteins, chromatin remodellers and the transcription machinery to overcome the 
negative influence of H3K27me3 and PRC2 at the gene promoter (Margueron and 
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Reinberg, 2011, Jia et al., 2012). Soshnikova and Duboule noted a wave of 
demethylation of H3K27me3 as ES cells differentiated, starting from Hoxd1 and 
moving onwards through the Hoxd cluster, in a way analogous to the colinearity 
observed for Hox gene expression (Soshnikova and Duboule, 2009). For Hoxa, 
however, it seems from these that H3K27 demethylation is still specific for each 
Hoxa gene, rather than a non-specific wave of demethylation progressing in one 
direction (figure 4.10). Hoxa2 and Hoxa3 are still noticeably more methylated at 
H3K27me3 than Hoxa4 at d5, and so follow the underlying expression of the 
genes rather than their position in the Hoxa cluster. The results for H3K4me3, 
however, show an increase in the mark on all Hoxa gene promoters, in a similar 
fashion to that observed for Hoxd (figure 4.10) (Soshnikova and Duboule, 2009).  
6.5.3 N-ChIP of differentiating ES cells provides a fresh perspective on the 
dynamics of bivalent histone modifications 
 
Recent studies using the method of ChIP-sequencing have also shed light on the 
distributions of histone modifications in the region of the Hoxa cluster. UCSC 
genome browser data shown in figure 6.1 shows the profiles of both bivalent 
histone modifications in both ES cells and differentiated liver cells (Rosenbloom et 
al., 2013). As reflected in the data shown in this study, a decrease in H3K27me3 
methylation occurs after differentiation at gene promoters (figure 4.10). Similarly 
to the N-ChIP data above, the H3K27me3 mark is still present after differentiation, 
although at a lower enrichment than before. However, the ChIP-seq data also 
shows that H3K4me3 enrichment is lower in terminally differentiated cells with 
respect to ES cells (Rosenbloom et al., 2013). Findings from this study clearly 
show an increase in H3K4me3 after differentiation to mirror the decrease in 
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H3K27me3 (figure 4.10). This observation indicates that the Hoxa cluster in 
developing cells goes through a number of stages of changes to its surrounding 
chromatin through the course of differentiation, as suggested by 
immunofluorescence images (figure 3.2). The likely mechanism for the changes 
to the bivalent mark would involve a rise in trimethylation at H3K4 after the loss of 
pluripotency in order to promote the transcription of the underlying Hox genes. The 
fall in H3K27me3 could also facilitate this change. The H3K4me3 mark is then 
eroded either specifically by KDM5B, or non-specifically due to loss of H3K4me3 
transmission through differentiation (Radman-Livaja et al., 2010, Lloret-Llinares et 
al., 2012). Both bivalent markers are still found at Hoxa loci after differentiation, 
although depleted, so that the epigenetic marker of developmental loci is 
maintained. This could form the basis of a heritable epigenetic signature, whilst 
still being plastic enough to respond to changing cellular environments (Turner, 
2000, Hemberger et al., 2009). These two roles of histone modifications may not 
be mutually exclusive, and could provide an answer to the question of how 
chromatin can control or assist in several aspects of the proper maintenance of 
the cell’s function as it is, and to indicate future expression profiles. 
It is probable that the loss of pluripotency has led to a specific increase in 
recruitment of MLL complexes to Hoxa through intermediate transcription factors 
that are up-regulated as a response to the fall in pluripotency factors such as Oct4 
(Lubitz et al., 2007). The increase in H3K4me3 is specific to the Hoxa cluster, as 
upstream and downstream sites are not enriched, although the increase in 
H3K4me3 seems to be similar for each gene within the cluster (figure 4.10). The 
discovery of asymmetrically bivalent nucleosomes points to a possible mechanism 
whereby two chromatin binding proteins with opposing effects on gene 
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transcription can recognise modified residues at each copy of histone H3 on the 
same nucleosome (Voigt et al., 2012). The evidence here suggests that as more 
and more nucleosomes gain H3K4me3 and lose H3K27me3, a switch occurs 
whereby the level of H3K27me3 around the gene promoter is no longer enough to 
repress transcription of Hoxa genes and expression is up-regulated (figures 4.3 
and 4.10). This can be thought of in a similar way to a transistor in a computer 
chip, which switches on only after a certain voltage threshold is reached (figure 
6.2).  
6.5.4 Boundary genes confirm bivalency as a marker of developmental loci 
 
This study has not only focused closely on the Hoxa cluster, but also on the genes 
and intergenic areas surrounding it (figure 2.3). This allows us to discern whether 
changes in histone modification patterns are specific to Hoxa genes, any gene, or 
just a large section of chromatin regardless of the underlying features. Both 
bivalent marks in d0 and d5 cells show depletion at intergenic sequences, as well 
as at the upstream Skap2 gene (figure 4.10). The Evx1 gene promoter does show 
a bivalent motif, as it is a developmentally regulated gene expressed during 
gastrulation with a role similar to that of Hox genes (Dush and Martin, 1992). Evx1 
remains enriched in H3K27me3 even at d5, reflecting the lack of gene expression 
found throughout the time course shown (figures 4.4 and 4.10). Skap2, on the 
other hand, is expressed at a fairly constant level throughout the seven days of 
differentiation thanks to its close association with the function of actin, a vital 
housekeeping protein (Shimamura et al., 2013). Interestingly, despite bordering 
the Hoxa cluster, the promoter of Skap2 shows very little H3K4me3 and 
H3K27me3 enrichment, and in fact appears to be depleted in every histone 
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Figure 6.2 Transistor model of bivalency at developmental gene promoters.
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modification tested in this study (figures 4.6, 4.7, 4.8). The high level of 
expression of Skap2 is independent of the action of any of these histone 
modifications, although as it is likely to be constitutively expressed in all cell types, 
there may be no need for this locus to have any epigenetic regulation. These 
observations provide evidence supporting the theory that bivalent signatures are 
specific to developmental loci such as Hoxa and Evx1, and do not extend to 
surrounding chromatin (Azuara et al., 2006). 
6.5.5 Dynamics of histone modifications at non-developmental loci 
 
The N-ChIP results for the housekeeping gene Gapdh and the pluripotency 
related genes Pou5f1 and Nanog also provide insight into the specific nature of 
histone modification distributions. The pluripotency genes show a decrease in 
H3K4me3 abundance from d0 to d5, reflecting the drop in gene expression 
(figures 4.4 and 4.9). This is similar to results for Hoxa1, which show an increase 
in H3K4me3 related to an increase in expression (figures 4.3 and 4.10). 
However, the pluripotency genes are not marked by a bivalent motif as confirmed 
by N-ChIP data showing depletion of H3K27me3 before and after differentiation 
(figure 4.9). Although H3K27me3 displays a higher enrichment at d5 at these loci, 
this is below the general background level of H3K27me3 present in the unbound 
ChIP sample. Gapdh, as a housekeeping gene, shows little change in enrichment 
of either H3K4me3 or H3K27me3 during differentiation (figure 4.9). 
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6.6 BIVALENCY AMONG HOX CLUSTERS IN PREVIOUS STUDIES 
6.6.1 ChIP-seq data mining in literature mouse studies 
 
Data obtained from ChIP-sequencing studies from previous studies are presented 
in chapter 5. Shown in figure 5.3 and 5.5 are graphs that demonstrate the wide 
variability between studies of differentiated embryonic mouse cells. This results 
from the difficulty in comparing studies that do not use cells from exactly the same 
stage in the differentiation process, from varying lineages or differentiated in 
diverse directions. For this reason, I have concentrated the analysis on the stage 
of development that is the most well-defined and well-studied; the d0 ES cell.  For 
this type of cell, there have been several studies that analyse H3K4me3 and 
H3K27me3, the two components of the bivalent mark. These data have also been 
compared to my own results from undifferentiated ES cells (figure 5.2 and 5.4). 
These results show a good agreement between previous results and my data for 
the Hoxa cluster, suggesting that the bivalent pattern that I have observed 
throughout the cluster is representative of the true epigenetic state of ES cells. 
This adds weight to the hypothesis that at developmental loci, the bivalent mark is 
intimately involved with the epigenetic regulation of the future initiation of Hox 
gene expression during embryonic development. This ties in with the earlier 
expression data, confirming that Hoxa1 and Hoxa4, which show particularly strong 
H3K4me3 enrichment, are also expressed more strongly once induced by 
differentiation (figures 4.3 and 5.6). These graphs show Hoxa5 as having a 
similar expression induction profile after differentiation to Hoxa4, but a different 
bivalent signature at d0, characterised in both my data and in literature data as 
having lower H3K4me3 and higher H3K27me3 than Hoxa1 and Hoxa4. This could 
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indicate that Hoxa5 has a different epigenetic control pathway to the other genes, 
or it may imply that Hoxa5 could share a regulatory pathway with Hoxa4, although 
the genomic distance between these two genes is in fact fairly substantial when 
compared to other Hoxa genes (figure 2.5).  
Once again, the specificity of the bivalent mark to Hox loci is suggested by these 
results, as other genes, even those involved with differentiation such as Shh and 
Foxd1, or those involved with maintaining pluripotency such as Nanog and 
Pou5f1, do not show the same bivalent signature as that found at all four Hox 
clusters (figures 5.6 - 5.8). These clusters show various patterns of distributions 
of the bivalent histone modifications, which could indicate a possible mechanism 
by which the epigenetic signature of the cluster affects the timing of expression 
activation in vivo. Judging by the changes in the enrichments of bivalent marks 
after initiation of differentiation, a gradual build-up of H3K4me3 as described in 
figure 6.2 could occur in Hoxb, Hoxc and Hoxd as well, although at different 
times, to direct the transcription machinery as to the appropriate time to express 
these factors. For example, although Hoxd shows, like Hoxa, the most 
transcriptionally favourable bivalent state at Hoxd1 and Hoxd3, Hoxb shows more 
favourable loci to be at the distal end of the cluster, and Hoxc shows no clear 
positional patterning. This may indicate that Hoxd is regulated in a similar way to 
Hoxa, and that Hoxb and Hoxc are not, or it could mean that proximal genes are 
switched on early in Hoxd, and later in Hoxb, for example (Zha et al., 2012). The 
timing of Hox gene expression is critical to the proper development of the embryo, 
so the epigenetic control of the on switch must be carefully controlled. An additive 
effect mechanism could be envisaged, whereby consecutive developmental 
stages are sensed by pathways involving various histone modifying enzymes and 
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H3K4me3 is added bit by bit. Once the embryo has reached the point where Hox 
expression is required, the level of H3K4me3 reaches the threshold for activation 
of expression and transcription proceeds.  
6.6.2 Genome-wide application of ChIP-seq data 
 
ChIP-sequencing is designed to analyse the entire genome of the studied cells, 
therefore it is appropriate to determine whether the genome-wide karyotype data 
presented in chapter 3 is consistent or conflicting with these studies. Figure 5.9 
shows that patterns of H3K4me3 enrichment correspond to patterns of 
fluorescence found in figures 3.11-3.17. The differences of the techniques can be 
seen clearly in these data, as ChIP-seq experiments give more fine detail on the 
peaks and troughs of H3K4me3 density than immunofluorescence can. However, 
ChIP-seq experiments require a large population of cells in order to provide 
results, whereas each individual genome karyotype can be seen as part of the 
immunofluorescence procedure. Immunostained cells are also photographed at a 
very distinct and discrete stage of the cell cycle, whereas ChIP-seq cell 
populations are at all and any parts of the cell cycle, which can vary widely in their 
histone modification profiles. This can be shown clearly in figure 6.3, which shows 
UCSC browser data for chromosomes 2,3 and 4 in the same way as figure 5.9. 
The ChIP-seq results have several spikes in H3K4me3 enrichment that obscure 
the rest of the data, making it difficult to see the overall picture of H3K4me3 
enrichment across the whole chromosome. This is not such a problem for 
immunofluorescence, with figure 3.11 showing clear patterns of H3K4me3 density 
across all three of these chromosomes. There are also regions of DNA that cannot 
currently be analysed using sequencing, as evidenced by the gaps in data in 
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Figure 6.3 UCSC browser data showing ChIP-seq results for ES cells (upper – accession
GSM307605) and embryonic fibroblasts (lower – accession GSM307608). The data bars
indicate the level of enrichment of H3K4me3 throughout A - mouse chromosome 2, B –
chromosome 3, C – chromosome 4. Chromosome ideograms and scale bar is shown
above
A
C
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figure 5.9 in chromosomes 1 and 7. This is due to long stretches of repeats in 
DNA which cannot be resolved using current sequencing techniques. Although 
both techniques have their strengths, they also both have weaknesses. 
Immunofluorescence is an excellent technique to use in order to look at single-cell 
histone modification profiles in a whole-genome at-once view, also maintaining a 
uniformity of cell-cycle phase between samples. The major drawback with this 
technique is its lack of resolution, which makes it impossible to distinguish histone 
modification patterns at the gene level. ChIP, and ChIP-seq specifically, do allow 
this resolution, and can offer valuable insights into the epigenetic profiles of cell 
populations at various stages of development. However, the construction of a 
whole-genome karyotype based on ChIP-seq data presents difficulties, as it must 
take a number of variables into consideration, such as cell to cell variation, cell 
cycle phase variation and sequencing difficulties. For these reasons, a wide-
ranging immunofluorescent approach to determine whole genome histone 
modification profiles, coupled with a ChIP-based study to investigate the 
intricacies of histone modification distributions in differentiating cells, is an 
appropriate method of determining locations and effects of histone modifications in 
ES cells. 
 
6.7 ACETYLATION THROUGH DIFFERENTIATION 
6.7.1 Widespread hyperacetylation of H3K9 at interphase in ES cells 
 
Other histone modifications assayed during this study did not show such a strong 
association with Hoxa gene transcription levels as the bivalent marks. The methyl 
marks H3K9me2 and H4K20me3 were not greatly enriched at the Hoxa cluster, 
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which is expected as they are markers of silent and heterochromatic regions of the 
genome (figure 4.7 and 4.8) (Schotta et al., 2004, Lienert et al., 2011). H3K27ac 
appears to be present at a constant level across the cluster and beyond, and does 
not show enrichment of greater than 2.5-fold anywhere (figure 4.8). H3K9ac, on 
the other hand, is enriched in asynchronous cells at most loci across the cluster 
and even within the intergenic stretch of chromatin upstream of Hoxa1 (figure 
4.7). This is also evident in immunofluorescence pictures for ES cells, which show 
widespread enrichment of H3K9ac in stem cells (figure 3.5). The enrichment of 
H3K9ac even in housekeeping genes and pluripotency related genes suggests 
that non-specific genome-wide acetylation is instigated during G1/S phase in ES 
cells (figures 4.5 and 4.7). The difference between asynchronous cells and 
colcemid-stalled cells could represent the difference between inherited H3K9ac 
and transient H3K9ac.  
6.7.2 Evidence of specific acetylation at Hoxa cluster after differentiation 
 
There does not seem to be a preferential acetylation of the highly expressed 
Hoxa1 and Hoxa4 in the asynchronous population, although this pattern does re-
emerge when looking at the data for G2/M cells (figure 4.7). At this stage, the 
acetylation of H3K9 is highest at Hoxa1 and Hoxa4, although the distinction 
between acetylation at these loci and at silent genes is less obvious than for 
H3K4me3 and H3K27me3. This may infer that histone H3 is heavily acetylated in 
ES cells, but on entering mitosis, these residues are methylated to facilitate 
chromatin compaction (Park et al., 2011). This is confirmed by data shown in 
figure 4.5, showing a general enrichment of H3K9ac during interphase, even in 
housekeeping genes such as Gapdh. However, figure 4.8 shows that H3K9me2 
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displays no changes in distribution within the Hoxa cluster through the cell cycle, 
perhaps indicating that H3K9 is methylated directly to H3K9me3. 
The lower level of acetylation present at G2/M phases may uncover the underlying 
chromatin signature that prepares the developmental loci for transcription soon 
after differentiation. This is borne out by the data presented in figure 4.11, which 
shows that acetylation of H3K9 has reduced in interphase to the same level as 
that at G2/M, and is present across the Hoxa cluster. Hoxa1 still shows the highest 
level of acetylation enrichment, although this is now only marginally higher than 
those seen for silent genes such as Hoxa2 and Hoxa10 (figure 4.11). The 
expression profiles for the Hoxa genes show that after the up-regulation of 
expression at d3, transcript levels decrease sharply after another 3 days of 
differentiation (figure 4.3). This could have implications for the transmission of 
histone modifications, as the H3K9ac mark could be specifically enriched at loci 
including Hoxa1 before the onset of transcription. Figures 4.10 and 4.11 suggest 
that H3K9ac is then no longer preferentially deposited at Hoxa1 after 
differentiation, whereas H3K4me3 is maintained and even increased to provide a 
heritable marker of the chromatin. This mechanism shows the distinction between 
transient H3K9ac sites that facilitate a loosening of chromatin with those laying 
down an epigenetic signature.  
6.8 HOXA EPIGENETIC SIGNATURES IN THE CONTEXT OF 
CHROMOSOME 6 
 
The Hoxa cluster is of particular interest as it comprises a broad area of related 
developmental loci to enable the examination of distributions of histone 
modifications in this environment (Larson and Yuan, 2010). The chromosomal 
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data displayed in figure 3.13 show that the region between 50 and 60 megabases 
from the centromere on chromosome 6 (containing Hoxa) is more heavily 
methylated at both H3K4me3 and H3K27me3 than for any other 10Mb block from 
0 to 50 megabases. This gives an indication that bivalent modifications are 
targeted towards this region of the genome. Using N-ChIP to look more closely at 
the region has allowed us to determine the precise relationship between these two 
marks at Hoxa promoters and surrounding chromatin. This more focused 
viewpoint has allowed the observation that these marks are targeted specifically at 
Hoxa promoters and are not enriched at intergenic loci, or at non-developmental 
loci nearby (figure 4.10). The combination of these two techniques can on the one 
hand show us a picture of the entire epigenome at once, laying bare all the areas 
of increased methylation or acetylation of a residue. The patterns discovered here 
can be explored further with the use of chromatin immunoprecipitation to produce 
a detailed and specific view of a region of interest highlighted by the wider scan 
derived from immunofluorescence data. The use of Hoxa in this instance gives us 
a clear perspective on the dynamics of these histone modifications through 
differentiation at a locus that is known to be epigenetically switched on at some 
point during development (Soshnikova and Duboule, 2009). It is shown here that 
the behaviour of bivalent modifications may signify and predict future transcription 
levels (figures 4.3 and 4.10). The presence of both at equilibrium prevents 
transcription but indicates future expression due to its poised nature (Bernstein et 
al., 2006). The subsequent reduction in H3K27me3 informs us of the loss of 
repression and the switching on of several Hoxa loci. 
 
227 
 
6.9 CONTROL OF DIFFERENTIATION BY THE BIVALENT MARK 
6.9.1 The epigenetic code – Implications for the bivalent mark 
 
These results also have significance for the examination of the histone code 
hypothesis (Strahl and Allis, 2000, Turner, 2000). This states that the 
modifications present on chromatin can inform the transcription machinery if, or 
maybe even when, underlying genes will be expressed. The results shown in 
figure 4.10 suggest that the bivalent mark has a key role in this, by predicting the 
order of expression of the Hoxa cluster. Hoxa1 shows a low enrichment of 
H3K27me3 at d0, and this gets even lower at d5 to become depleted below 
background H3K27me3 levels (figure 4.10). Hoxa1 is also the first gene to 
become expressed and has the highest relative level of expression of all Hoxa 
genes (figure 4.3). Hoxa4 has the second lowest level of H3K27me3 at d0, and 
the second highest H3K4me3 enrichment behind Hoxa1. This gene is also highly 
expressed after differentiation. Hoxa5 has a higher than average level of 
H3K4me3 and lower than average H3K27me3, and is also expressed at d5 
(figures 4.3 and 4.10). These three Hoxa genes are more highly expressed than 
the other Hoxa genes, and looking at the bivalent landscape at d0, one could infer 
a model to predict the expression of other genes through differentiation. Certainly 
the lack of H3K4me3 at Hoxa2, 3 and Hoxa6-11 would suggest that they are not 
likely to be expressed, or are not yet poised for expression. Therefore, these 
genes display a low level of transcription relative to Hoxa1 (figure 4.3). The 
changes in H3K9ac at G2/M after differentiation reflect the data for H3K4me3 in 
that there is a general increase in acetylation across the entire Hoxa gene cluster 
(figure 4.11). Looking at the changes in heritable H3K9ac at G2/M from d0 to d5, 
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the pattern of acetylation follows the pattern of H3K4me3 methylation in that 
Hoxa1 and Hoxa4 show the highest levels of acetylation. The link between 
H3K9ac and transcription is not as clear as that for H3K4me3, however, as there 
are several Hoxa genes including Hoxa10 that show high levels of H3K9ac but not 
much expression (figures 4.3 and 4.11). It may be that general Hoxa acetylation 
facilitates the methylation of H3K4me3 in order to drive a switch in gene 
expression, in accordance with other studies (Ha et al., 2011). 
6.9.2 A transcriptional switch for developmental loci 
 
The theory of the bivalent mark being acutely involved in marking developmental 
loci is given added weight by these findings (Bernstein et al., 2006). However, the 
results shown here have added an extra dimension to the argument behind the 
theory. It has been suggested that the bivalent mark denotes a ‘poised’ state 
whereby upon differentiation one half of the bivalent mark is lost and the gene is 
switched on (Bernstein et al., 2006). However, close examination of the N-ChIP 
results shows that bivalent histone modifications could denote several different 
states of chromatin in different circumstances. 
The Hoxa cluster is a developmental locus, and would be expected to be marked 
with bivalency in ES cells (Kashyap et al., 2011). Indeed, for many of the Hox 
genes that is the case (figure 4.6). However, even within the relatively small 
genomic region of the Hoxa cluster, there are several different bivalent signatures 
present. Hoxa1 shows a clear dominance of H3K4me3 over H3K27me3, which 
reveals its nature as being rapidly activated when responding to differentiation. 
Hoxa2, on the other hand, displays a reversal of these marks, its low abundance 
of H3K4me3 indicating that it is not poised for activation, although the increase in 
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the activating mark shown after 5 days of differentiation indicates that expression 
of Hoxa2 is likely to occur at some point soon after the 7 days assayed here 
(figures 4.3 and 4.10). Hoxa7, on the other hand, shows a low level of H3K4me3 
even after differentiation and strong (although reduced) enrichment of H3K27me3 
at d5. This gene, according to the theory presented here, would be the last to be 
expressed. It may be the case that the bivalent mark signifies an analogue rather 
than a binary system, whereby the respective levels of the two marks can denote 
the timings where the underlying genes are activated. An assay of the bivalent 
mark at a given point in the process of differentiation could determine whether a 
gene is ‘poised’ or about to be expressed (Hoxa1 at d0), is currently being 
expressed (Hoxa1 at d5), is unlikely to be expressed soon (Hoxa7 at d0 or d5), or 
is not developmentally regulated (Skap2 at d0 and d5) (figures 4.3, 4.4 and 4.10). 
Since the levels of H3K4me3 and H3K27me3 are dependent on a number of 
factors and a number of other histone modifications, the control of differentiation 
likely rests in the hands of crosstalk between chromatin modifications, 
transcription factors and chromatin binding proteins, like other cellular processes 
(Van Attikum and Gasser, 2009, Zippo et al., 2009). This can provide the 
responsiveness, specificity and plasticity needed to direct the progress of 
differentiation in a proper and carefully regulated manner. 
 
6.10 CONCLUSIONS 
 
The research into the locations and functions of histone modifications have in 
recent years grown into a vast wealth of data that indicate an ever more complex 
and elegant system for controlling many aspects of cellular regulation. These 
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results have given insight into where marks are heritable throughout the cell cycle, 
and throughout many cell cycles in the process of differentiation in mice. Heritable 
histone marks have been shown to persist through metaphase by chromosome 
immunofluorescence and through G2/M by N-ChIP. Both methyl and acetyl 
modifications can be persistent, again shown in both immunofluorescence and 
ChIP experiments, although plasticity of histone modifications has been shown for 
other marks. H4K20me3 shows remarkable changes in its genomic distribution, 
being distributed throughout the chromosome arms in ES cells, but confined in 
differentiated cells to heterochromatic centromeres. More subtle changes were 
also seen in the H3K4me3 and H3K9me3 marks on chromosomes through 
differentiation, indicating some involvement in the differentiation process. The link 
between bivalent modifications and differentiation led to the definition of a mouse 
epigenomic karyotype being produced for both H3K4me3 and H3K27me3. This 
represents the sum total of the genomic organisation of these marks at 
metaphase, and can be aligned with genetic sequence data to produce an 
epigenetic map of these two marks and to discover the connections and 
relationships between histone modifications and their underlying DNA. The 
H3K4me3 karyotype data shows a close association between H3K4me3 and 
gene-rich regions, and could predict highly expressed regions of the genome. The 
H3K4me3 data correlated well with previous ChIP-seq studies in mice. H3K27me3 
has been shown to loosely follow the same distributions as H3K4me3, although 
chromosome immunofluorescence has suggested that trimethyl H3K27 is a more 
widespread feature across the genome than H3K4me3.  
Dynamic changes in histone modifications were also seen at more specific gene 
loci in results for N-ChIP, revealing a deeply nuanced relationship between 
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H3K4me3 and H3K27me3, the two bivalent marks. Data obtained here for the 
Hoxa cluster in d0 cells are mainly consistent with previous ChIP-seq studies. The 
state of the bivalent motif appears to be predictive of the expression of Hoxa 
genes during the differentiation process, and may form the basis for epigenetic 
control of differentiation. The trend throughout the differentiation process at Hoxa 
is the demethylation of H3K27me3 and methylation of H3K4me3 at all Hoxa 
promoters. The extent to which these processes occur is determined by how 
poised the genes are towards expression. The first genes to switch on are more 
heavily methylated at H3K4, and less methylated at H3K27me3. The genes 
retaining a relatively high level of H3K27me3 and a relatively low level of 
H3K4me3 after differentiation show no signs of being expressed. This relationship 
between H3K4me3 and H3K27me3 is deeply involved in the active or repressed 
status of chromatin, and this feature will be a major player in the elucidation of the 
histone code. Further investigation is required into how important a role in the 
determination of expression status the bivalent marker has. I have postulated the 
basis of a predictive model based on the status of the bivalent mark at two points 
during the differentiation process. If differentiation were continued for a more 
sustained period of time, it could be determined whether those predictions ring 
true, or whether other modifications and factors are influencing the switching on of 
developmental genes during differentiation. Investigation of other developmentally 
regulated genes, and not just Hox genes, would also confirm if this bivalent 
transistor switch is widely applicable to developmental loci. Extending the 
comparison with ChIP-seq data by determining the expression changes for Hoxb, 
Hoxc and Hoxd would also provide valuable comparison data for these other Hox 
gene clusters. 
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Appendix figure 1 Alignment of A. H3K4me3 FITC emittance data from
chromosome 1 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 2 Alignment of A. H3K4me3 FITC emittance data from
chromosome 2 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 3 Alignment of A. H3K4me3 FITC emittance data from
chromosome 3 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 4 Alignment of A. H3K4me3 FITC emittance data from
chromosome 4 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 5 Alignment of A. H3K4me3 FITC emittance data from
chromosome 5 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 6 Alignment of A. H3K4me3 FITC emittance data from
chromosome 6 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 7 Alignment of A. H3K4me3 FITC emittance data from chromosome
7 identified by FISH (shown above) with genomic features. Shown here are the NCBI
data for B. genes, C. CpG islands and D. repeats in 10 megabase windows. Error bars
denote standard deviation between replicates
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Appendix figure 8 Alignment of A. H3K4me3 FITC emittance data from
chromosome 8 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10 megabase
windows. Error bars denote standard deviation between replicates
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Appendix figure 9 Alignment of A. H3K4me3 FITC emittance data from
chromosome 9 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 10 Alignment of A. H3K4me3 FITC emittance data from
chromosome 10 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 11 Alignment of A. H3K4me3 FITC emittance data from
chromosome 11 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 12 Alignment of A. H3K4me3 FITC emittance data from
chromosome 12 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 13 Alignment of A. H3K4me3 FITC emittance data from
chromosome 13 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 14 Alignment of A. H3K4me3 FITC emittance data from
chromosome 14 identified by FISH (shown above) with genomic features. Shown
here are the NCBI data for B. genes, C. CpG islands and D. repeats in 10
megabase windows. Error bars denote standard deviation between replicates
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Appendix figure 15 Alignment of A. H3K4me3 FITC emittance data from
chromosome 15 identified by FISH (shown above) with genomic
features. Shown here are the NCBI data for B. genes, C. CpG islands and
D. repeats in 10 megabase windows. Error bars denote standard
deviation between replicates
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Appendix figure 16 Alignment of A. H3K4me3 FITC emittance data
from chromosome 16 identified by FISH (shown above) with genomic
features. Shown here are the NCBI data for B. genes, C. CpG islands
and D. repeats in 10 megabase windows. Error bars denote standard
deviation between replicates
279 
 
0
20
40
60
80
100
F
IT
C
 e
m
it
ta
n
c
e
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Distance from centromere (Mb)
Distribution of H3K4me3 on chromosome 17 of OS25 
cells d0
0
50
100
150
200
250
300
350
400
450
N
u
m
b
e
r 
o
f 
g
e
n
e
s
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
200
400
600
800
1000
1200
1400
N
u
m
b
e
r 
o
f 
C
p
G
 i
s
la
n
d
s
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
10000
12000
14000
16000
18000
20000
22000
N
u
m
b
e
r 
o
f 
re
p
e
a
ts
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
A
B
C
D
Appendix figure 17 Alignment of A. H3K4me3 FITC emittance data from
chromosome 17 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats
in 10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 18 Alignment of A. H3K4me3 FITC emittance data
from chromosome 18 identified by FISH (shown above) with genomic
features. Shown here are the NCBI data for B. genes, C. CpG islands and
D. repeats in 10 megabase windows. Error bars denote standard
deviation between replicates
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Appendix figure 19 Alignment of A. H3K4me3 FITC emittance data from
chromosome 19 identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats in
10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 20 Alignment of A. H3K4me3 FITC emittance data from
chromosome X identified by FISH (shown above) with genomic features.
Shown here are the NCBI data for B. genes, C. CpG islands and D. repeats
in 10 megabase windows. Error bars denote standard deviation between
replicates
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Appendix figure 21 Alignment of A. H3K4me3 FITC emittance
data from chromosome Y identified by FISH (shown above) with
genomic features. Shown here are the NCBI data for B. genes, C.
CpG islands and D. repeats in 10 megabase windows. Error bars
denote standard deviation between replicates
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